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Abstract 
 
Enterococcus faecalis is a firmicute of the human gastrointestinal tract 
(GIT) core-microbiome. This commensal bacterium is one of the first to 
colonize the GIT of humans after birth and remains associated with the 
adult human gut microbiota at sub-dominant levels. Although harmless, 
certain strains can become pathogenic in immune-compromised and 
elderly patients causing urinary tract infections, bacteremia and infective 
endocarditis. This bacterial species has been recognized as an 
opportunistic pathogen for several decades, and now ranks as a major 
cause of hospital-acquired infections worldwide. Some E. faecalis isolates 
are particularly adapted to the hospital environment, and this adaptation 
was recently linked with enrichment in mobile genetic elements, including 
plasmids and temperate bacteriophages.  
Lysogeny is frequently considered as an adaptive evolutionary 
process in which a temperate bacteriophage is maintained in the 
prophage state, as it confers additional properties to the bacterial strains. 
Temperate phages can contribute to bacterial fitness or virulence in at 
least three ways: lysogenic conversion, gene disruption and lysis-
mediated competitiveness.  
E. faecalis phages studies are mostly dedicated to the applications of 
lytic phages and, in spite of the temperate bacteriophage status as key 
players in the evolution of pathogenic strains, studies on E. faecalis 
prophages are scarce. Therefore, using the polylysogenic E. faecalis 
strain V583 as a model, two main goals were established for this thesis: to 
study the ability of V583 prophages to engage on a lytic cycle and 
produce active phage particles; and to determine their impact on E. 
faecalis pathogenicity. 
To accomplish the first goal we have established which of the seven 
V583 prophages (pp1 to pp7) were able to excise from the bacterial 
 
chromosome in the wild-type strain. We next constructed a set of isogenic 
strains lacking one to all of the six excisable prophages. Polylysogenic 
and monolysogenic strains were characterized regarding prophage activity 
at four levels: excision from bacterial chromosome, replication, DNA 
encapsidation and virion infectivity. From the six active prophages only 
pp1, pp3, pp5 and pp7 produce active phage particles. Intricate 
interactions were unraveled between V583 prophages: i) pp1 inhibits 
excision of pp4 at 37°C, ii) pp3 and pp5 inhibit excision of pp6, and iii) pp7 
was identified as the first enterococcal phage-related chromosomal island 
(PRCI) and was named EfCIV583 for Enterococcus faecalis chromosomal 
island of V583. This PRCI is involved in a molecular piracy phenomenon 
that culminates with the hijacking of P1 structural proteins. The E. faecalis 
EfCIV583/P1 system resembles that of Staphylococcus aureus SaPIs. 
Though PRCIs are suspected to be widespread in Gram-positive bacteria, 
such molecular piracy phenomenon has never been reported or 
demonstrated in gram-positive species other than S. aureus. Moreover, 
we determined that certain environmental cues, such as antibiotics, 
increase prophage induction as well as virion production and would thus 
contribute to horizontal gene spreading, especially in the hospital setting.  
In order to investigate prophage contribution to bacterial pathogenic 
traits, the wild-type (polylysogenic) and the phage-deleted strains were 
compared under various conditions such as, sensitivity to chemical 
compounds, including antibiotics, biocides and oxidative stress inducing 
compounds, biofilm formation and adhesion to human platelets. While 
prophages were not shown to impact on bacterial resistance to chemical 
compounds or on biofilm-forming abilities, they did contribute to bacterial 
adhesion to human platelets. Opportunistic pathogens, including E. 
faecalis, can occasionally gain entry into the human circulatory system, 
induce a transient bacteremia and develop an infected thrombus on the 
surface of the heart valve. Adhesion to platelets is thought to be a key 
 
 
step towards this infective endocarditis. E. faecalis is known to bind and 
aggregate human platelets but the underlying molecular mechanisms 
have yet to be discovered. Interestingly, pp1, pp4 and pp6, involved in 
platelet binding, encode predicted phage tail proteins homologous to the 
platelet binding proteins PblA and/or PblB of Streptococcus mitis phage 
SM1. This suggests that these proteins are likely to mediate E. faecalis 
binding to platelets. This work provides for the first time a direct correlation 
between prophages and bacterial adhesion to human platelets, 
suggesting a role of E. faecalis prophages in the development of 
nosocomial infective endocarditis. 
 
This thesis reports the first thorough genetic study of E. faecalis 
prophages in a polylysogenic strain. It sheds light on complex prophage 
interactions including molecular piracy by a phage-related chromosomal 
island, which resembles the SaPIs of Staphylococcus aureus. It also 
unravelled a direct correlation between prophages and E. faecalis 
adhesion to human platelets. The data generated by this thesis work 
constitute solid foundations for future research on both functional and 
ecological impact of E. faecalis temperate phages. 
 
 
 
 
Resumo 
 
Enterococcus faecalis é uma das espécies bacterianas constituintes 
da microbiota natural do trato gastrointestinal humano. Esta espécie 
bacteriana comensal coloniza o trato gastrointestinal logo após o 
nascimento e permanece associada à microbiota do indivíduo adulto, em 
níveis subdominantes. Apesar de inofensiva para pessoas saudáveis, 
pode tornar-se patogénica em pacientes imunocomprometidos e idosos, 
causando infeções urinárias, bacterémias e endocardites. Esta espécie 
bacteriana é reconhecida como patogénica oportunista sendo uma das 
mais frequentes causas de infeções nosocomiais no mundo. Algumas 
estirpes de E. faecalis estão particularmente bem adaptadas ao ambiente 
hospitalar, tendo sido recentemente reconhecido que esta adaptação está 
associada a um enriquecimento dos seus genomas em elementos 
genéticos móveis, nomeadamente plasmídeos e bacteriófagos 
temperados. 
A lisogenia é considerado um processo evolutivo no qual um 
bacteriófago temperado permanece no cromossoma bacteriano como 
profago, conferindo propriedades adicionais ao hospedeiro bacteriano. A 
existência de bacteriófagos temperados no genoma bacteriano pode 
contribuir de diferentes formas para a adaptabilidade da bactéria ao meio 
e/ou virulência, nomeadamente pela conversão lisogénica, interrupção de 
genes e aumento da competitividade devido à lise bacteriana. 
Apesar do seu carácter importante na evolução de estirpes 
patogénicas, estudos de bacteriófagos temperados em E. faecalis são 
praticamente inexistentes. De modo a colmatar a falta de conhecimento 
deste tipo de bacteriófagos em E. faecalis, foi escolhida como modelo 
neste estudo a estirpe E. faecalis V583 e foram estabelecidos dois 
grandes objectivos para esta tese: estudar a capacidade dos 
bacteriófagos da estirpe V583 de efetuarem um ciclo lítico e produzirem 
 
partículas fágicas funcionais; e determinar o contributo destes 
bacteriófagos na  patogénese de E. faecalis. 
Para atingir o primeiro objectivo começou por se determinar quais 
dos 7 profagos (pp1-pp7) de V583 são capazes de se excisar do 
cromossoma bacteriano na estirpe selvagem. Seguidamente foi 
construído um conjunto de estirpes isogénicas, que variando na sua 
composição em genomas fágicos, permitiram caracterizar a atividade dos 
profagos a quatro níveis: excisão do cromossoma bacteriano, replicação, 
encapsidação do DNA e infetividade das partículas fágicas. Dos 6 
profagos ativos, só pp1, pp3, pp5 e pp7 são capazes de produzir 
partículas fágicas funcionais. Foram ainda identificadas interações 
complexas entre os profagos de V583: i) pp1 inibe a excisão de pp4 a 
37°C, ii) pp3 e pp5 inibem a excisão de pp6, e iii) pp7 foi identificado 
como a primeira ‘phage-related chromosomal island’ (PRCI) em 
enterococos e foi renomeada EfCIV583 para ‘Enterococcus faecalis 
chromosomal island of V583’.  
Esta PRCI está envolvida num mecanismo de “pirataria” molecular 
que culmina no sequestro das proteínas estruturais do fago P1. O sistema 
EfCIV583/P1 de E. faecalis é semelhante ao sistema das SaPIs de 
Staphylococcus aureus. As PRCIs são conhecidas sobretudo em S. 
aureus, e embora exista a noção de que estarão disseminadas entre as 
bactérias Gram positivas, não existem evidências experimentais da sua 
existência noutras espécies bacterianas. O presente estudo revelou 
também que determinadas condições ambientais, tais como a presença 
de antibióticos, aumentam a indução dos profagos e consequentemente a 
produção de partículas fágicas, podendo deste modo contribuir para a 
disseminação de genes por transferência horizontal, particularmente em 
ambiente hospitalar. 
De modo a avaliar a contribuição dos profagos de E. faecalis para o 
seu poder patogénico, uma estirpe selvagem (WT) e um conjunto de 
 
 
estirpes com diferentes composições em genomas fágicos foram 
comparadas, em diferentes condições: sensibilidade a compostos 
químicos, como antibióticos, biocidas e compostos que induzem o stress 
oxidativo, formação de biofilmes e adesão às plaquetas humanas. Não foi 
evidenciada qualquer associação entre a presença de profagos e a 
resistência aos compostos químicos testados ou a formação de biofilmes. 
No entanto os profagos pp1, pp4 e pp6 contribuem para a adesão dos 
enterococos às plaquetas humanas. Devido ao seu carácter oportunista, 
E. faecalis acede à corrente sanguínea, onde pode induzir uma 
bacterémia e consequentemente originar um trombo na superfície de uma 
válvula cardíaca. A adesão de bactérias às plaquetas humanas é 
considerada uma etapa importante no desenvolvimento de endocardite. 
Apesar dos enterococos poderem aderir, assim como agregar plaquetas, 
os mecanismos moleculares envolvidos nestes processos ainda não 
foram descobertos. Os profagos envolvidos na adesão de E. faecalis 
V583 às plaquetas humanas (pp1, pp4 e pp6), contêm nos seus genomas 
proteínas estruturais homólogas às proteínas do fago SM1 de 
Streptococcus mitis PblA e/ou PblB, envolvidas na adesão destas 
bactérias às plaquetas humanas. Isto sugere que as proteínas de E. 
faecalis possam ter uma função semelhante. Este trabalho evidencia pela 
primeira vez uma correlação direta entre profagos e a adesão de E. 
faecalis às plaquetas humanas, indicando uma contribuição dos profagos 
para o desenvolvimento de endocardites em meio hospitalar. 
 
A tese aqui apresentada constitui o primeiro estudo genético 
sistemático dos profagos de uma estirpe poli-lisogénica de E. faecalis, um 
pré-requisito que estabeleceu a atividade dos profagos e gerou dados 
sólidos que facilitarão os estudos futuros em bacteriófagos temperados 
de enterococos. Adicionalmente, este trabalho revelou interações 
complexas entre os profagos de E. faecalis, entre as quais um fenómeno 
 
de “pirataria” molecular envolvendo EfCIV583 e o fago P1, semelhante à 
SaPI de Staphylococcus aureus. Por último evidenciou também uma 
relação direta entre determinados profagos e a adesão de E. faecalis às 
plaquetas humanas. 
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3 
Thesis outline 
 
Polylysogeny is frequently considered as the result of an adaptive 
evolutionary process in which temperate bacteriophages shape bacterial 
genomes by the acquisition of new genes, thus making them important for 
evolution of both bacterial populations and infectious agents. Although 
considered a harmless commensal of the gastrointestinal tract of humans, 
Enterococcus faecalis ranks among the leading causes of hospital 
acquired bacterial infections. It is therefore recognized as an opportunistic 
pathogen. Though important in other bacterial species and well studied 
regarding their impact on bacterial evolution, fitness, and pathogenicity, 
bacteriophages have been scarcely studied in E. faecalis. Recent data on 
the impact of temperate bacteriophages for the diversity of E. faecalis 
genomes and the potential use of phages against antibiotic resistant 
strains have renewed the interest on E. faecalis bacteriophages. Thus, the 
poor knowledge on E. faecalis temperate bacteriophages motivated the 
work of this thesis.  
Chapter 1 gathers updated knowledge on the three key players of this 
thesis: E. faecalis, bacteriophages and phage-associated genetic 
elements. The dual lifestyle of E. faecalis is discussed in correlation with 
its rise as major cause of nosocomial infections. Bacteriophage biology 
and general characteristic are reviewed and their relevance for community 
species composition in complex microbial ecosystems is emphasized. 
Finally, the molecular piracy mechanisms used by phage-associated 
genetic elements to hijack phage structural proteins are described in 
detail: starting from the best studied case, satellite phage P4 of 
Escherichia coli, for which most of the molecular interplay is known, to a 
more recent described family of phage-related chromosomal islands 
(PRCIs), from which the best studied are the Staphylococcus aureus 
pathogenicity islands (SaPIs).  
4 
Chapter 2 is focused on the study of E. faecalis V583 prophages 
activity. We report the conditions that induce prophages into the lytic cycle 
together with a sophisticated interplay between prophages that dictates 
the functionality of some of them. Furthermore we identify the first 
enterococcal phage-related chromosomal island and its helper phage.  
Chapter 3 reports a series of experiments performed in order to 
identify conditions in which prophages contribute to E. faecalis biological 
traits. By establishing the importance of prophages carrying platelet-like 
binding proteins for E. faecalis adhesion to human platelets we provided a 
link between enterococcal bacteriophages and pathogenesis. 
The general discussion of Chapter 4 summarizes the main 
achievements and future directions of the work developed during this 
thesis in regards with the current knowledge on prophage-prophage 
interactions and their contribution to host biological traits. The importance 
of E. faecalis prophages in natural ecosystems such as human associated 
microbial communities is brought up.  
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6 
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General Introduction 
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I. ENTEROCOCCUS 
 
1. General description of the genus 
Enterococci are robust Gram-positive, catalase-negative, facultative 
anaerobic bacteria. They are ovoid in shape and grow in short chains, 
pairs or single cells and belong to the phylum Firmicutes, class Bacilli and 
family Enterococcaceae. Initially classified as group D streptococci, 
enterococci were proven to be different from the streptococci on the basis 
of DNA hybridization experiments [1]. Sequentially, Enterococcus was 
given formal genus status in 1984 [1]. Enterococci have the capacity to 
grow between 10°C and 45°C, in 6.5% NaCl and at pH 9.6, to survive 
upon heating at 60°C for 30 min, and to hydrolyze esculin into esculitin [2]. 
They produce lactic acid from glucose through the homofermentative 
pathway, and thereby belong to the group of lactic acid bacteria (LAB). 
Given their intrinsic robustness, they are ubiquitous in several ecological 
niches: they colonize the gastrointestinal and genito-urinary tracts and the 
oral cavity of humans and animals; they are also found in soil, sand, 
water, food products and plants and their detection in water is considered 
as an indicator of faecal contamination [3-6]. Contrary to other LAB, 
enterococci are not considered “Generally Recognized As Safe” (GRAS) 
[7], nevertheless, they have been used in food processing due to their 
proteolytic and esterolytic activities, which contribute to the ripening and 
aroma development of traditional cheeses such as Cheddar, Feta and 
Mozzarella [8]. They are also considered as potential probiotics for human 
and animals, to treat or prevent diarrhea and irritable bowel syndrome, 
and for health improvement such as reducing cholesterol in the plasma or 
immune regulation [9-11]. Indeed, E. faecalis Symbioflor 1 is used for 
immune regulation to combat recurrent chronic sinusitis or bronchitis 
[12,13]. However, despite their potential beneficial roles, their ability to 
produce biogenic amines in cheese and fermented sausages as well as 
Chapter 1 
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their propensity for genetic exchange constitute negative aspects for their 
utilization as probiotics [14,15].  
Nowadays, the genus Enterococcus is composed of 44 species [16] 
from which Enterococcus faecalis is currently the most studied due to its 
prominence in nosocomial infections. However, the interest on 
Enterococcus faecium has risen since it became also an important cause 
of nosocomial infections over the years [17]. Of the two species, E. 
faecalis harbors the greater innate capacity to cause disease whereas E. 
faecium relies mostly on its multiple antibiotic resistances to drugs of last 
resort to become infectious [18]. As an example of their propensity to 
acquire antibiotic resistance, from 1993 to 2002, E. faecium isolates 
resistant to vancomycin raised from 28.9% to 72.4% [19]. 
Genetic diversity of E. faecalis has been reported using various 
molecular typing methods, comparative genome hybridization (CGH) or 
analysis of full genome sequences. The most informative molecular typing 
method for enterococci epidemiology is the multi locus sequence typing 
(MLST). This method is based on nucleotide sequences of seven 
housekeeping genes and allows to compare genetic relatedness between 
strains. It generates an allelic profile that is compared to those within a 
database to identify the sequence type (ST) or define a new one, if the 
allelic profile is new. The use of MLST to study E. faecalis population 
unraveled a non-clonal structure for which recombination plays an 
important role driving genetic variation of this species [20]. At present, a 
total of 517 STs exist in the database (http://efaecalis.mlst.net). The 
diversity is so remarkable among E. faecalis isolates that the MLST 
analysis of 110 strains of different sources and geographical locations 
were resolved into 55 STs [20]. A similar study, with 386 strains generated 
105 STs [21]. MLST analyses group the majority of multi-drug resistant 
isolates of E. faecalis into seven major clonal complexes: CC2, CC9, 
CC16, CC21, CC30, CC40 and CC87, designated as High-Risk 
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Enterococcal Clonal Complexes (HiRECC), of which CC2 and CC87 
include almost exclusively hospital isolates [20-23]. CGH studies of E. 
faecalis isolates revealed considerable differences in the genomic content, 
as already suspected by MLST-generated data. This diversity was mostly 
related to the presence and absence of genetic mobile elements such as 
phages and conjugative transposable elements [24-27]. The first complete 
genome sequence of E. faecalis was released in 2003 and belongs to 
strain V583 [28]. This isolate is a member of the HiRECC-2, and was the 
first vancomycin resistant clinical isolate reported in the United States [28]. 
Since then, the analysis of sixteen E. faecalis genomes, recovered from 
strains isolated over a period of 80 years, confirmed the association of the 
genomic content differences among E. faecalis strains with the presence 
or absence of genetic mobile elements [29,30]. Interestingly, genome size 
was inversely correlated with the presence of a CRISPR/Cas functional 
system, defined as a bacterial system directed against invading DNA (see 
below on section II.1.2.3). Actually, strains with greater average genome 
size lacked CRISPR/Cas, like V583. Palmer and collaborators suggest a 
model in which increased genome size is the result of mobile element 
accretion due to compromised genome defenses [30,31]. They also 
correlated the loss of a functional CRISPR/Cas system in the modern E. 
faecalis hospital-adapted lineages with the influx of acquired antibiotic 
resistance genes [29-31]. A large variety of conjugative plasmids, 
transposons and integrative and conjugative elements (ICE) have been 
involved in genetic transfer of resistance and virulence determinants, thus 
contributing to the success of E. faecalis as a nosocomial pathogen [32-
34]. Even if CC2 isolates are enriched in mobile genetic elements and 
surface protein encoding genes [35], the E. faecalis opportunism factors 
characterized so far are widespread among isolates independently of their 
origin, and none is essential for enterococcal infections [36-38].  
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In all, the high genetic diversity contributes to the difficulty to predict E. 
faecalis pathogenic potential from the gene content.  
 
2. E. faecalis: commensal & opportunistic pathogen 
E. faecalis is a commensal bacterium of the gastrointestinal tract (GIT) 
of humans and other animals as well as insects [39,40]. It colonizes the 
GIT of humans just after birth and remains associated with the adult 
human gut microbiota as part of the sub-dominant species [41]. Despite its 
status as primary colonizing bacteria in the human gut and although 
harmless in healthy individuals, it has emerged, for the last 30 years, as 
an important cause of nosocomial infections. It is responsible for 70% of 
enterococcal-induced infections in hospital setting [42]. This opportunistic 
pathogen causes wound-, bloodstream- and urinary tract infections and 
endocarditis, mainly in hospitalized patients [4,43,44].  
The mechanisms by which inoffensive commensal E. faecalis may 
become major hospital-acquired pathogens are still not understood but 
this seems to be a multiparametric phenomenon. Both host and bacterial 
factors are implicated: equilibrium of the intestinal microbiota and immune 
system on the host side, as well as bacterial opportunistic traits [45]. A key 
step in this process concerns E. faecalis entry into the bloodstream, which 
can be achieved through two pathways. The first one involves direct entry 
by rupture of physical barriers. The second is related to the colonization of 
the GIT associated with an imbalance of the microbiota. In this case the 
bacteria need to cross the epithelial barrier to reach the bloodstream and 
the lymphatic system [46]. Bacterial opportunistic traits are defined as 
genetic elements that increase the capacity of a microorganism to induce 
disease [45]. Three main features contribute to the success of E. faecalis 
in hospital environments and to its emergence and prevalence as a 
nosocomial pathogen: i) its inherent capacity to withstand environmental 
stresses; ii) a wide range of opportunism factors [47]; and, iii) the 
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accumulation of different antimicrobial resistance mechanisms, both 
innate and acquired [48,49].  
E. faecalis is a very robust bacterium with an outstanding ability to 
cope with relatively high concentrations of host-produced inhibitory 
compounds and nutrient limitations as well as antibiotics used for therapy 
[50-52]. In addition, it owns a plethora of opportunism factors, effectors 
and regulators, that allows it to thrive in the hospital setting and participate 
in the four main stages of the infectious process (Table 1): persistence on 
abiotic surfaces, entry into the bloodstream, colonization of infection site 
and tissue damage [53-55]. The best way to survive in hospital 
environment is through biofilm growth, which protects bacteria against the 
action of antibiotics and biocides [56]. Indeed, E. faecalis counts on 
several proteins that contribute to biofilm formation such as Esp [57], Ebp 
[58], Bee [59] and StrA [60,61]. To enter the bloodstream and further 
colonize the host, E. faecalis uses factors such as adhesins, like 
aggregation substance (AS) [62], enterococcal surface protein (Ebp) [63] 
and Ace [64] that promote adherence to host tissues. Moreover, factors 
that possess immune evasion properties are essential to cell survival and 
persistence, such as the exopolysaccharides (Epa and Cps) [65,66] or 
GelE [67]. The final stage is the clinical manifestation of infection that 
leads to cell and tissue damage (like heart valves) from the activity of 
proteins that include cytolysin, gelatinase and serine protease [68-70].  
Antibiotics interrupt cellular functions through different modes of 
action: attack of the cell wall and cell membrane integrity or interference 
with DNA and protein synthesis. E. faecalis exhibits a broad range of 
intrinsic tolerance to low concentrations of several classes of antibiotics 
including aminoglycosides, β-lactams and quinolones [5,71,72]. In 
addition, single or multiple antibiotic resistance may arise by point 
mutations in the drug binding site, like for quinolones [73] and ampicillin, 
or by acquisition of resistance genes, as observed for the β-lactams [74], 
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aminoglycosides, macrolides, chloramphenicol, tetracycline and 
glycopeptides, of which vancomycin resistance is the most clinically 
relevant [5,71-73,75] (Figure 1).  
 
Table 1. E. faecalis opportunism factors [49,53]. 
Gene or locus Virulence factor Putative role References 
Cell surface 
determinants  
   
AS proteins Aggregation substance Adhesion, tissue 
colonization, 
endocarditis 
[62,76,77] 
Esp Surface protein Biofilm formation [57] 
Ace Adhesion to collagen Adhesion to ECM, 
endocarditis 
[64,78] 
Bee Biofilm enhancer Biofilm formation [59] 
Ebp Endocarditis and biofilm 
associated pili 
Biofilm formation and 
adhesion to human 
platelets 
[58,79] 
ElrA Surface protein Role in experimental 
peritonitis, resistance 
to host defenses 
[80] 
StrA Sortase Biofilm formation, role 
in catheter-associated 
UTIs  
[60,61] 
Exopolysaccharides    
cps cluster Capsular 
polysaccharides 
Resistance to host 
defenses 
[66] 
epa cluster Enterococcal 
polysaccharide antigen 
Resistance to host 
defenses 
[81] 
Secreted factors    
GelE Gelatinase Tissue damage, 
formation of biofilms, 
immune evasion 
[67,70,82] 
SprE Serine protease Tissue damage [69] 
CylA-M Cytolysin  Tissue damage [68] 
Regulators    
FsrA-D - gelE, sprE and ace 
regulation 
- 
CylR1-R2 - Cytolysin regulation - 
 
 
From a clinical point of view, multidrug-resistant E. faecalis isolates 
are difficult to treat and constitute a major medical challenge due to limited 
therapeutic options. A recent study with strains from various human 
sources in Europe supports the concept that E. faecalis is globally highly 
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resistant to clinically used antibiotics, and higher levels of resistance are 
associated with hospital environment [21,83]. 
 
 
 
 
 
Figure 1. Mechanism of E. faecalis antibiotic resistance. In addition to their intrinsic 
resistance to several antibiotics, E. faecalis can acquire new antibiotic resistances as well 
as high-level antibiotic resistance either by point mutations and/or acquisition of genetic 
mobile elements. High-level resistance to aminoglycosides can be acquired by point 
mutation on ribosomal subunits, resulting in altered target binding, or by capture of genes 
for aminoglycoside–modifying enzymes. Resistance to vancomycin involves two pathways: 
replacement of the terminal D-Ala of peptidoglycan precursors by D-Lac or a D-ser, 
resulting in high or low-level resistance, respectively. Resistance to linezolid involves 
mutations in genes encoding domain V of 23S rRNA. Resistance to the lipopeptide 
daptomycin involves altered interactions with the cell membrane by the action of 
membrane proteins LiaF and GdpD. Resistance to β-lactams can be acquired through 
mutations on pbp4 gene or acquisition of β-lactamases. Adapted from [53]. 
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Severe E. faecalis infections can be treated by the synergistic action 
of ampicillin and aminoglycosides (gentamycin or streptomycin). When a 
strain is resistant to vancomycin, new antibiotics such as quinupristin-
dalfopristin, linezolid or daptomycin can be administered. However, strains 
resistant to those antibiotics have already been identified (Figure 1) [84]. 
Furthermore, since antibiotic resistance is frequently linked to genetic 
mobile elements, their dissemination to pathogenic bacteria in hospitals, 
such as Staphylococcus aureus, represents a major health concern. 
Actually, S. aureus isolates resistant to vancomycin were found to contain 
the enterococcal transposon Tn1546 harboring the vanA resistance 
operon [85,86] 
One of the most serious complications of E. faecalis bacteremia is the 
development of infective endocarditis, characterized by the formation of 
an infected thrombus on the surface of a heart valve. Enterococci, 
staphylococci and streptococci are responsible for the majority of 
nosocomial infective endocarditis that has a case-fatality rate of more than 
50% [87,88]. This infection is very difficult to treat due to low antibiotic 
penetration in the thrombus and to multidrug resistance. Host tissue 
damage factors, such as cytolysin [89], pili [58], Asc10 [77], Ace [78] and 
gelatinase [90,91] described above, are important to the development of 
infective endocarditis. In addition, recent studies suggest that E. faecalis 
pili and platelet-binding proteins can also be involved in endocarditis 
development due to their ability to bind and aggregate platelets. This is 
considered as a first step in the development of infective endocarditis 
[79,92]. The existence of different factors causing the same disease, 
together with the multidrug-resistance illustrates the multifactorial nature 
of E. faecalis pathogenesis. 
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II. BACTERIOPHAGES 
 
1. Biology  
Bacteriophages are viruses that specifically infect bacteria and 
represent the most abundant ecological entities on earth with an 
estimation of population size of more than 1030 viral particles [93]. After 
their independent discovery in 1915 by Frederick Twort and in 1917 by 
Felix d’Herelle for their antibacterial activity, bacteriophages were mainly 
explored in the western countries for their applications in molecular 
biology and genomics. While empirically used for phage therapy in Soviet 
Georgia, phages have gained recent attention for their potential use as 
therapeutic and biocontrol agents of pathogens in the era of multidrug-
resistant bacteria (Figure 2) [94]. 
 
 
 
Figure 2. Timeline of major milestones in phage history. Adapted from [94]. 
Chapter 1 
22 
Phages exist as extracellular entities made of proteins that protect the 
genetic material, double- or single-stranded DNA or RNA. Regarding 
morphology, they are divided in four morphotypes: tailed, polyhedral, 
filamentous and pleomorphic (Table 2). Tailed phages account for 96% of 
all prokaryotic viruses, and are grouped in the order Caudovirales [95]. 
The Siphoviridae family with long non-contractile tails represent 61% of 
them [96]. They infect mostly enterobacteria and members of the 
Streptomyces, Mycobacterium, Bacillus, Lactococcus, Streptococcus, 
Lactobacillus, Pseudomonas and Vibrio genus [95].  
 
Table 2. Overview of prokaryotic virus families [95]. 
Shape Nucleic acid Family Characteristics Members 
Tailed dsDNA (L) Myoviridae Tail contractile 1320 
  Siphoviridae Tail long, non-contractile 3229 
  Podoviridae Tail short 771 
Polyhedral  ssDNA (C) Microviridae Conspicuous capsomers 40 
 dsDNA (C, S) Corticoviridae  Complex capsid, lipids 3 
 dsDNA (L) Tectiviridae  Inner lipid vesicle, 
pseudotail 
19 
 dsDNA (L) SHI group* Inner lipid vesicle 1 
 dsDNA (C) STV1 group* Turret-shaped protrusions 1 
 ssRNA (L) Leviviradae  Poliovirus-like 39 
 dsRNA (L, M) Cystoviridae  Envelope, lipids 3 
Filamentous ssDNA (C) Inoviridae  Long filaments, short rods 67 
 dsDNA (L) Lipothrixviridae Envelope, lipids 7 
 dsDNA (L) Rudiviridae  Stiff-rods, TMV-like 3 
Pleomorphic dsDNA (C, S) Plasmaviridae  Envelope, lipids, no 
capsid 
5 
 dsDNA (C, S) Fuselloviridae Lemon-shape, envelope 11 
 dsDNA (L, S) Salterprovirus  Lemon-shape, envelope 1 
 dsDNA (C, S) Guttaviridae  Droplet-shape 1 
 dsDNA (L) Ampullaviridae  Bottle-shape, helical NC 1 
 dsDNA (C)  Bicaudaviridae Two-tailed, helical NC 1 
 dsDNA (L) Globulaviridae Envelope, spherical, 
lipids, helical NC 
1 
C, circular; L, linear; M, multipartite; NC, nucleocapsid; S, supercoiled; *, waiting classification.  
Members indicate number of phages examined by electron microscopy. 
 
1.1 Lytic vs temperate bacteriophages  
Typically, phage genomes are organized into large operons of 
functionally related genes that are temporally and sequentially expressed 
[97]. They present a conserved overall gene order reflecting their modular 
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organization: left attachment site (attL), lysogeny control, DNA replication, 
transcriptional regulation, DNA packaging, head morphogenesis, tail 
morphogenesis, lysis module and the right attachment site (attR). 
Lysogenic conversion genes, defined as prophage genes that improve 
host fitness, are normally located between the lysis module and the attR, 
and have a different GC content when compared with the rest of the 
phage genome. Tailed bacteriophages use mostly two strategies to 
propagate: the lytic and the lysogenic cycles. During the lytic cycle, 
phages produce progeny right after infection and cause bacterial lysis. 
The lysogenic cycle is performed by temperate phages, and is 
characterized by the establishment of a prophage state in which the 
phage genome is integrated into the bacterial chromosome by reciprocal 
recombination. It is thus, replicated and segregated as part of the bacterial 
chromosome until induction of the lytic cycle (Figure 3). Both cycles begin 
by phage recognition of specific receptors on the surface of the bacterial 
host. Sequentially, DNA is injected into the bacterial cell and circularizes 
by annealing of the cohesive cos sites then, one of the cycles is initiated 
depending on phage nature. In the lysogenic cycle, recombination, 
coordinated by the phage integrase, occurs between unique attachment 
sites on both phage DNA (attP) and bacterial chromosome (attB) 
promoting phage integration. A recent survey of prophages found in the 
sequenced bacterial genomes showed that prophage integrates into 
tRNA, intergenic regions and open reading frames for genes at similar 
frequency [98]. In order to maintain the prophage state, lytic genes are 
turned-off by a phage-encoded repressor. This repressor is also 
responsible for immunity against incoming phages of the same type. The 
prophage state is usually very stable, however prophages can be induced 
to enter the lytic cycle through different genetic switches the most 
common being the SOS response (Figure 3) [99]. The SOS response is a 
conserved pathway that controls a set of genes involved in DNA repair 
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through the action of two proteins, LexA and RecA. Upon DNA damage, 
RecA forms a complex with ssDNA and becomes activated (RecA*). This 
complex works as a co-protease that promotes LexA autocleavage. The 
resulting decrease of LexA cellular pool leads to the activation of the SOS 
regulon [100]. Prophages are repressed by a phage-encoded repressor 
that, like LexA, undergoes autocleavage in presence of RecA*. This will 
induce the prophage into the lytic cycle [101].  
 
 
 
Figure 3. Lytic vs lysogenic cycle. In the lytic cycle, the phage adsorbs to the surface of 
the cell and injects its genome into the host cytoplasm followed by circularization. Phages 
hijack the host cell machinery in order to replicate its genome and produce its proteins. 
Phage proteins are assembled into mature phage particles and released by a cell-lysis 
event coordinated by the action of two phage-encoded proteins, holin and endolysin. In the 
lysogenic cycle, after DNA injection and circularization, the phage integrates its genome at 
a specific attachment site (attB) into the host chromosome establishing a prophage state. 
The phage DNA replicates along with the bacterial host chromosome. Prophages are 
stably maintained in the host chromosome until environmental stimuli (i.e. pressure, 
temperature and nutritional deficiency) or cellular damage induces the prophage into the 
lytic cycle and release progeny.  
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Upon prophage excision, a process mediated by both integrase and 
excisionase, temperate phages engage the lytic pathway, a set of 
coordinated events that they share in common with the cycle of lytic 
phages. Bacterial genome is rapidly degraded, and the phage genome is 
replicated. Late genes, encoding proteins involved in virion assembly and 
cell lysis, are transcribed. Once produced and accumulated at suitable 
levels, head and tail structural proteins are assembled independently and 
then joined to form a functional virion. Head assembly begins with the 
production of a procapside (an empty coat protein shell) followed by 
phage genome uptake into the procapside through the portal protein. 
Phage genome is recognized and packaged by the terminase complex. 
During genome packaging the procapsid shell undergoes expansion and 
becomes more angular in overall appearance [102]. Next, generally 
through the action of two phage proteins, holin and lysine, bacterial cell 
lysis occurs, releasing the phage progeny that can search for a new host 
and begin a new cycle [103]. 
 
1.2 Bacterial immunity to phage infection 
Bacteriophages have co-evolved with their bacterial host for more 
than 35 billion years resulting in an everlasting arms race that leads to 
continuous variation and selection towards adaptations of the host, and 
counter-adaptations of the phage [104]. Most steps of phage lytic cycle 
can be targeted by an anti-phage mechanism and counteracted by a 
phage adaptation. The understanding of the phage-host dynamics is 
particularly relevant in two circumstances: in the dairy industry, for which 
phages can impair drastically fermentation processes and thus the overall 
production, and also in phage therapy to avoid mutual resistances.  
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1.2.1 Preventing phage adsorption  
In order to infect host cells, bacteriophages must recognize a specific 
receptor on the surface of the bacteria. In addition to the diversity of 
receptors, achieved by receptor direct alteration through mutagenesis, 
down-regulation or loss, bacteria have evolved a number of ways to 
prevent phage adsorption such as production of extracellular matrix or 
competitive inhibitors [105]. Phages have counteracted by changing their 
specificity for another receptor, producing carbohydrate-degrading 
enzymes such as lyases or hydrolases or by recognizing 
lipopolysaccharides as receptors. In a very elegant experiment of 
coevolution between phage λ and E. coli, Meyer and collaborators 
demonstrated that upon downregulation of phage λ natural receptor LamB 
by the host strain, λ has acquired several point mutations in its receptor 
binding protein that allows it to bind to a new receptor, OmpF [106]. 
 
1.2.2 Preventing phage DNA entry 
Superinfection exclusion systems block phage DNA entry into the host 
cell conferring immunity to a specific phage. They are normally coded in 
prophage genomes and their principal role is to avoid an infection by a 
second phage. Two distinct superinfection exclusion mechanisms that 
block DNA injection of a particular subset of 936-phage group were 
identified in Lactococcus lactis strains MG1363 and IL1402 [107]. Each of 
the systems allows normal phage adsorption but affects phage DNA 
replication [107]. Gene ltp from Streptococcus thermophilus temperate 
phage TP-J34, codes for a lipoprotein involved in superinfection exclusion 
against S. thermophilus phages and also phage P008 from L. lactis [108]. 
 
1.2.3 Degradation of foreign DNA  
Two different mechanisms for degradation of invading DNA have been 
described: restriction-modification and CRISPR/Cas systems. 
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Restriction-modification systems are composed of two sequence-
specific recognition activities: a restriction endonuclease (REase) that 
digests incoming foreign genetic material and a methyltransferase 
(MTase) that protects host genetic material from degradation through 
methylation of specific bases [109]. Thus, all non-methylated DNA is 
recognized as foreign and digested. Phages overcome this system by 
stimulating host MTase to methylate phage DNA, by inhibiting the REase 
or incorporating unusual bases in their DNA to evade the REase. This was 
observed for Bacillus subtilis phages that replace thymine by 5-
hydroxymethyluracil [110]. 
CRISPR interference is the only adaptive immunity system in 
prokaryotes. CRISPR loci consist of an array of short direct repeats 
separated by highly variable spacer sequences of precise length that 
correspond to previously captured foreign DNA from bacteriophages or 
plasmids [111,112]. CRISPR associated (cas) genes are located 
immediately downstream of the repetitions and encode the protein 
machinery in charge of the CRISPR activity. In the adaptation phase 
CRISPR loci incorporates additional spacer sequences to enlarge their 
activity against invader foreign DNA (Figure 4). Thus, the spacer content 
reflects the many different elements that have been encountered by the 
bacterial host. Once a spacer is established it can be used for protection 
through the interference phase of the CRISPR pathway. This phase 
involves the transcription of the CRISPR loci into a single RNA transcript 
that is cleaved by the Cas proteins in order to generate CRISPR RNA 
(crRNA) units, each containing one targeting spacer. These units will then 
interfere with the incoming foreign nucleic acid through hybridization, 
leading to its degradation by the bacterial cell degradation machinery 
(Figure 4) [112]. Despite CRISPR/Cas adaptive character, bacteriophages 
have already stroke back by finding a way to circumvent CRISPR 
immunity.  
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Figure 4. CRISPR/Cas immunity mechanism. In the adaptation phase of CRISPR 
immunity, new spacers from the invading DNA are incorporated into CRISPR loci. During 
the interference phase, repeats and spacers are transcribed into a long precursor that is 
processed by a complex, made of Cas proteins, to generate CRISPR RNAs (crRNAs). This 
complex together with the correspondent crRNA detects the foreign incoming DNA, 
targeting the phage genome for degradation. Adapted from [113]. 
 
Bondy-Denomy and collaborators described recently several anti-CRISPR 
phage-encoded genes mediating phage evasion to CRISPR/Cas system 
in Pseudomonas aeruginosa by a yet unknown mechanism [114]. Seed 
and collaborators report a Vibrio cholerae phage, ICP1, which uses its 
own CRISPR/Cas system to evade a phage immunity system coded on a 
host chromosomal island, PLE. Interestingly, and in relation with section 
III.2 of this chapter, PLE has been recognized as a phage-related 
chromosomal island (PRCI) due to its length, base composition and 
genome organization [115]. Upon ICP1 infection, PLE on the bacterial 
host circularizes and inhibits ICP1 lytic infection by an unknown 
mechanism. In order to progress on the lytic cycle, ICP1 uses its 
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CRISPR/Cas to target PLE for destruction. If ICP1 has not a complete 
CRISPR/Cas system, lytic infection is abolished due to the lack of 
complementarity between ICP1-CRISPR spacers and the target 
chromosomal island [115]. 
 
1.2.4 Abortive infection (Abi)  
Abortive infection (Abi) system acts later in the phage infectious 
process and targets phage replication, transcription, translation or genome 
packaging [116]. Abi leads to the premature death of the phage-infected 
bacteria, which limits phage replication and favours the surrounding 
bacterial population. Although widespread in different bacteria such as E. 
coli and B. subtilis, most of Abi systems have been identified in L. lactis 
[116]. Abi systems are generally coded by plasmids. Similarly in E. coli 
and L. lactis, Lit and AbiD1, respectively, code for an enzyme activated 
upon phage infection that promotes cleavage of essential and conserved 
components of the bacteria translational apparatus [117,118]. Recently, 
the mechanism underlying L. lactis AbiQ abortive infection was unravelled. 
AbiQ belongs to the type III toxin-antitoxin systems,	 which involve an 
antitoxic RNA molecule interacting with its cognate toxic protein [119]. 
This system resembles to another type III toxin-antitoxin system also 
involved in an abortive infection mechanism described in Erwinia 
carotovora [120]. ABIQ protein has an endoribonuclease activity. 
However, the exact mechanism through which it kills phage-infected 
bacteria is still unknown [119].  
 
2. Ecological impact 
Bacteriophages have a major impact on the ecological balance and 
dynamics of microbial life. They are found where bacteria thrive, whether it 
is on sediments, aquatic systems or the human body. In nature, phages 
face several constraints imposed by the different environmental conditions 
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they can encounter. The most important conditions are the host availability 
and its nutritional and metabolic states that dictate the outcome of viral 
infections and proliferation [121]. Regardless of the difficulties, 
bacteriophage influence many biogeochemical and ecological processes, 
determining biological production and community species composition, as 
well as patterns of matter and energy transfer [122]. Although most of the 
bacteriophage ecological studies have been performed in the aquatic 
environment, the dynamic relationship phage-host can be extended to 
other complex microbial ecosystems such as human associated microbial 
communities [123]. For example, in the gut, phages are suspected to 
shape the functionality and diversity of the human intestinal microbiome 
[124]. One of the models that explain how phages control community 
species composition is called ‘killing-the-winner’. It stipulates that viruses 
control the most abundant or fastest growing population, enabling less-
competitive or slower-growing populations to co-exist with the dominant, 
fast-growing hosts. The reduction in size of the dominant host population 
gives the opportunity for new hosts to become abundant thus maintaining 
the high diversity in the population [125]. Metagenomic studies have 
recently revealed the bacteriophage diversity and abundance within the 
human gastrointestinal tract [126,127]. Imbalanced composition of the 
intestinal microbiota or dysbiosis is associated with many intestinal 
diseases, such as inflammatory bowel disease (IBD), irritable bowel 
syndrome (IBS) and obesity [128,129]. Given the beneficial or harmful 
effects of phages on a bacterial population, phages are suspected to 
influence the balance between intestinal symbionts and pathobionts under 
certain circumstances [124,130]. 
 
2.1 Prophage induction & impact on host fitness 
It is largely accepted that temperate phages have a major impact on 
the development of bacterial pathogenesis and they are key players in the 
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evolution of bacteria by shaping their genomes through horizontal gene 
transfer [131]. Lysogeny is a common trait among bacteria, suggesting 
that prophages provide advantages to their host whether it is a pathogen, 
commensal or free living organism. This would compensate the potential 
negative aspects of carrying extra DNA, such as metabolic burden from 
extra DNA replication and cell lysis after prophage induction. Thus, to 
benefit bacterial fitness, evolution would select lysogenic strains with 
mutations that inactivate the prophage ability to perform the lytic cycle. 
Next, large-scale deletion of prophage genes would decrease the 
metabolic burden, while genes that increase host fitness would be 
maintained [132]. In support of this theory, it is common to find multiple 
prophages in various stages of functionality in the same bacterial 
chromosome, as is the case of Streptococcus pyogenes, Lactobacillus 
plantarum and different strains of E. coli [133-136]. Indeed, in addition to 
fully functional prophages that can be induced to start a lytic cycle and 
release phage progeny, bacterial genomes, also harbor non-functional 
prophage-like entities: i) defective prophages, that are prophages in a 
state of mutational decay. This is the case of the nine E. coli K-12 
prophages, CP4-6, DLP12, e14, rac, Qin, CP4-44, CPS-53, CPZ-55 and 
CP4-57 [136]; ii) prophage satellites, that are elements whose genome 
has evolved to hijack structural proteins from a helper phage. The best 
characterized example of such an interaction occurs between satellite 
phage P4 and phage P2 (see section III.1 of this Chapter for details) [137]; 
and iii) gene transfer agents (GTAs), that are tailed phage like particles 
that package random fragments of the bacterial genome. These virion-like 
particles can transduce bacterial DNA into another host, in which they can 
recombine with the chromosome and be vertically inherited. The best 
characterized GTA is encoded on the Rhodobacter capsulatus 
chromosome [138]. 
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When bacterial strains harbor more than one prophage they are called 
polylysogenic. Polylysogeny is frequent among pathogens, such as 
Escherichia coli O157:H7 strain Sakai (18 prophages) and Streptococcus 
pyogenes M3 (6 prophages) (Figure 5) [133,134], but also among 
opportunistic pathogens and dairy strains such as E. faecalis V583 (7 
prophages) and Lactococcus lactis IL1403 (6 prophages), respectively 
[28,139].  
 
Figure 5. Polylysogeny in human bacterial pathogens. Examples of human pathogens 
for which the accumulation of prophages has a major impact for pathogenesis. From the 
center to periphery: (A) Escherichia coli genomes from O157:H7 Sakai, O157:H7 EDL933, 
K12 and CFT073; (B) Salmonella enterica genomes from serovar Thyphimurium LT2 and 
serovar Tiphy CT18; (C) Staphylococcus aureus genomes from Mu50, N315, MW2 and 
8325; (D) Streptococcus pyogenes genomes from M1, M3 and M18. Prophages are 
indicated by dots, which size if proportional to phage genome length. Circles represent 
bacterial chromosomes, but are not at scale. Adapted from [140]. 
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A well studied case of impact of polylysogeny on pathogenesis and 
emergence of hypervirulent clones is illustrated by Streptococcus 
pyogenes. Serotype M3 strains isolated in the 1920s contains φ315.5 
(encoding the SpeA1 exotoxin) while M3 strains causing disease in the 
1940s have an additional prophage, φ315.2, encoding the streptococcal 
superantigen (SSA). At the same time, a nonsynonymous mutation in 
SpeA1 on φ315.5 gave rise to SpeA3, a significantly more mitogenic 
variant. Contemporary serotype M3 strains have one more prophage, 
φ315.4, which encodes exotoxin SpeK and streptococcal phospholipase 
A2, Sla (Figure 6) [141]. Thus, subclone M3 has accumulated prophages 
over time resulting in the emergence of a superbug built from a unique 
combination of phage-encoded virulence factors [134]. 
 
 
Figure 6. Hypothesis for the emergency of M3 hypervirulent clones. Early in the 20th 
century, an ancestral strain, harboring phage 315.5, acquired phage 315.2, harboring SSA. 
Subsequently, a single nucleotide mutation resulting in a single amino acid transformed 
SpeA1 in SpeA3 variant encoded by phage 315.5. Later, this strain gained phage 315.4 
that encodes both Sla and SpeK toxins and disseminated widely in the mid late 1980s. 
Adapted from [141]. 
 
Prophages can impact bacterial fitness in several ways: introduction of 
new fitness factors through lysogenic conversion, gene disruption and 
lysis-mediated competitiveness upon prophage induction and [142]. They 
Chapter 1 
34 
initiate lytic cycle upon induction, frequently due to SOS-response 
activation. Antibiotics targeting DNA replication, such as ciprofloxacin and 
trimethoprim, can induce the SOS response and consequently prophages. 
Frequently, they also enhance the expression of phage-encoded virulence 
factors [143]. Some β-lactams, like ampicillin, penicillin, cloxacillin and 
ceftriaxone, are also able to induce an SOS-response [144]. Antibiotic-
induced SOS response and consequent prophage and prophage-related 
elements induction, promotes horizontal gene transfer of virulence genes 
[145]. β-lactams induced SOS response has been attributed to the 
formation of reactive oxygen species (ROS) [146,147]. However recent 
reports claim that these antibiotics do not induce the production of ROS, 
and that their effect is probably due to direct inhibition of cell-wall 
assembly, protein synthesis and DNA replication [148,149]. 
 
2.1.1 Lysogenic conversion  
Lysogenic conversion was first reported in Corynebacterium 
diphtheriae, the etiological agent of diphtheria. Freeman reported that 
non-lysogenic strains become toxicogenic after infection with a tox+ 
corynebacteriophage β [150]. This is the typical situation in which 
bacteriophages encoding virulence factors can convert their bacterial host 
from a non-pathogenic strain into a strain with increased virulence. The 
tox gene, which codes for diphtheria toxin (DT), is activated by low iron 
concentration. After production, DT is secreted and attached to the cell 
surface of respiratory epithelium cells where it promotes cell death [151]. 
Since, the list of lysogenic conversion genes and their mechanisms of 
action in many other bacterial pathogens has grown and includes both 
Gram-positive and Gram-negative bacteria such as S. aureus, S. 
pyogenes, E. coli, S. enterica, Pseudomonas aeruginosa and Vibrio 
cholerae (Table 3) [142]. The most important factors for the success of a 
bacterium in hospital setting are those that contribute to host colonization, 
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acquisition of nutrients and evasion to the innate and adaptive immune 
systems. In many of these circumstances, prophage-encoded factors can 
provide an advantage to the bacterial host (Table 3) [142,152]. For 
example, different phage-encoded proteins promote bacterial evasion 
from the immune system through the modification (glucosylation or 
acetylation) of the O-antigen of different bacteria, such as S. enterica 
[153,154], P. aeruginosa [155,156], Shigella flexneri [153,157] and 
Neisseria meningitidis [158]. Other phage-encoded proteins contribute to 
bacterial survival to eukaryotic cell environment such as oxidative stress. 
Phages Gifsy-2 and Fels-1 from S. enterica code for superoxide 
dismutases protecting the bacteria against host produced ROS [159]. 
Finally, prophages carry an arsenal of extracellular toxins used by their 
bacterial host to induce damage in eukaryotic cells. They perform 
functions such as cytotoxic (as CTX from P. aeruginosa) [160], cardiotoxic 
(as TOX from C. diphtheriae) [150] or neurotoxic (as C1 from C. 
botulinum) [161]. Interestingly, two prophages of the E. coli O157:H7 
strain and other Shiga-toxins producing E. coli (STEC) encode Shiga-
toxins, Stx1 and Stx2, which cause severe hemorrhagic colitis and 
hemolytic uremic syndrome [162]. Antibiotic treatments of these infections 
are deleterious for the patients as they induce prophages, and 
consequently increase toxin production [163,164].  
 
2.1.2 Gene disruption  
Lysogenization of S. aureus by φ13 results in loss of β-toxin 
expression due to prophage integration into the 5' end of β-toxin gene 
(hlb) [165]. In Listeria, φ10403S insertion interrupts comK gene, which 
corresponds to the master regulator of DNA uptake competence system in 
B. subtilis. Prophage excision restores ComK that can activate its target 
genes, involved in Listeria pathogenesis [166].  
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Table 3. Phage encoded bacterial virulence factors [142,152]. 
Protein Gene Phage Bacterial host References 
Adhesion for bacterial 
host attachment 
    
Vir vir MAV1 Mycoplasma 
arthritidis 
[167] 
PblA and PblB pblA, pblB SM1 Streptococcus mitis [168] 
Effector proteins 
involved in invasion 
    
Effector protein sopE SopEφ S. enterica [169] 
Effector protein  sseI 
(gtgB) 
Gifsy-2 S. enterica [159] 
Effector protein sspH1 Gifsy-3 S. enterica [159] 
Proteins altering 
antigenicity 
    
O-antigen acetylase Iap, oac, 
wzy 
D3 P. aeruginosa  [155,156] 
Membrane protein Pmn1 Mu-like Neisseria 
meningitidis  
[158] 
Glucosylation  rfb ε34 S. enterica [154] 
Glucosylation gtr P22 S. enterica [153] 
O-antigen acetylase oac Sf6 S. flexneri [157] 
Glucosyl transferase gtrII SfII, SfV, SfX S. flexneri [153] 
Enzymes      
Superoxide dismutase sodC Sp4, 10 E. coli O157 [170] 
Superoxide dismutase sodC-I Gifsy-2 S. enterica [159] 
Superoxide dismutase sodC-III Fels-1 S. enterica [159] 
Neuraminidase  nanH Fels-1 S. enterica [159] 
Hyaluronidase  hylP H4489A S. pyogenes [171] 
Staphylokinase  sak φ13 S. aureus [172] 
Phospholipase  sla 315.2 S. pyogenes [141] 
DNase/streptodornase sdn, sda 315.6, 8232.5 S. pyogenes [141] 
Extracellular toxins     
Diphtheria toxin tox β-phage C. diphtheriae [150] 
Neurotoxin C1 Phage C1 C. botulinum [161] 
Shiga toxins stx1, stx2 H-19B E. coli [173] 
Enterohaemolysin  hly2 φFC3208 E. coli [174] 
Cytotoxin ctx φCTX P. aeruginosa [160] 
Enterotoxin see, sel NA S. aureus [175] 
Enterotoxin P sep φN315 S. aureus [176] 
Enterotoxin A entA φ13 S. aureus [172] 
Enterotoxin A sea φMu50A S. aureus [176] 
Exfoliative toxin A eta φETA S. aureus [177] 
Toxin type A speA T12 S. pyogenes [178] 
Toxin type C speC CS112 S. pyogenes [179] 
Cholera toxin ctxAB CTXφ V. cholerae [180] 
Leukocidin  pvl φPVL S. aureus [181] 
Superantigens  speA1-A3, 
speC, I, H, 
M, L, K, 
ssa 
8232.1 S. pyogenes [142] 
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Since competence is not known for Listeria, the DNA uptake system is 
believed to act as a secretion system of proteins involved in phagosomal 
escape [166]. 
 
2.1.3 Lysis-mediated competitiveness  
Being a lysogen can be advantageous for the host since they can 
perform phage-mediated killing of sensitive competitors [182] or 
deleterious as for S. aureus lysogenic strains whose prophages are 
induced through the activation of the SOS-system in response to H2O2 
produced by a niche competitor such as Streptococcus pneumoniae in the 
nasopharynx [183]. In a different scenario, prophage-induced lysis allows 
the release of the platelet binding proteins, PblA and PblB, from 
Streptococcus mitis φSM1 and their interaction with other S. mitis cells 
promotes their fixation to human platelets [168,184,185].  Finally, phage-
induced lysis is important to the dispersion of biofilm cells, considered a 
key step in biofilm development. The dead cells release enzymes that 
help to break down the biofilm matrix and provide nutrients for the bacteria 
to found a new biofilm structure [186]. 
 
3. Technological applications 
Bacteriophages are nowadays recognized for their technological 
applications in the modern biotechnology industries. Although phage 
therapy is their main application, many other applications have been 
developed such as: i) phage display, in which heterologous peptides or 
proteins are displayed on the surface of M13 and related filamentous 
phages through fusion with a coat protein [187,188]; ii) development of 
phage delivered vaccines by phage-display vaccination, in which phages 
are designed to present a specific antigenic peptide [189] and, iii) as 
deliver vehicles for gene therapy. Phages can be targeted to specific 
eukaryotic cell types and deliver gene cassettes [190].  
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If phage therapy or the use of bacteriophages as anti-bacterial agents 
started early in the 20th century, it was abandoned in the Western Europe 
and United States due to a lack of understanding of phage biology and to 
the appearance and generalization of antibiotic therapy. However, it 
continued to be developed in some Eastern countries and in the former 
Soviet Union, mainly at the Eliava Institute in Georgia where they 
constructed a considerable collection of lytic phages targeting bacterial 
pathogens (Figure 2) [191,192]. The renewed interest on phage therapy is 
mostly due to the emergence of multidrug resistant pathogenic bacteria.  
Nowadays, phage therapy follows two main approaches: the 
development of phage-encoded lytic enzymes (lysins) or phages as direct 
antimicrobial agents [94,193]. Lytic enzymes participate in the lysis of the 
host cell by degrading one of the 5 major bounds within the peptidoglycan 
[194]. Lysins of Gram-positive bacteria have 2 domains: N-terminal that 
has at least one catalytic activity and the C-terminal that binds specifically 
to a substrate in the cell wall of the host bacteria [193]. Studies of different 
laboratories have shown that lysine domains can be swapped to obtain 
lytic enzymes with multiple lytic activities and/or multiple binding domains. 
[195,196]. This capacity allows the creation of new enzymes with high 
specificity and cleavage potential. For example, Garcia and collaborators 
created a new lysine harboring the same binding domain for pneumococci 
but able to cleave different peptidoglycan bounds which increases its 
therapeutic potential [197]. Lysins present a number of therapeutic 
advantages comparing with phages, as they have not yet presented 
adverse reactions during in vivo trials or bacterial resistance [198-200]. 
They were tested successfully in animal models to treat infections caused 
by gram-positive pathogens such as Bacillus anthracis [200], S. 
pneumoniae [198] and S. aureus [201].  
Phage therapy has known a great development and successful tests 
have been done in animal models of infection with antibiotic-resistant 
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bacteria such as E. coli [202], P. aeruginosa [203,204] and S. aureus 
[205]. Recently, several phage-based products have reached clinical trials 
in order to: control nasal carriage of S. aureus [206], treat chronic otitis 
induced by antibiotic resistant P. aeruginosa [207] and treat young 
children with E. coli induced diarrhea (clinical trial identifier 
NCT00937274). Bacteriophages have also been successfully used as 
biocontrol agents against biofilms and for food protection [208]. Growing 
interest in such application is facilitated by less stringent regulations than 
for medical use. For example, LISTEXTM, a phage product against Listeria 
monocytogenes in meat and cheese products, has been readily approved 
by the FDA and USDA and commercialized in Europe [209]. In conclusion, 
phage-based products are getting public acceptance due to improved 
biomedical technologies together with a better understanding of the 
biological properties and the mechanisms of phage-bacteria interactions. 
 
4. Bacteriophages of E. faecalis  
Within Gram-positive bacteria, temperate bacteriophages are key 
vectors of horizontal gene transfer of virulence genes and evolution. 
Despite bacteriophage impact in the emergence of pathogenesis, and 
their role in E. faecalis genome diversity, the interest on these mobile 
genetic elements is scarce [24-26]. However the potential use of 
enterococcal phage for therapeutic applications has been renewed in the 
era of multidrug resistance. Studies on E. faecalis bacteriophages are 
mainly focused on the development of lytic phages and/or their lysins as 
therapeutic options against E. faecalis, including vancomycin resistant 
strains. E. faecalis phages have been isolated from diverse types of 
environments such as sewage, effluent and stool specimens [210], human 
saliva [211] and teeth root canals [212]. Typically, they are tailed dsDNA 
bacteriophages and belong to the Siphoviridae and Myoviridae families. 
To a lesser extent, non-tailed filamentous (Inoviridae), polyhedral 
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(Leviviridae) and pleomorphic (Guttaviridae and Fuselloviridae) 
bacteriophages have also been identified [210].  
So far, four E. faecalis lytic phages and their respective lysins have 
been reported as suitable for phage therapy in vitro but only φEF24C was 
successfully tested in vivo in a sepsis mice model [213-218]. Generally, E. 
faecalis phages and their lysins are specific for their host and cell wall 
targets however, in two cases, PlyV12 and EFAL-1, were found to be also 
active against other Gram-positive pathogens such as staphylococci and 
streptococci [214,218]. In a different scenario E. faecalis lytic phages have 
been also developed as microbial source tracking tools to detect human 
faecal pollution in aquatic environments [219,220].  
As they are not considered suitable for phage therapy due to their 
intrinsic ability to recombine, studies on temperate bacteriophages have 
been regarded as secondary. Three publications have started to tackle the 
impact of temperate phages in E. faecalis strains [212,217,221]. Those 
studies report that E. faecalis strains are frequently lysogenic and 
polylysogenic: strain V583 harbors 7 prophages, and from a collection of 
47 E. faecalis isolates, 5 were lysogenic and 12 polylysogenic [28,217]. 
Among these temperate phages several potential fitness factors were 
predicted such as platelet-binding proteins suggesting a potential role of 
prophages in E. faecalis pathogenesis [217]. Furthermore, two studies 
report that E. faecalis temperate phages are able to mediate transduction 
of antibiotic resistance traits emphasizing the need for a better knowledge 
on these elements [217,221]. 
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III. PHAGE-ASSOCIATED GENETIC ELEMENTS 
 
Genomes of bacterial species can evolve through mutation, 
rearrangements or horizontal gene transfer. The acquisition of external 
DNA is a fundamental process in the diversification of the majority of 
Bacteria and Archaea, and has particular importance for plant and human 
pathogens [222].  
Genomic islands are large chromosomal regions that differ in base 
composition from the core genome. They can confer selective advantages 
to host bacterium under different environmental conditions or niches [223]. 
Therefore they have been grouped, accordingly with their functions in: i) 
metabolic islands (utilization of new carbon and nitrogen sources), ii) 
degradation islands (degradation of novel compounds), iii) resistance 
islands (resistance to heavy metals and antibiotics) and iv) pathogenicity 
islands (virulence determinants). Their mobility may involve the help of 
other mobile elements such as plasmids, integrative conjugative elements 
(ICEs) or phages. Since 1963 chromosomal islands are known to use 
helper phages for transduction [224]. They were discovered in Escherichia 
coli and involve phage satellite P4 and helper phage P2. Since then, the 
mechanisms of interaction between these two elements, and other P2-
related phages, have been thoroughly studied and reviewed [137,225]. 
Later in 1998, phage-related chromosomal islands (PRCIs) were identified 
in Staphylococcus aureus. Members of this family are called SaPIs, for 
Staphylococcus aureus pathogenicity islands. PRCIs are a family of 
genetic elements that share genome organization and uses helper phages 
to package their genomes and get disseminated. These elements are 
suspected to be widespread in Gram-positive bacteria, such as 
Staphylococcus epidermidis, Streptococcus pyogenes, Lactococcus lactis 
and Enterococcus faecalis [226,227]. A similar system has also been 
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described in Sulfolobus and it involves nonconjugative plasmids that use 
fuselloviruses for packaging and dissemination [228,229]. 
B. Lindqvist used the words ‘molecular piracy’ to describe the 
relationship between P4/P2. G. Christie has extended these words to the 
description of PRCI/helper phage system. In both cases, a genetic 
element uses another genetic element (helper phage) to obtain structural 
proteins and get transduced, compromising helper phage propagation. 
The following section will detail the bacterial molecular piracy mechanisms 
of P4/P2 and SaPI/helper phage systems and to a lesser extent the 
knowledge on the pSSVx/i archaeal system.  
 
1. Satellite bacteriophage P4  
P4 is a natural phasmid (phage-plasmid) that, as a prophage 
lysogenizes their hosts and expresses superinfection immunity, or 
replicates autonomously and maintains itself as a multicopy plasmid, in 
the absence of a helper phage [230]. P4 is also able to perform a lytic 
cycle, but requires a P2-related phage [230]. P2 is an E. coli temperate 
phage of the Myoviridae family [231]. The helper phage provides the 
proteins needed for assembly of phage particles, packaging of P4 DNA 
and lysis of the host cell. The resulting P4 particles are made of P2 
proteins. The small P4 genome (11.6 kb) is packaged in a capsid of 1/3 
the size (45 nm) of those of P2 capsids (60 nm) [232]. P2 is a prototype of 
non-inducible class of temperate phages and is only induced in the 
presence of P4 [233]. Even if most of the interplay mechanism has been 
established between P4 and P2, other P2-like phages function as helpers 
for P4 and are disseminated in 30% of E. coli strains as well as other 
Enterobacteriaceae [234].  
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1.1 P4 genome organization 
P4 linear map and its transcripts are depicted in Figure 7. All functions 
required for lysogenic, lytic and plasmid growth comprises 80% of the 
genome. P4 genome harbors 3 main promoters: PLE and PLL, which 
control leftward genes, and Psid that controls rightward genes, transcribed 
divergently from the origin of replication, ori1 [235] (Figure 7). The leftward 
genes comprise functions required for the lysogenic, lytic and plasmid 
propagation such as the integration att site, the integrase gene (int) and 
the α operon, that encodes functions required for P4 lytic and plasmid 
propagation (replication: α and cnr; helper prophage derepression: ε) and 
the immunity determinant, required to prevent P4 replication [236]. The 
rightward genes belong to the sid operon and encode regulatory and 
morphogenetic proteins involved in the plasmid and/or lytic development 
[237]: the positive regulator gpδ, and the two head morphogenesis 
proteins Sid and Psu. Sid determines the small size of the P4 capsid [238] 
and Psu helps to stabilize the viral particle (Figure 7) [239].  
Sequence homology between P4 and genome of the helper phage P2 
is less than 1%. It is restricted to the 55 bp cos sites and to the positive 
regulators gpδ (P4) and Ogr (P2). The cos sites determine DNA 
maturation and packaging specificity for P4 and P2 DNA by P2 head 
proteins [240] and the positive regulators activate transcription from both 
P4 and P2 late promoters [241].  
 
1.2 P4 lifestyle 
After infection of a host cell, P4 can adopt different life styles 
depending on the presence/absence of the helper phage (Figure 8). If a 
helper phage is present, the outcome of the infection is usually lytic 
growth where P4 is dependent on all morphological and lytic functions of 
the helper phage. In the absence of a helper phage the lytic cycle does 
not proceed, and P4 infection may lead to either an immune-integrated 
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phase, analogous to the lysogenic state, or the establishment of the 
multicopy plasmid mode of maintenance [230].  
 
1.3 The regulatory network 
A reciprocal intricate network that involves the interaction between P2 
and P4 regulators maintains the different developmental stages of P4 
(uncommitted phase, immune integrated, multicopy plasmid and the lytic 
states). The uncommitted replication phase starts immediately after P4 
infection of a bacterial strain. It is characterized by an early transcriptional 
burst of the α operon from the PLE promoter, followed by the activation of a 
negative control system, the immunity control. The establishment of 
immunity is irreversible and marks the end of the uncommitted phase 
upon which P4 can integrate or follow the lytic-plasmid state. Generally, 
the immune-integrated state is preferred at 99% in the absence of P2, 
whereas the lytic cycle is favored at 50 to 70% in the presence of P2 
(Figure 8) [242]. In the immune-integrated state, P4 gene expression is 
limited to the PLE immunity region and the P4 genome is passively 
replicated by the bacterial chromosome. The lytic and multicopy plasmid 
states are characterized by the activation of late promoters PLL and Psid. 
 
 
Figure 7. P4 genome and P2-P4 regulatory network. The arrows above and below the 
maps indicate early and late transcripts from P2 and P4 main operons. Transcription starts 
and terminators are represented by arrows and hanging circles, respectively. I. P4 genes 
and sites; II. P4 early transcripts; III. P4 late transcripts, activated during the multicopy 
plasmid state or lytic growth; IV. Partial P2 map, early and late transcripts. P2-P4 mutual 
derepression (dark green lines): Cox protein coded by P2 genome derepress P4 PLL 
promoter leading to activation of replication functions as well as P4 excision. Epsilon (ε) on 
P4 genome binds directly to P2 repressor inducing transcription of early P2 genes from Pe. 
P2-P4 reciprocal transactivation (light green lines): P2 and P4 transactivate late gene 
operons through the action of the activators Ogr and δ. Adapted from [230]. 
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Figure 8. P4 life style scenarios. The presence of P2 helper phage dictates the outcome 
of P4 infection. P4 lytic cycle is preferentially used when P2 is present, whereas P4 
immune state is preferred in the absence of P2. Adapted from [137]. 
 
1.3.1 P4 uncommitted phase  
P4 replication occurs right after infection, producing a large number of 
P4 DNA molecules [243]. Replication requires the multifunctional P4 α 
protein that has primase and helicase activities and specifically binds to 
DNA sequences at P4 replication origin, composed of ori1 and crr sites 
[244]. During the uncommitted phase, α operon is transcribed from the 
strong constitutive promoter PLE. Transcription from PLE yields RNA 
molecules of different length (Figure 7): (i) full-length mRNA 4.1 kb long, 
which covers the entire operon; (ii) 1.3-kb mRNA, which stops at t151, a 
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terminator upstream of the replication genes cnr and , and (iii) a family of 
transcripts less than 0.5 kb long, which stops at timm [245-247]. Therefore 
different portions of the α operon are differentially expressed. The long 
transcripts are no longer detected beyond 15 minutes after P4 infection, 
meaning that transcription from PLE allows the expression of the 
replication genes for a restricted time, after which expression is limited to 
the 5’ untranslated portion of the operon encoding the immunity functions 
[248]. The immune mode of transcription from PLE is then irreversibly 
established. The change on transcriptional patterns, from expression of 
the entire α operon, to the immune mode correlates with the appearance 
of the mature CI RNA, encoded by the cI gene. The CI RNA is produced 
by processing of transcripts that cover the immunity region. CI RNA is a 
short stable RNA and functions as P4 immunity factor [245-249].  
 
1.3.2 P4 immune-integrated phase 
This phase requires establishment of the immune condition, which 
prevents expression of the replication genes, and leads to P4 integration 
into the bacterial chromosome. P4 integration occurs at the preferential 
site attB that corresponds to the 3’ end of leuX gene, coding for tRNALeu 
by the action of P4 integrase, which acts also as an excisionase [250-
252]. Excision requires a second P4 protein, Vis. It occurs spontaneously 
at low frequency and, at much higher efficiency, upon infection of a P4 
lysogen by the helper P2 [253]. Vis is also a regulatory protein that 
controls transcription of late promoters PLL and Psid (see III.1.3.3). 
 
1.3.3 P4 multicopy plasmid state 
Maintenance of the plasmid state requires a balanced expression of α 
and cnr (copy number regulation) genes that activate replication and 
negatively controls P4 copy number, respectively [254]. Control of PLL is 
essential for expression of the replication functions when P4 is in the 
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plasmid state. PLL is controlled by the opposing actions of the δ gene 
product, expressed from Psid, and Vis, encoded by the first gene 
transcribed from PLL. These two proteins activate and repress PLL, 
respectively. PLL is located 400 nucleotides upstream of PLE [236] and the 
transcription termination barrier imposed by the immunity system is 
bypassed through the activation of termination-insensitive transcription 
from an upstream promoter, PLL (Figure 7) [236,255]. Indeed, translation 
of two small ORFs from PLL prevents CI RNA-mediated transcription 
termination [255].  
 
1.3.4 P4 lytic cycle 
P4 lytic cycle requires P2 morphogenetic and lytic functions. P4 takes 
over P2 regulatory network through mutual derepression in order to lift the 
immunity mechanisms and reciprocal transactivation of the late operons. 
P4 lytic cycle may occur within different frameworks: i) P4 infecting a P2 
lysogen, ii) P4 and P2 co-infecting a nonlysogenic host, iii) P4 lysogen 
being infected by P2 and, iv) P4 plasmid carrier being infected by P2. In 
each case, P4 senses the presence of the helper phage and responds 
through activation of its own functions in order to take over helper phage 
gene expression [137].  
P2 early operons are controlled by a pair of divergent promoters that 
regulate lysogeny functions (Pc and Pe) (Figure 7). P2 immunity repressor 
C is part of the leftward promoter. It regulates itself, and represses Cox 
that reciprocally blocks C expression [256]. Cox is also responsible for P2 
excision from the host chromosome [257]. Derepression of P2 prophage 
by P4 is controlled by ε gene product that binds directly to P2 immunity 
repressor [233,258]. On the other hand, P2 may derepress P4 prophage 
via activation of PLL late promoter by Cox [253]. P4 and P2 late operons, 
code for morphogenic functions and can be reciprocally transactivated by 
Ogr and gpδ, coded in P2 and P4 genomes, respectively. They activate 
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transcription of both the four P2 late operons as well as the two P4 late 
operons, which are controlled by PLL and Psid (Figure 7) [259]. Ogr and gpδ 
recognize the same promoters on both genomes with distinct binding 
efficiencies: gpδ has higher affinity for P2 promoters and Ogr for P4 [137]. 
This differential affinity allows P4 to control the production of the P2 
structural proteins independently of P2 regulators. 
The outcome of the satellite-helper interaction depends on the 
infection conditions. When a P2 lysogen is infected by P4, the helper 
prophage immunity is lifted by P4 gpε, which leads to P2 early-gene 
expression and P2 DNA replication in situ without excision of the 
integrated prophage genome [260]. P2 late expression may occur either 
by normal P2 activation mechanism, that requires P2 DNA replication and 
Ogr transcriptional activation, or directly through P4 transactivation of P2 
late genes by gpδ [259], which activates P2 transcription from the same 
promoters used by Ogr. The low excision efficiencies of P2 together with 
the redirection of its capsids explain the low P2 titers in this situation [261]. 
When P4 and P2 co-infect a host, progeny of both prophages is produced 
at similar proportions and gpε is dispensable for P4 lytic cycle [261]. On 
the contrary, when a P2 infects a P4 lysogen, P4 lytic cycle is activated, 
but the production of P4 particles is very low. P2 Cox activates P4 late 
promoter PLL and consequently the expression of the α operon. Later on, 
P4 Psid may be efficiently activated by Ogr [260]. Finally, when P2 infects a 
P4-plasmid carrier, P4 lytic cycle is already activated and thus Cox is no 
longer needed. In this case P4 strongly interferes with P2 growth 
[242,243]. 
 
1.4 P4 morphogenesis 
In order to get its DNA packaged, P4 needs to interfere with P2 
packaging. P2 capsids (60 nm) are assembled as precursors called 
procapsids from gpN, several copies of a gpO scaffolding protein and a 
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portal, gpQ, that forms a vertex through which the DNA is packaged 
(Figure 9) [262]. During the assembly pathway these proteins are 
processed yielding mature cleaved products called N*, Q* and O* 
[262,263]. The protein O is process in O*, which corresponds to the N-
terminal proteolytic domain [262]. P4 gets packaged into small phage 
particles (45 nm) hijacking helper phage structural proteins [232]. This 
molecular piracy phenomenon depends on a P4-encoded size 
determination protein (Sid) that forms an external scaffold surrounding the 
P4 procapsids [264,265]. P4 capsid assembly is completed through the 
maturation of gpN, gpO and gpQ, as for P2, removal of Sid and by the 
addition of the Psu decoration protein, which stabilizes P4 capsids against 
environmental stress [239,266]. P2 and P4 share the same cos site 
sequence, which determines that they will be packaged through the same 
pathway [240].  
 
Figure 9. P2 and P4 capsid assembly and DNA encapsidation [226]. Phage procapsids 
are assembled from the major capsid protein (gpN), scaffolding protein (gpO) and portal 
protein (gpQ). The presence of P4 Sid protein leads to the formation of an external scaffold 
and is sufficient for small phage particle formation. DNA is packaged into procapsids by 
terminase complexes coded by P2 (gpP and gpM) that recognize the same cos sequences 
on both P2 and P4 genomes. P4-encoded Psu is added to P4 capsids as decoration. 
 
Their genomic DNAs are packaged into the empty large and small 
procapsids, respectively, through the action of P2 terminase proteins gpM 
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and gpP [267].Next, the capsids undergo major structural transitions that 
lead to more hexagonal mature capsids [262,268]. Capsid size 
determination seems to be the only mechanism of interference that P4 
uses against P2 [226]. 
 
As the first example of molecular piracy in which a genetic element 
uses a helper phage to get packaged and transduced at high rates, the 
molecular partners and the regulatory networks of the P2/P4 system has 
served as a foundation work to study of SaPI/helper phage system in S. 
aureus. 
 
2. Phage-related chromosomal islands  
The first phage-related chromosomal islands (PRCIs) were identified 
as highly mobile, superantigen-encoding genetic elements known as the 
Staphylococcus aureus pathogenicity islands (SaPIs). S. aureus is a 
serious nosocomial pathogen that relies on genetic mobile elements, such 
as chromosomal islands, to acquire and disseminate virulence and 
antibiotic resistance genes. SaPIs transport genes of toxic shock 
syndrome toxins (TSST) and enterotoxins (SE) [269]. The first 
pathogenicity island identified in S. aureus was SaPI1 that encodes 
TSST1 and SEK toxins [270]. The interaction between SaPI1 and its 
helper phage, 80α, led to the first model of SaPI molecular piracy [271]. 
SaPI1 was described as a chromosomal island that specifically needs 
phage 80α to excise from the host chromosome and to get its genome 
packaged. SaPI1 DNA is packaged in small phage-like particles 
compatible with its genome size that are released upon phage-induced 
lysis [271]. The authors also noticed that SaPI1 induction interferes with 
phage 80α, multiplication, blocking plaque formation and phage burst-size 
[271]. Since then, 16 more SaPIs have been identified, from which 9 are 
inducible by a helper phage (Figure 10).  
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As described below, subsequent work from Novick-Penades-Christie 
groups refined the initial model, and unraveled the molecular players 
involved in the molecular piracy phenomenon.  
 
2.1 SaPI genome organization 
SaPIs share a core of genes that controls major steps of their life 
cycle and a set of variable accessory genes, such as superantigen-, 
antibiotic resistance- or toxin-encoding genes. SaPIs carry their own 
integrase gene (int), required for self-integration into the host 
chromosome. Two divergently oriented promoters located downstream of 
the int gene regulate two major transcript units: stl and str. Stl is the 
master repressor of str transcript, that controls SaPI excision to packaging 
cycle, and is inactivated during phage induction [227,272] (Figure 10). 
 
 
 
 
Figure 10. SaPI genomes, virulence factors, helper phages and genome 
organization. Genes are coloured according to their sequence and function: int and xis 
(excisionase) are yellow; transcription regulators are dark blue; replication genes (including 
the primase gene (pri) and the replication initiator gene (rep)) are purple; the replication 
origin (ori) is red; encapsidation genes are green, with the terminase small subunit gene 
(terS) in light green; superantigen and other accessory genes are pink; and pif is light blue. 
Genes encoding hypothetical proteins are orange. Helper phages correspond to SaPI 
inducing phages. tst: toxic shock syndrome toxin 1; seb: enterotoxin B; sec: enterotoxin C, 
ear: penicilin-biding protein; sek: enterotoxin K; sel: enterotoxin L; seq: enterotoxin Q; eta: 
exfoliatin A; bap: biofilm-associated protein (BAP); fhuD: ferrichrome ABC transporter; mdr: 
multidrug resistance; aad: aminoglycoside adenyl transferase (aminoglycoside resistance); 
fosB: glutathione thionyl phosphatase (fosfomycin resistance); fusB: FusB (fusidic acid 
resistance); ermA: ribosome methylase (macrolide-lincosamide-streptogamin B 
resistance); actA: GNAT family homologue (acetyl transferase protein); EP: endogenous 
phage; - not known. Adapted from [227]. 
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2.2 SaPI lifestyle 
SaPIs are stably maintained in the chromosome until a resident helper 
phage, induced by the SOS-response, or a superinfecting helper phage, 
deactivates the stl-mediated integration state of the SaPI and induces 
SaPI life cycle (Figure 11). Helper phages are temperate phages found in 
S. aureus that belong to the Siphoviridae family, with dsDNA genomes 
ranging from 39.6 to 45.9 kb [273]. They are induced by antibiotics largely 
used in therapy, such as fluoroquinolones and β-lactams. Thus, antibiotic 
use indirectly promotes dissemination of the SaPIs and their toxins in the 
hospital environment [144,145]. 
 
2.2.1 SaPI integration 
SaPIs integrate into the host chromosome at specific sites, called attC, in 
a reaction catalyzed by their integrase. The known SaPIs occupy six 
different attC sites in the S. aureus chromosome determined by their 
integrase specificity (Figure 12) [274] and each SaPI has a corresponding 
attS insertion site sequence. The six different attC sites occur only once in 
all S. aureus genomes sequenced so far, and when a strain carries more 
than one SaPI, they occupy different attC sites. SaPIs integrate in 
secondary attC sites if their preferential site is already occupied [227]. 
 
 
Figure 11. SaPI life style scenarios [227]. (A) SaPI induction by an SOS-induced helper 
prophage. After induction and excision of the helper phage, phage dUTPase relieves the 
Stl-mediated repression of the SaPI, allowing production of SaPI proteins. SaPI 
excisionase (Xis) subsequently promotes the excision of the SaPI, restoring attC and attS 
sites. Subsequent SaPI replication generates concatenated linear copies of SaPI, which 
are cleaved by the terminase complex into individual copies during packaging into small 
phage-like particles entirely made of phage proteins. (B) SaPI infection. SaPI DNA 
circularizes upon entry into the bacterial cell. The circular DNA is integrated at the 
chromosomal attC site by cross-over with the SaPI attS site. This process requires the 
SaPI integrase. Stl silences the expression of SaPI genes, keeping the element integrated. 
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Figure 11. SaPI life style scenarios [227] (cont.). For A and B see page 54. (C) Co-
infection of a SaPI and a helper phage. In this case, SaPI DNA is replicated prior to 
integration. Phage proteins are synthetized leading to the production of phage capsids, 
which after size adaptation are also used to package the replicated SaPI DNA. attP and 
attS are the prophage and SaPI core attachment sequences, respectively; attB and attC 
are the prophage and SaPI core chromosomal attachment sequences, respectively. 
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Figure 12. Chromosomal locations of the SaPI attC sites. The circle represents a 
composite staphylococcal chromosome with scales in minutes. All elements at a given site 
have the same integrase, thus the sites are designated “att/int” and are numbered in 
clockwise order. Adapted from [274]. 
 
 
 
2.2.2 SaPI derepression 
As mentioned before, SaPIs are stably inserted in the chromosome 
until a helper phage relieves Stl-dependent repression on str promoter. 
Helper phage genes that conduct this action are different depending on 
the SaPI [275]. Phage 80α induces 3 different SaPIs using 3 different 
phage non-essential proteins, which act as antirepressors by direct 
binding to the Stl proteins: SaPI1 is induced by sri, SaPIbov1 by dut and 
SaPIbov2 by orf15 (Figure 13). The specific interaction between different 
SaPI repressors and helper-phage-encoded antirepressors constitutes a 
primary determinant of the SaPI-helper phage specificity [276]. Dut is a 
dUTP phosphatase and controls SaPIbov1 derepression by switching 
between the active dUTP-bond form and the inactive (apo-state) 
conformation. This conversion is catalyzed by its intrinsic dUTPase activity 
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[277]. Once str transcription is activated, excision, catalyzed by SaPI int 
and xis (excisionase) proteins, and replication can occur [278]. SaPI 
replication is initiated at the SaPI-specific replication origin using SaPI-
coded initiator and primase [279,280]. SaPI DNA replicates as linear 
concatemers using the host cell replication machinery, and is packaged by 
a headful mechanism, like helper phage DNA [271]. In some cases, like 
for SaPIbov1 and SaPIbov2, SaPIs carry a Sip protein (staphylococcal 
integration protein) that allow them to excise and integrate at the attC site 
independently of the presence of a helper phage [281].  
 
 
 
Figure 13. SaPI derepression by multiple helper phage genes [226]. The known 
derepression functions are highlighted in yellow circles on the 80α genome map. The 
immunity regions from three different SaPIs are shown below. Transcriptional activation 
and repression are represented by green and red lines, respectively.  
 
 
2.2.3 SaPI capsid size redirection and DNA packaging 
SaPI DNA is packaged mostly in small particles composed of phage 
proteins [282,283]. In order to produce smaller capsids, SaPIs must 
redirect the helper phage assembly pathway to form capsids that are 1/3 
smaller (45 nm) than those of the helper phage (60 nm) [271,284].  
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SaPI1 and its helper phage 80α is the most well studied system regarding 
capsid size redirection and DNA packaging. Capsid assembly of phage 
80α, as in other dsDNA bacteriophages, starts with the formation of a 
precursor procapsid made of major capsid protein (gp47) and a 
scaffolding protein (gp46) that acts as a chaperone for the assembly 
process [226]. The portal protein (gp42) and a few copies of a minor 
protein of unknown function (gp44) are also incorporated into the 
procapsid [282,285]. SaPI1 proteins involved in size determination are 
called capsid morphogenesis proteins and have been named CpmB (gp6) 
and CpmA (gp7) (corresponding to SaPIbov1 gp8 and gp9, respectively) 
(Figure 14). CpmB act as an internal scaffold protein while CpmA function 
is less clear [284,285].  
 
 
Figure 14. SaPI and phage 80α capsid assembly pathways [226]. Phage procapsids 
are assembled from the major capsid protein (gp47), scaffolding protein (gp46), portal 
protein (gp42) and a minor capsid protein (gp44). The presence of CpmAB of SapI leads to 
the formation of small capsids. CpmB forms an internal scaffold. DNA is packaged into 
procapsids by terminase complexes together with the removal of the scaffold and 
expansion of the capsids.  
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CpmA and CpmB are conserved and always appear together in 13 out of 
16 SaPIs sequenced to date [227]. SaPIbov2 and SaPIbov5, two 
exceptions that do not present cpmAB genes in their genomes, are 
packaged in large capsids [275,286]. Moreover, in the case of SaPIbov2, 
the large size of its genome makes it impossible to package into small 
capsids [275].	 Although essential for small capsid formation, CpmAB are 
not essential for SaPI packaging and propagation, since that in their 
absence, SaPIs are transduced at high frequencies but in large capsids 
[287].  
Phage 80α DNA is packaged through a classical mechanism that 
requires a portal protein and the terminase complex, consisting of the 
small (TerS) and large (TerL) terminase subunits (Figure 15). TerL is 
responsible for prohead binding, DNA translocation and cleavage whereas 
TerS recognizes and binds to DNA [102]. When a SaPI is present, SaPI 
encoded TerS binds to a phage encoded TerL and both direct the specific 
cleavage and packaging of SaPI DNA through the binding to SaPI-specific 
pac sequence [226]. SaPI TerS binding to phage TerL is promoted by 
SaPI Ppi protein, which interferes with packaging of phage DNA by direct 
binding to phage TerS (see below) [286]. The majority of SaPI particles 
are packaged into small capsids, however in some cases they are 
packaged into large capsids as multimers with full transducing capacity. 
Fragments of phage DNA can also be packaged into small capsids during 
mobilization by SaPI1 but not with SaPIbov1. Since the DNA will represent 
only a fragment of the genome, the resulting virions will not be viable 
[288]. The ability of SaPI TerS to form a functional complex with the helper 
phage TerL illustrates another level of specificity between the SaPIs and 
their helper phages. 
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Figure 15. Model for SaPI packaging redirection [226]. pac sites on the concatemeric 
phage DNA are recognized by the phage encoded TerS and packaged into procapsids 
through the action of phage TerL. The pac sites of SaPI DNA are specifically recognized 
by the SaPI encoded TerS that also uses the phage TerL for DNA packaging. 
 
2.2.4 Interference 
SaPIs interfere with the multiplication of their helper phage by blocking 
plaque formation and reducing burst-size [270,286]. So far, three 
mechanisms of SaPI interference with the production of their helper 
phages have been described  [286].  
CpmAB-mediated diversion of capsomer proteins to produce small 
sized capsids is a very efficient interference mechanism as reported for 
SaPI1, a SaPI cpmAB-encoding gene. SaPIbov2 that doesn’t produce 
small sized particles nor harbors cpmAB genes, uses another mechanism: 
Ppi-mediated interference with packaging. Ppi is a SaPI-coded protein 
dedicated to phage interference against packaging of the helper phages. 
Ppi interferes with the interaction between phage TerL and TerS subunits, 
blocking the cleavage and packaging of phage DNA [286]. SaPIbov2 
efficiently blocks phage 80α multiplication by this mechanism. All SaPIs 
sequence have a ppi gene indicating that they can use it for phage 
interference alone or in addition to other mechanisms depending on the 
target helper phage. Different allelic variants of both cpmAB and ppi 
determine different levels of interference that in some cases are additive 
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or redundant. For example, SaPIbov1 cpmAB and ppi are redundant 
against phage 80α since they can both interfere at the same level with 
phage multiplication. On the other hand SaPI2 cpmAB and ppi produce 
additive interference against the helper phage [286]. A third interference 
mechanism was identified between SaPI2 and phage 80 involving SaPI2 
ORF17 by a yet unknown mechanism [286].  
 
2.3 PRCIs in other bacteria 
SaPIs are extremely well adapted to their pirate life using at least 
three different mechanisms (Cpm, Ppi and ORF17) to interfere with their 
helper phages life cycle and ultimately hijack their structural proteins and 
get transduced. Particularly prone for dissemination of their toxin genes to 
staphylococci [275], and to other species such as Listeria monocytogenes 
[289], phage-like particles of SaPIs represent a major human health 
concern. PRCIs are a family of genetic elements that share genome 
organization and uses helper phages to package their genomes and get 
disseminated. If their functionality has been established only in S. aureus, 
PRCI-like elements are dispersed in gram-positive bacteria and were 
recently predicted in the Gram-negative bacterium Vibrio cholerae [115]. 
However, packaging and transfer of these predicted elements (e.g. LlCI1 
and LlCI2 in L. lactis, EfCI538 and EfCI18508 in E. faecalis, SsuC1 in 
Streptococcus suis, SpyCIM1 in S. pyogenes, and PLE in V. cholerae) 
have yet to be demonstrated [115,227]. Based on gene organization, and 
despite evidence of molecular piracy a S. pyogenes defective prophage 
SF370.4 was renamed SpyCIM1 for S. pyogenes chromosomal island M1 
[227,290]. Interestingly, SpyCIM1 acts as a genetic switch to control DNA 
mismatch repair (MMR) in strain M1 by dynamic excision and reintegration 
into the 5’ end of mutL in response to cell growth or upon DNA damage. 
During exponential growth or in response to DNA damage, SpyCIM1 
excises from the chromosome and replicates as an episome allowing 
Chapter 1 
62 
mutL to be transcribed and restores DNA mismatch repair (MMR). As cell 
density rises, SpyCIM1 reintegrates into the chromosome restoring the 
mutator phenotype [290,291]. This example illustrates how the integrated 
or episomal state of a predicted PRCI may impact on a bacterial 
population. 
 
3. Satellite plasmids: pSSVx and pSSVi 
Sulfolobus solfataricus and Sulfolobus acidocaldarius of the order 
Sulfolobales are tractable species used as model organisms for molecular 
biology studies among hyperthermophiles and extremophiles Archaea 
[228]. The genome sequence of Sulfolobus revealed a high number of 
extrachromosomal genetic elements from which fusellovirus is the most 
studied [292]. Sulfolobus REY15/4 strain harbors a fusellovirus, SSV2, 
and small plasmid molecule (pSSVx) disseminated in small phage-like 
particles made of SSV2 components. It is believed that pSSVx replicates 
in the host cell as a plasmid and belongs to the pRN family of Sulfolobus 
plasmids [228]. Upon superinfection with the viruses SSV2, infectious 
virus particles of two different sizes are released. The smaller virus 
particles probably contain the smaller genome of pSSVx whereas the 
larger particles contain the viral genome of SSV2. The genome of pSSVx 
contains two conserved open reading frames (ORFs) present only in 
plasmids that use a helper phage for transduction. Therefore, they were 
suspected to be involved in the hijacking of the fusellovirus packaging 
system [228]. Another Sulfolobus non-conjugating plasmid, pSSVi, was 
identified in S. solfataricus P2 that is able to integrate into the host 
chromosome and disseminate in phage-like particles like pSSVx. pSSVi 
did not harbor the two ORFs predicted to be involved in phage 
components hijacking, however, pSSVi and pSSVx share another ORF 
that is proposed to be involved in viral packaging and spreading. 
Differently from PRCIs and P4 that impair their helper phages 
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propagation, pSSVi seems to have a positive impact on its helper phage 
by improving SSV2 replication [229]. 
 
4. Concluding remarks 
Temperate bacteriophages are multifaceted genetic elements. They 
are traditionally involved in bacterial evolution through lysogenic 
conversion; they also have the ability to perform horizontal gene transfer 
of their own, or other bacterial genes. Molecular piracy in which a genetic 
element, such as a chromosomal island, a defective prophage or a 
plasmid, uses a temperate phage to get its genome packaged is a 
widespread phenomenon in both Bacteria and Archaea. Despite the 
diversity of molecular mechanisms, all of the pirate elements manipulate 
their helper phages in order to gain control of their structural proteins. The 
evolutionary origins of the parasite element are still unknown but they 
seem different as P4 would have evolved from a plasmid and SaPIs from 
a prophage [226,227]. Since the identification of the first SaPI in S. 
aureus, the phage-related chromosomal islands are suspected to be 
disseminated among Gram-positive bacteria. Experimental evidence of 
molecular piracy in Gram positive, other than staphylococci was provided 
during this thesis with the identification of the first enterococcal phage-
related chromosomal island, EfCIV583 (Chapter 2).  
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SUMMARY 
 
Polylysogeny is frequently considered to be the result of an adaptive 
evolutionary process in which prophages confer fitness and/or virulence 
factors, thus making them important for evolution of both bacterial 
populations and infectious diseases. The Enterococcus faecalis V583 
isolate belongs to the high-risk clonal complex 2 that is particularly well 
adapted to hospital environment. Its genome carries 7 prophage-like 
elements (V583-pp1 to -pp7), one of which is ubiquitous in the species. In 
this study, we investigated the induction and activity of the V583 
prophages. We systematically analyzed the ability of each prophage to 
excise from the bacterial chromosome, to replicate and to package its 
DNA. We also created a set of E. faecalis isogenic strains that lack from 
one to all six non-ubiquitous prophages by mimicking natural excision. Our 
work reveals that prophages of E. faecalis V583 excise from the bacterial 
chromosome and are able to produce active phage progeny. Intricate 
interactions between V583 prophages were also unveiled: pp7, coined 
EfCIV583 for E. faecalis chromosomal island of V583, hijacks capsids 
from helper P1 leading to the formation of distinct virions and pp1, pp3 
and pp5 inhibit excision of prophages pp4 and pp6. The hijacking exerted 
by EfCIV583 on helper P1 capsids is the first example of molecular piracy 
in Gram positive, other than staphylococci. Finally, we have shown that 
fluoroquinolone increases prophage activity and can thus contribute to 
horizontal gene spreading. 
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INTRODUCTION 
 
Acquisition of external DNA by horizontal gene transfer and gene loss 
are major driving-forces of bacterial genome evolution. Temperate 
bacteriophages contribute actively to such evolution as they integrate into 
and excise from the bacterial chromosome [1]. They also mediate 
horizontal gene transfer by transduction within and across bacterial 
species [2,3]. By doing so, the integration of a temperate phage into the 
bacterial genome can provide new genetic properties to the bacterial host, 
and under some circumstances lead to the emergence of new pathogens 
within species, as shown for Corynebacterium diphtheriae, Escherichia 
coli and Vibrio cholerae [4-6].  
Frequently, prophages are found in various stages of functionality in a 
bacterial chromosome. In addition to fully functional prophages that can 
be induced to start a lytic cycle and release phage progeny, bacterial 
genomes harbor also prophage-like entities that are defective as they fail 
to give progeny alone. Nevertheless, they can still harbor functional genes 
that contribute to their DNA mobilization and/or to bacterial host fitness by 
providing active genes such as S. aureus toxins or E. coli effectors [7-9]. 
This is the case of the Phage-Related Chromosomal Islands (PRCIs) of 
some Gram-positive bacteria that are mobile genetic elements, initially 
described as S. aureus pathogenicity islands (SaPIs). They encode 
mobilization functions as well as toxic shock toxins, other virulence and 
antibiotic resistance genes [7,10]. They can also modulate host gene 
activity by dynamic excision and reintegration like the PRCI SpyCI of 
Streptococcus pyogenes [11]. PRCIs are mobilized by hijacking structural 
proteins of a helper phage to form specific-virions [12]. The genomic 
organization and the current knowledge of the molecular mechanisms of 
these pirate elements have been reviewed recently [13,14]. Excision of 
SaPIs from the bacterial chromosome is induced upon infection by a 
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helper phage or by induction of an endogenous prophage [15]. Following 
excision, DNA of SaPIs self replicates as concatemers and is packaged 
as monomers and multimers within small and large capsids, respectively, 
made of helper phage proteins [16,17]. Redirection of helper phage 
proteins by SaPIs has been associated with interference mechanisms, 
which differ between SaPI elements [18,19]. While PRCIs have been 
recently predicted in other gram-positive bacteria in silico [13], 
demonstration of their activity is still pending.  
Beyond the understanding of the involvement of individual prophages 
in bacterial strain phenotypes and ecology, a few studies have started to 
tackle the more complex question of the impact of polylysogeny on 
bacterial physiology. For example, cryptic prophages of E. coli improve 
growth, contribute to protection against antibiotics or stress and increase 
virulence or biofilm formation [20,21], while temperate phages contribute 
to virulence of S. enterica [22] and S. aureus [23] and confer competitive 
fitness to S. enterica [24]. Polylysogeny often leads to intricate 
phenomenon of prophage interferences that are likely to influence 
behavior of the bacterial host as shown in E. coli and S. enterica [20-22]. 
Enterococcus faecalis is a low-GC Gram-positive bacterium whose 
primary habitat is the gastrointestinal tract of a wide range of animals and 
humans. This member of the core human microbiota [25] exhibits different 
lifestyles. It is commonly found in diverse environments including food, 
water, soil and plants but it is also associated with life threatening 
infections. E. faecalis ranks among the leading causes of hospital 
acquired bacterial infections, and causes mostly urinary tract and intra-
abdominal infections, infective endocarditis and bacteremia [26]. 
Epidemiological studies have revealed few enriched clonal complexes 
(CCs) of multi-drug resistant colonizing and/or invasive isolates among 
hospital-associated strains [27,28]. Of these high-risk enterococcal clonal 
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complexes, CC2 isolates are particularly well adapted to hospital 
environment and associated with invasive disease [29].  
The strain V583 belongs to CC2 and was the first vancomycin 
resistant isolate found in the United States [30]. The chromosome of V583 
harbors seven prophage-like elements (V583-pp1 to V583-pp7, named 
hereafter pp1 to pp7), one of which (pp2) is found in all E. faecalis isolates 
and is considered to be part of the core genome [31,32]. Interestingly, 
CC2-isolates are enriched in prophage-genes, supporting the idea that 
these mobile genetic elements may contribute to increased survival of 
CC2 isolates in the host [33]. Noticeably, E. faecalis polylysogeny has 
been reported recently in a collection of clinical isolates, which carried up 
to 5 distinct inducible phages [34], indicating that polylysogeny is not 
specific to the V583 isolate. Even though several phage-encoded potential 
fitness factors have been pointed out [31,34,35], the contribution of these 
prophages to the lifestyle of E. faecalis and to its biological traits remains 
largely unknown. 
The aim of this study was to establish if the E. faecalis V583 
prophages are biologically active and determine the conditions that allow 
their induction and dissemination. Out of the seven prophages predicted, 
we show that six are inducible and four form infectious virions through a 
sophisticated regulatory network, which revealed the first enterococcal 
phage-related chromosomal island. Moreover, our findings demonstrate a 
correlation between the use of antibiotics, such as fluoroquinolones, and 
the induction and release of phage particles, which can promote bacterial 
fitness, and the dissemination of virulence and antibiotic traits. 
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MATERIALS AND METHODS 
 
Bacterial strains and growth conditions 
Strains used in this study are listed in Table S1. E. coli strains were 
grown at 37°C in LB medium with shaking. E. faecalis strains were grown 
in static conditions in appropriate media, either BHI or M17 supplemented 
with 0.5% glucose (M17G) at 37ºC, unless differently stated. Growth was 
monitored by measuring optical density at 600 nm (OD600). Antibiotics 
were used at the following concentrations: erythromycin, 10 µg/ml for E. 
faecalis and 150 µg/ml for E. coli; and ampicillin 100 µg/ml. 
 
Prophage induction, total DNA extraction and semi-quantitative PCR 
E. faecalis strains were grown at 37°C in M17G up to OD600 = 0.2, and 
prophages were induced by adding mitomycin C, ciprofloxacin, 
trimethoprim or ampicillin at a final concentration of 4 µg/ml, 2 µg/ml, 0.04 
µg/ml and 2 µg/ml, respectively. Cultures were grown for 2 hours at 28, 37 
or 42°C, depending on the experimental assay. Cells were collected by 
centrifugation at 4°C and total DNA was extracted as previously [36]. The 
resulting DNA samples were screened for circular form of phage DNA 
(attP region) and for the excision site left on the chromosome (attB region) 
after prophage induction, by PCR using primer pairs (Table S2): ef303f / 
ef0355f and ef0302f / ef0357f (pp1), OEF591 / OEF592 (pp2), OEF531 / 
OEF532 and OEF653/ OEF654 (pp3), OEF546 / OEF547 and OEF551 / 
OEF640 (pp4), OEF533 / OEF534 and OEF655 / OEF656 (pp5), OEF548 
/ OEF549 and OEF557 / OEF624 (pp6) and OEF560 / OEF561 and 
OEF585 / OEF657 (pp7). Control PCR was performed with primers 
targeting the chromosomal gene ef3155 using ef3155f and ef3155r 
primers, listed in Table S2. PCR amplifications were carried out in a 
Mastercycler gradient apparatus (Eppendorf, Courtaboeuf, France) using 
Taq DNA polymerase (Qbiogene, Illkirch, France). Analysis of PCR 
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products was monitored by agarose gel electrophoresis. Semi-quantitative 
PCR was performed on serial dilutions of quantified DNA recovered from 
both induced and non-induced cultures. For each DNA sample, both attB 
and attP regions were amplified using from 20 to 32 cycles. Excision 
versus replication was evaluated by comparing the amount of attB and 
attP PCR products, respectively, after gel electrophoresis. For each 
prophage, attachment site sequence was determined by sequencing the 
PCR products corresponding to the junction of both the circular form and 
the excision site. Sequencing was performed by GATC Biotech, France. 
 
Construction of prophage deleted strains 
Independent markerless deletions on different phage combinations 
were constructed through double-crossing over as described previously 
[37]. The 5’- and 3’-terminal regions of each phage were PCR-amplified 
from V583 chromosomal DNA and fused by PCR in such a way that the 
attachment site (attB) was reconstructed allowing for re-infection by the 
cognate phage. PCR amplifications were made with the following primers: 
OEF634 / OEF635 and OEF636 / OEF637 (pp1), OEF470 / OEF471 and 
OEF472/ OEF473 (pp3), OEF626 / OEF627 and OEF628 / OEF629 (pp4), 
OEF476 / OEF477 and OEF478 / OEF479 (pp5), OEF618 / OEF619 and 
OEF620 / OEF621 (pp6), OEF641 / OEF642 and OEF643 / OEF644 
(pp7), listed in Table S2. All the plasmids obtained during this work are 
listed in Table S1. The strain deleted for all studied prophages (strain pp¯) 
was obtained by removing prophages 3, 5, 4, 6, 7 and 1 sequentially. 
Sequencing of the deletion site and PFGE confirmed the deletion and the 
absence of other major genome rearrangements. 
 
Phage DNA extraction  
V583 prophages were induced by addition of ciprofloxacin at 2 µg/ml 
to 100 ml of an exponential-phase culture (OD 600 = 0.2) further cultivated 
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for 4 h at 28, 37 and 42°C. The induced culture was centrifuged at 6 500 g 
for 20 minutes at 4 °C. The supernatant was collected and filtered through 
a 0.22 µm filter. Filtrate was supplemented with PEG 6000 (10% final 
conc., v/v) and NaCl 1 M and incubated overnight at 4°C. Phage particles 
were then pelleted by centrifugation at 7 600 g for 1 hour at 4°C. 
Supernatant was discarded and the phage pellet was soaked. The pellet 
was resuspended in 100 µl of SM buffer [38]. PEG was removed by 
chloroform extraction before treating the phage particles with 4 units of 
DNase I (Sigma) for 1 hour at 37°C to remove contaminating bacterial 
chromosomal DNA. Next, phage particles were disrupted at 80°C for 10 
minutes in the presence of SDS 1%, proteins were removed by 
phenol/chloroform extraction, DNA was precipitated with ethanol and 
finally resuspended in 20 µl of TE containing 20 µg/ml of DNAse-free 
RNaseA (Sigma).  
 
Field-inverted gel electrophoresis (FIGE) and Southern-blot 
DNA from phage particles was analyzed by field inversion gel 
electrophoresis (FIGE, BioRad) on 1% agarose gel in TBE for 22h at 
11°C. Migration conditions were the following: forward voltage 6 V/cm, 
reverse voltage 4 V/cm, switch time 0.2 - 1.0 sec, linear ramp. The gel 
was stained with ethidium bromide and monitored on a UV 
transillumination table, before transferring DNA onto a Nylon membrane 
(QBiogene) by Southern-blot [36]. Individual phage genomes were 
identified by hybridization with phage-specific probes amplified by PCR on 
genomic DNA with the following primers (Table S2): OEF573/OEF574 
(pp1); OEF575/OEF576 (pp3); OEF577/OEF578 (pp4); OEF488/OEF489 
(pp5); OEF579/OEF580 (pp6); OEF581/OEF582 (pp7). Probe labelling 
and hybridization detection was performed with DIG DNA labeling and 
detection kit (Roche) according to manufacturer’s instructions. 
 
E. faecalis prophage dynamic interactions 
91 
Phage lysis plaque assay 
Two ml of ciprofloxacin phage-induced cultures were collected after 
centrifugation for 20 min at 6000 g at 4 °C. Supernatants were collected 
and filtered on 0.22 µm filters. Filtrates were tested on indicator strain for 
plaque formation. Briefly, 50 µl of indicator strain grown in BHI up to OD600 
= 0.2 was mixed with 4 ml of BHI containing 0.2% agarose (Lonza, LE) 
and 10 mM MgSO4 and plated to form a lawn. 10 µl of each filtered-
supernatant sample were spotted on the indicator bacterial lawn. Plates 
were incubated overnight at 28°C, 37°C or 42°C. Plaque formation was 
visually detected. When needed, plaques were identified by PCR in two 
independent experiments. Briefly, twenty plaques formed on each 
indicator strains were probed systematically for by both pp1 and EfCIV583 
with specific primers (Table S2). 
 
Scanning Electron Microscopy (SEM) 
Bacterial suspensions immersed in a fixative solution (2.5% 
glutaraldehyde in 0.2 M sodium cacodylate buffer, pH 7.4) were deposited 
on sterile cover-glass discs (Marienfeld, VWR, France) and kept 1 hour at 
room temperature before overnight storage at 4°C. The fixative was 
removed, and samples were rinsed three times for 10 min in the sodium 
cacodylate solution (pH 7.4). The samples underwent progressive 
dehydration by soaking in a graded series of ethanol (50 to 100%) before 
critical-point drying under CO2. Samples were mounted on aluminum 
stubs (10 mm diameter) with conductive silver paint and sputter coated 
with gold-palladium (Polaron SC7640; Elexience, France) for 200 s at 10 
mA. Samples were visualized by field emission gun scanning electron 
microscopy. They were viewed as secondary electron images (2 kV) with 
a Hitachi S4500 instrument (Elexience, France). Scanning Electron 
Microscopy analyses were performed at the Microscopy and Imaging 
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Platform MIMA2 (Micalis, B2HM, Massy, France) of the INRA research 
center of Jouy-en-Josas (France). 
 
Transmission Electron Microscopy (TEM) 
Lysates of strains pp1+ and pp1+ pp7+ were recovered 6h after 
ciprofloxacin-induction at 2 µl/ml. P1 was propagated on pp¯ strain and 
EfCIV583 on pp1+ as described previously for phage plaque assay. 
Phages were recovered from the top agarose by addition of water and 
diffusion at 4°C during 4 hours. Next, samples were centrifuged for 15 
minutes at 7 000 g and supernatant was filtrated through 0.22 µm pore 
filters. Phages samples were concentrated by ultra filtration through a 
Centricon YM-100 filter unit (Millipore, Molsheim, France). Bacteriophage 
solutions were applied on carbon-coated grids and subsequently stained 
with uranyl acetate (2% in water). Observations were performed with a 
JEOL 1200 EXII electron microscope. 
 
E. faecalis prophage dynamic interactions 
93 
RESULTS 
 
Prediction of phage functions coded by the V583 prophages 
Generally, temperate phage genomes are organized in modules of 
genes corresponding to important functions for their life cycle, which 
facilitates temporal order of gene transcription. Six modules are classically 
recognized: lysogeny, replication, transcriptional regulation, head and tail 
morphogenesis, DNA packaging and lysis [39,40]. The chromosome of E. 
faecalis V583 harbors seven prophage-like elements [31]. Table 1 
summarizes the presence and absence of functions relevant to the 
identifiable modules on V583 prophages. Five of the seven prophages 
(pp1, pp3, pp4, pp5 and pp6) contain genes for all modules suggestive of 
genome completeness. All five contain an integrase, but only pp1 bears a 
recognizable excisionase function, which enables prophages to excise 
from the bacterial chromosome. However, it cannot be excluded that 
integrases use alternative accessory proteins such as recombination 
directionality factors allowing them to mediate prophage integration and 
excision [41]. Thus, prophages 1, 3, 4, 5 and 6 seem to have all 
necessary functions to undertake a complete lytic cycle (Figure 1). Among 
them, pp3 and pp5 have similar gene organization. Genes encoding 
potential fitness factors, namely homologs of S. mitis platelet binding 
proteins PblA and PblB (pp1, pp4 and pp6), a ferrochelatase (pp4) and a 
more recently identified toxin ADP-ribosyltransferase (pp1) have been 
predicted [31,35]. The genomes of pp2 and pp7 are particularly small in 
comparison with the five other prophages (~12 Kb versus >36 Kb). 
According to recent reports, pp2 belongs to the E. faecalis core genome 
[32,33,42] and the lack of an integrase gene suggests that pp2 is a 
remnant phage. Prophage 7 encodes an integrase and a replication 
related protein, however it lacks the head and tail morphogenesis modules 
essential for capsid formation as well as genes involved in DNA packaging  
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Figure 1. Genomic organization of E. faecalis V583 prophages. Open-reading frames 
are indicated by arrows. Only genes encoding predicted function are annotated. Colors 
correspond to the seven functional modules of temperate phages as depicted at the 
bottom right corner. 
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and lysis. These predictions suggest that pp7 is either defective or 
belongs to the family of the phage-related chromosomal islands (PRCIs) 
predicted in Gram-positive bacteria, including E. faecalis [13]. Altogether, 
five of the V583 prophages are predicted to form active particles 
autonomously. 
 
Prophages 1, 3, 4, 5 and 7 excise from the chromosome 
Prophages excise from the bacterial chromosome by inactivation of 
their repressor triggered either spontaneously or by a signal, which 
frequently depends on the induction of the SOS response [43]. To confirm 
our predictions on prophage activity, we tested the ability of the V583 
prophages, under various environmental stresses, to accomplish the four 
major steps of temperate phage life cycle: excision, replication, DNA 
packaging and production of infectious particles. 
We studied the activity of V583 prophages in the strain VE14089, 
which is a V583 derivative cured of its plasmids, and referred to as WT 
hereafter, a genetically tractable strain compared to the original V583 [36]. 
To determine whether prophages were able to excise from the 
chromosome, bacteria were challenged either with chemical compounds 
known to trigger prophage induction through SOS response and/or 
formation of reactive oxygen species (mitomycin C, ciprofloxacin, 
thrimetoprim, ampicillin), or with varying temperatures (28, 37 and 42°C) 
for 2 hours. Total DNA was recovered and analyzed by PCR to search for 
expected products of chromosomal excision and prophage circularization, 
referred as attB and attP region, respectively (Figure 2A). Results of 
amplification of the attB region resulting from prophage excision obtained 
with or without mitomycin C and ciprofloxacin are presented in Figure 2B. 
The excision of pp1, pp3, pp5 and pp7 was already detected under non-
inducing conditions, indicating a basal natural excision in laboratory 
growth conditions.  
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Figure 2. Prophage excision and replication. Agarose gel analysis of prophage excision 
and circularization products corresponding to attB and attP regions, respectively, probed 
by PCR. (A) Experimental approach: two sets of primers were used to detect prophage 
excision from the chromosome. The first set in red targets the excision site on the 
chromosome (attB) and the second set in green targets prophage circular forms (attP). (B) 
Prophage excision products corresponding to attB region were probed by PCR in WT 
cultures induced with 2 µg/ml of mitomycin C (M), or ciprofloxacin (C) or uninduced (-) at 
28, 37 and 42°C. Ch corresponds to amplification of a strain specific chromosomal gene. 
(C) Prophage excision products in strain pp3¯ pp5¯ at 37°C. (D-F) Excision and 
circularization products probed by semi-quantitative PCR on 100, 10 and 1 pg of total 
bacterial DNA prepared from cultures of WT (D) and strains pp3¯ pp5¯ (E) pp4+ (F) induced 
for 2 h with 2 µg/ml of ciprofloxacin at 37°C except for detection of pp4 products in the WT 
strain that were obtained from DNA prepared after induction at 42°C. Twenty and 32 PCR 
cycles were used to amplify products of pp1 and pp7 and products of pp3, pp4 and pp5, 
respectively. These results are representative of three independent experiments. 
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Yet, prophages responded differently to environmental challenges. While 
pp3 was equally induced at 28, 37 and 42°C, natural induction of pp1 
increased with temperature but those of pp5 and pp7 decreased with 
temperature. Strikingly, excision of pp4 was detected only at high 
temperature (42°C) (Figure 2B). Both mitomycin C and ciprofloxacin 
increased or triggered pp1, pp3, pp4, pp5 and pp7 excision from the 
bacterial chromosome at all tested temperatures. Trimethoprim challenge 
induced prophages similarly to ciprofloxacin, while ampicillin had no effect 
on prophages induction (data not shown). No excision of pp2 and pp6 was 
detected in any of the tested conditions. The PCR amplification fragments 
of the excision and integration sites were sequenced and confirmed the in 
silico predictions from V583 genomes of the attachment (att) core 
sequences (Table 2). This information was further used to reconstitute the 
prophage integration sites upon deletion by homologous recombination 
(see below). Note that excision of pp4 restores an open reading frame in 
an operon encoding competence-like genes [44] and that pp7 integrates in 
the promoter region of a putative xanthine/uracil permease gene. 
Together, these results revealed that pp1, pp3, pp4, pp5 and pp7 excise 
from the chromosome and that all prophages, but pp3 show different 
responses to environmental cues such as temperature and antibiotics, 
suggesting potential population heterogeneity of WT strain depending on 
each growth condition. However, in all conditions tested pp2 and more 
surprisingly pp6, were not excised. 
 
Prophages 3 and 5 inhibit excision of pp6 
Because complex mechanisms of interference between prophages 
have been reported [18,45], we wondered whether elimination of some 
prophages would facilitate excision of pp2 and pp6. For this purpose, we 
deleted successively prophages pp3 and pp5 (see materials and 
methods) and then checked for pp2 and pp6 excision. Interestingly, pp6 
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was excised in strain pp3¯ pp5¯ deleted for pp3 and pp5 (Figure 2C), 
whereas it was not excised in strains deleted either for pp3 or pp5 alone 
(data not shown). Although excisable in the absence of pp3 and pp5, pp6 
does not replicate (Figure 2E). While pp6 basal level of excision was not 
increased upon temperature or chemical challenge, this finding allowed us 
to determine the pp6 att core sequence (Table 2). Finally, prophage 
deletions were performed to generate strain pp¯ deleted for all prophages 
but pp2. Again, no excision of pp2 was detected validating that pp2 is a 
phage remnant. We conclude that pp6 excision is repressed by both pp3 
and pp5. Thus we demonstrated that prophages carried by the V583 E. 
faecalis chromosome, with the exception of pp2, can excise and thereby 
may form phage progeny. 
 
Table 2. Prophage att core sequence predicted and confirmed experimentally from V583 
genomea. 
Prophage Genes Integration site Sequence 5’-3’
pp1 ef0303-ef0355 3’ end of ef0302  CCTTGGGATCCAATGGG 
pp3 ef1417-ef1489 3’ end of ef1416  ACAAACGCAACATGTTCGCTTTA
TTAGGTAAACCAGG 
pp4 ef1988-ef2043 Within cglD-likeb gene  CCACTCCCCATCTGAAATT 
pp5 ef2084-ef2145 3’ end of tRNA-Thr2 GGCAGGTGGCT 
pp6 ef2798-ef2855 Downstream of 3’ end of 
ef2856 
TAAATTATTTAGTTTCACGGTGT
AA 
pp7 c ef2936-ef2955 Upstream of 5’ end of 
ef2935 
TATTAATGAAACAACGTG 
a Genome accession number: AE016830 
b cglD stands for for comG-like [44] 
c Renamed EfCIV583 in this work 
 
 
Prophages 1, 3, 5 and 7 form infectious virions 
We then established which V583 prophages were able to replicate 
their genome after excision. Levels of both prophage circular forms and 
chromosomal excision regions from non-induced and ciprofloxacin-
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induced cultures were compared using semi-quantitative PCR. Circular 
forms of pp4 at 42°C, and pp1, pp3, pp5 and pp7 at 37°C were at least 
10-fold more abundant than the corresponding chromosomal excision 
regions, respectively (Figure 2D). In contrast, no replication activity was 
detected for pp6 in a pp3¯ pp5¯ strain (Figure 2E). To further investigate 
whether DNA of prophages could be packaged into phage particles, we 
precipitated phage particles from ciprofloxacin-induced cultures of wild-
type strain at 28ºC, 37ºC and 42°C and strain pp3¯ pp5¯ at 37°C and 
extracted packaged DNA. Samples of phage DNA were analyzed by FIGE 
followed by Southern-blot hybridization with prophage-specific probes. In 
all the tested conditions, packaged DNA of pp1 (38.2 kb), pp5 (43.0 kb) 
and pp7 (12 kb) were detected, showing that pp1, pp5 and pp7 DNAs 
were encapsidated whereas DNA of pp3, pp4, and pp6 was not detected 
(Figure 3).  
 
 
Figure 3. Detection of prophage packaged DNA. Encapsidated prophage DNA 
recovered from supernatant of WT cultures obtained at different temperatures 2h after 
ciprofloxacin treatment at 2 µg/ml and detected by southern-blot hybridization with 
prophage specific probes. Non-treated and ciprofloxacin treated cultures correspond to 
lanes (-) and (C), respectively. DNA of pp1, pp5 and pp7 is encapsidated at all 
temperatures under inducing conditions. 
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As pp7 does not encode its own capsid proteins (Table 1), it might need a 
helper phage to form particles like PRCIs (see below). Packaged DNA of 
pp5 and pp7 was less abundant at 42°C, as expected (see Figure 2B). 
While the absence of pp6 DNA-containing particles correlates with the 
lack of pp6 replication, non-detection of particles of pp3 and pp4 DNA 
could be explained either because their DNA was not packaged or the 
techniques used were not appropriate to isolate the cognate phage 
particles.  
Finally, to determine which E. faecalis prophages have kept full viral 
activity, we examined their ability to form infectious virions. As a way to 
recognize the different virions generated by the WT strain, we constructed 
a set of isogenic strains deleted for individual prophages, namely strains 
pp1¯, pp3¯, pp4¯, pp5¯, pp6¯ and pp7¯, which harbored the natural attB 
integration site of the deleted prophage previously determined (see 
materials and methods) (Table S1). In a naïve scheme, such strains 
should be immune to superinfection by all phages except the one that no 
longer stands in the bacterial genome. Phage-deleted strains were 
infected with supernatants of ciprofloxacin-induced cultures from WT and 
pp3¯ pp5¯ strains (Table S3). Plaques were detected on strains pp3¯, pp5¯, 
and pp7¯, suggesting that particles containing pp3, pp5 or pp7 DNA are 
infectious. Interestingly, despite encapsidation of pp1 DNA (Figure 3), lytic 
activity of pp1 DNA-containing particles was not detected on strain pp1¯. 
This result suggested that either pp1 DNA-containing particles were non-
infectious, or that strain pp1¯ was still immune to P1 (see below). No 
plaque formation was observed on indicator strains pp4¯ and pp6¯, 
indicating that although pp4 and pp6 were excised and pp4 replicated, 
these prophages are deficient for the formation of infectious particles. 
Since phage interactions or interference could occur during particle or 
plaque formation we constructed monolysogen strains for each prophage, 
named pp1+ to pp7+, and tested the ability of their ciprofloxacin-induced 
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supernatants to form infectious particles on a pp¯ strain deleted for all 
prophages (Table S3). The results confirmed that pp3 and pp5 produced 
infective virions and that pp4 and pp6 did not. As expected, we confirmed 
that pp6 circular forms were detected in strain pp6+ in non-induced 
conditions (data not shown). Prophage 4, which excision depends on a 
high temperature (42°C) in strain WT, excises readily and replicates at 
37°C in strain pp4+, deleted of all prophages but pp4 (Figure 2F). This 
observation suggests that some of the other V583 prophages could 
interfere with pp4 excision at 37°C in the WT strain. Interestingly, 
supernatant of the pp1 monolysogen strain (pp1+) formed plaques on 
strain pp¯, indicating that pp1 DNA containing particles were infectious in 
the absence of other prophages. In contrast, the pp7 monolysogen strain 
(pp7+) failed to produce infectious particles; further supporting that pp7 
requires a helper phage. 
Despite the absence of visible lysis upon prophage-inducing 
treatments, we evaluated the effect of prophage induction on bacterial 
population by assessing the growth of the strains WT, pp¯, pp1+ and pp3+ 
pp5+ 6 h after ciprofloxacin-mediated induction. Ciprofloxacin treatment of 
wild-type strain lowered the growth of approximately 10 % compared to 
the untreated culture while similar treatment had no effect on strain pp¯ 
deleted for all prophages (Figure S1). Moreover, the strains pp1+ and pp3+ 
pp5+ showed significantly decreased biomass when treated with 
ciprofloxacin. These observations suggest that V583 prophages are 
induced or perform full lytic cycle in a fraction of the bacterial population 
only, thereby leading to a mixed population with different combination of 
excised prophages. 
In sum, these results demonstrate that pp1, pp3, pp5 and pp7 
produce infective virions in specific conditions. Despite their excision, pp4 
and pp6 are unable to produce infectious particles. Noticeably, pp4 and 
pp6 genomes contain several pseudogenes located in the morphogenesis 
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module (ef2000, ef2009, ef2026, ef2029 for pp4 and ef2809 for pp6) that 
could explain that these phages are defective in capsid assembly. While 
phages 1 (P1), 3 (P3) and 5 (P5) are autonomous, pp7 requires a helper 
phage to form infectious particles. P3 and P5 provide self-immunity to 
their bacterial host, and P1 shows cross-immunity with at least one of the 
other prophages. 
 
Prophage 7 requires P1 as a helper phage for encapsidation 
Subordination of pp7 to a helper phage to form infectious particles 
was correlated with comparative genomic hybridization data (Akary and 
Serror, unp. data) and sequence analysis of available genomes, which 
indicate that pp7 is present only in few CC2 isolates, which also carry pp1 
whereas pp1 is sometimes present alone [33,46]. Thus, we hypothesized 
that P1 acts as a helper phage of pp7. To test our hypothesis, we 
constructed strain pp1+ pp7+, which contains pp1 and pp7 only (Table S1). 
Supernatants of ciprofloxacin-treated isogenic strains pp1¯ and pp1+ pp7+ 
were tested for plaque formation on the indicator strain pp7¯. While the 
dilysogen strain pp1+ pp7+ gave plaques, deletion of pp1 abrogated plaque 
formation, demonstrating that pp1 is necessary and sufficient for 
production of P7 virions. We conclude that the presently described pp7 
corresponds to the phage-related E. faecalis chromosomal island, 
predicted by Novick and collaborators [13], and rename pp7 as EfCIV583 
for E. faecalis chromosomal island V583. 
To identify the step at which pp1 was required for production of 
EfCIV583 virions, we analyzed both the excision and replication of 
EfCIV583 and the packaging of EfCIV583 DNA in WT and the isogenic 
strains pp1¯, pp1+ pp7+, pp7+ and pp1+ by semi-quantitive PCR. Excision 
(attB region) and replication (attP region) products of EfCIV583 were 
detected in pp1¯ and pp7+ strains at the same level as strains wild type and 
pp1+ pp7+ (Figure 4A), showing that pp1 is not required for EfCIV583 
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excision and replication. Next, DNA from phage particles produced by 
ciprofloxacin-treated WT and the isogenic strains pp1¯, pp1+ pp7+, pp7+ 
and pp1+ was recovered and analyzed as described above. Particles 
containing EfCIV583 DNA were recovered from WT and pp1+ pp7+ strains, 
while EfCIV583 DNA was no longer packaged in the absence of pp1 
(strain pp1¯) or when present as a single element (strain pp7+) (Figure 
4B), indicating that pp1 is required for packaging of EfCIV583 DNA. 
Independent hybridizations revealed that EfCIV583 DNA is encapsidated 
as monomers only since no signal was detected at high molecular weight 
(data not shown). Noticeably, while the amount of the EfCIV583 DNA was 
similar between strains, the amount of pp1 DNA increased significantly 
when EfCIV583 was deleted (strain pp1+), suggesting that EfCIV583 DNA 
hijacks P1 proteins at the expense of P1 particles production. 
 
Figure 4. Interaction between E. faecalis pp1 and pp7 (EfCIV583). (A) Semi-
quantitative PCR detection of EfCIV583 circular forms (attP) and excision sites (attB) in 
wild-type (WT) and strains pp1¯, pp1+ pp7+ and pp7+. Excision and circularization products 
probed by semi-quantitative PCR on 100, 10 and 1 pg of total bacterial DNA prepared from 
cultures of WT and strains pp1¯, pp1+ pp7+ and pp7+ induced for 2 h with 2 µg/ml of 
ciprofloxacin at 37°C. Twenty cycles were used to amplify products of pp1 and EfCIV583. 
These results are representative of two independent experiments. (B) Prophage DNA 
extracted from precipitated phage particles obtained from lysates of WT and strains pp1¯, 
pp1+ pp7+ and pp7+ was separated by FIGE and analyzed by Southern-blot and hybridized 
sequentially using specific probes for pp1 and EfCIV583 genomes. The approximately 38.2 
kb and 12 kb band corresponds to P1 and EfCIV583 genome, respectively. As ascertained 
by pp1-specific hybridization, migration of P1 DNA was delayed in lane pp1+ and pp7¯ 
compared to lanes WT and pp1+pp7+. Lambda DNA mono-cut mix (NEB) was run next to 
the samples to validate band sizes. (C) Scanning electron microscopy images of bacterial 
cells from strains pp¯ and pp1+pp7+ after ciprofloxacin treatment. (D) Transmission electron 
microscopy images of phages produced by strain pp1+pp7+ after ciprofloxacin treatment. 
White and black arrows indicate big and small sized particles attributed to P1 and 
EfCIV583, respectively. Enlarged images of EfCIV583 and P1 (renamed vB_EfaS_V583-
P1) are shown on the right. 
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 The above molecular evidences for EfCIV583 pirating P1 proteins 
correlate with respective phage titers (Table 3). First, EfCIV583 titer was 
10-fold higher than the titer of P1 in lysates from strain pp1+ pp7+, 
supporting that when present, EfCIV583 outnumbers P1 particles. 
Secondly, P1 titer of lysates from strain pp1+ was 100-fold higher than in 
lysates from strain pp1+ pp7+, indicating that EfCIV583 impairs the 
production of P1 particles. Interestingly, P1 particles are infectious on 
strains pp1¯ pp7¯ and pp¯, but not on strains pp1¯ nor pp7+ (Tables 3 and 
S3), further supporting that EfCIV583 interferes with P1 growth. 
 
Table 3. Production of infectious P1 and EfCIV583 virions. 
Indicator strain Lysate (pfu/ml)
WT pp1+ pp7+ pp1+ 
pp¯ 3.0 x 102 1.6 x 103 1.1 x 105 
pp1¯ pp7¯ 1.5 x 102 4.0 x 103 1.5 x 105 
pp1¯ - - - 
pp7¯ 2.0 x 103 1.8 x 104 - 
 
SaPI are usually encapsidated into small-headed phage particles, 
distinguishable from their helper phage particles [16]. Indeed here, as pp1 
and EfCIV583 genomes differ in size, P1 and EfCIV583 particles were 
expected to be distinguishable in size. Scanning electron microscopy 
observation of a ciprofloxacin treated culture from the pp1+ pp7+ dilysogen 
revealed the existence of two phage size particles (Figure 4C), which 
were further confirmed by transmission electron microscopy (Figure 4D). 
Measurement of the capsids grouped the particles into small and large-
size groups of ~ 46 nm and ~ 62 nm of width, respectively (Figure 5). Both 
particles harbored similar size tail of ~165 nm in length. As a control, P1 
particles obtained from strain pp1+ were also analyzed. Their size 
corresponds to the size of the large-size capsids produced by strain pp1+ 
pp7+, strongly indicating that large and small capsids belong to P1 and 
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EfCIV583 virions, respectively. In addition, we confirmed that P1 belongs 
to the Siphoviridae family with a non-contractile tail (Figure 4D). 
Accordingly to Kropinsky’s nomenclature proposal for bacterial virus [47], 
we propose to rename phage 1 “vB_EfaS_V583-P1”.  
 
 
Figure 5. Capsid size distribution of virions produced by strains pp1+ pp7+ and pp1+. 
Scatter plot of the capsid width (nm) measured particles for strains pp1+ pp7+ (n=42) and 
pp1+ (n=24). Strain pp1+ pp7+ produced two groups of different capsid size, small and large 
with a mean width of 46.1 ± 3.7 nm and 61.1 ± 1.3 nm, respectively. Strain pp1+ produced 
homogenous capsid size with a mean width of 62.9 ± 3.3 nm. 
 
During completion of this manuscript, Duerkop et al, proposed that P1 and 
EfCIV583 were encapsidated together in a composite phage [48]. This 
hypothesis does not fit with the results reported here, and to completely 
exclude this possibility, we investigated particles infectivity on different 
indicator strains and identified the resulting plaques by phage-specific 
PCR (Figure 6). A mixed lysate of P1 and EfCIV583 was propagated on 
strains devoid of both pp1 and EfCIV583 (e. g. strains pp¯ and pp1¯ pp7¯). 
Under such circumstance, EfCIV583 should not form plaques, unless its 
DNA is indeed always encapsidated with that of its helper phage (Figure 
6). Plaques were screened for the presence of EfCIV583 DNA, and none 
were found positive. As a control, the same lysate grown on a pp1 positive 
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lawn gave EfCIV583 positive plaques, as expected. Thus, we conclude 
that EfCIV583 DNA is encapsidated separatly into small size particles, 
and does not travel along with its helper phage. We can nevertheless 
explain how Duerkop et al. came to their inappropriate conclusion (see 
discussion). According to our results and in keeping with SaPIs elements, 
pp1 and EfCIV583 DNA are packaged in distinct particles and we propose 
that large and small phages correspond to packaging of pp1 and 
EfCIV583 DNA, respectively. Altogether, our results demonstrate that 
EfCIV583 is a self-excisable and -replicative phage-related element, using 
P1 as a helper phage. 
 
 
 
 
 
 
 
Figure 6. DNA of pp1 and EfCIV583 are packaged in separated capsids. Presentation 
of two working hypotheses for pp1 and EFCIV583 DNA packaging in a dilysogen strain 
and experimental results corroborating one of them. On the left, DNAs are packaged inside 
the same capsid. The resulting virions are predicted to deliver both DNA during infection 
and to form plaques containing both P1 and EFCIV583 virions since pp1 is required for 
formation of EfCIV583 virions on indicator strains pp¯ and pp1¯ pp7¯, both deleted for pp1 
and EfCIV583. On the right, pp1 and EfCIV583 DNAs are packaged separately in two 
different capsids. The resulting virions would deliver either pp1 or EfCIV583 DNA during 
infection of strains pp¯ and pp1¯ pp7¯, and would form only P1 plaques since pp1 is required 
for formation of EfCIV583 virions and co-infection by two particles is highly improbable. 
However, EfCIV583 virions would be detected on the indicator strain pp7¯ (harboring pp1). 
Lysates of strain pp1+ pp7+ were tested on indicator strains pp¯, pp1¯ pp7¯ and pp7¯ and the 
resulting plaques were identified by pp1 and EfCIV583-specific PCRs. Our results strongly 
support that P1 and EfCIV583 genomes are packaged in two different capsids since 
plaques formed by pp1+ pp7+ lysates on indicator strains pp¯ and pp1¯ pp7¯ were identified 
as P1 plaques only, while EfCIV583 virions were detected on indicator strain pp7¯.  
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Prophage 1 interferes with pp4 excision 
Having observed that pp4 excises spontaneously at 37°C in a 
monolysogen strain, we analyzed the presence of pp4 circular forms in a 
panel of strains containing various prophages to understand which one(s) 
was interfering with its excision (Figure S2). Interestingly, the presence of 
pp4 circular form at 37°C was strictly correlated with the absence of pp1 
prophage, indicating that pp4 excision is blocked at 37°C when pp1 is 
present.Spontaneous excision of pp4 at 42°C in WT strain suggests that 
the inhibitory effect of pp1 is thermosensitive. Indeed, P1 titer of 
supernatants of a monolysogen strain increased 10-fold, from 104 pfu/ml 
to 105 pfu/ml when grown at 42°C, further supporting that P1 repressor is 
thermosensitive. This result reveals another level of E. faecalis prophage 
interactions, in which prophage pp1 interferes with excision of pp4. 
 
Potential plasmid-prophage interactions 
We next investigated whether phages were produced as readily in the 
V583 parental strain as in the plasmid-cured strain used hitherto. For this, 
supernatants of V583 cultures treated or not with ciprofloxacin were plated 
on the same set of indicator strains pp1¯, pp3¯, pp4¯, pp5¯, pp6¯, pp7¯ as 
above. PRCI EfCIV583, but not P3 nor P5 was found to form plaques on 
the corresponding deleted strains. These results show that strain V583 
exhibits a lower efficiency to produce phages compared to its plasmid-
cured derivative, and suggest that plasmid-curing has somehow caused 
an increase of the basal level of prophage induction, indicating a possible 
interference of plasmids with prophages. If plasmid pCM194 can increase 
phage production of a SPO2 lysogen Bacillus subtilis strain [49], it is also 
possible that plasmids interfere negatively with phage production and 
contribute to prophage accumulation leading to polylysogenic strains.  
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DISCUSSION 
 
In the present study, we characterized the biological activity (excision, 
replication and virion production) of six E. faecalis predicted prophages of 
a plasmid-cured derivative of the polylysogenic V583 isolate, a 
representative of the hospital-adapted clade CC2. We show that all of the 
predicted prophages, except V583-pp2, are able to start a lytic cycle, with 
four of them (V583-pp1, V583-pp3, V583-pp5 and V583-pp7) leading to 
the production of phage progeny, which is exacerbated by clinically 
relevant antibiotics. Besides showing that phages P1, P3 and P5 are 
autonomous and confer self immunity to their bacterial host, we identified 
three levels of prophage interactions: i) the herein demonstrated phage-
related chromosomal island EfCIV583 (V583-pp7) hijacks P1 capsids and 
interferes with P1 infectivity, ii) pp1 exerts a temperature-dependent 
inhibition of pp4 excision, and iii) pp3 and pp5 block excision of pp6. 
Altogether, the interplay between these prophages potentiates their 
mobility and biological activities.  
Polylysogeny is found in a variety of bacterial species, including E. 
faecalis [34] and it is frequently considered as the result of an adaptive 
evolution process in which prophages are maintained as they confer 
advantageous properties to the bacterial strains [23,50-54]. As a way to 
maintain and propagate themselves, prophages interfere with each other 
through a variety of mechanisms in different bacterial species [18,52,55]. 
We demonstrate that EfCIV583 is a phage-related chromosomal island 
that excises and replicates autonomously as an episome, but specifically 
requires P1 structural proteins for production of infectious virions. 
Correlating the genome length of each prophage with the electron 
microscopic observations and virion infectivity, we propose that P1 and 
EfCIV583 virions encapsidate into large and small size particles, 
respectively. Moreover, as packaging of EfCIV583 DNA mobilizes P1 
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structural proteins, EfCIV583 outcompetes with the formation of P1 
particles and interferes with P1 plaque forming ability. Our conclusions on 
P1 and EfCIV583 DNA packaging and autonomy of the helper phage P1 
differ from those recently reported by Duerkop et al., 2012 [48]. Their data 
can be fully explained by the chromosomal island-helper phage interaction 
that we have described between EfCIV583 and P1, except for the 
apparent absence of P1 particles in the supernatant of a V583 strain 
mutated for EfCIV583 (their Fig. 2D), which leads the authors to suggest 
that P1 depends on EfCIV583 for its growth. However, the indicator 
strains used in this experiment are not appropriate to count P1 plaques as 
they are lysogen for P1 and therefore immune to P1 (WTs of their Fig. 
S6). According to our data and as depicted in Figure 7, the interaction 
between E. faecalis P1 and the phage-related chromosomal island 
EfCIV583 is a case of molecular piracy, which involves hijacking of P1 
structural proteins by EfCIV583 DNA to be disseminated into small 
capsids. This is to our knowledge the first example of Gram positive, other 
than staphylococci, in which such molecular piracy phenomenon has been 
described. In spite of the resemblance with the well studied system of the 
SaPIs and their helper phages [13,14], EfCIV583/P1 system is different in 
several ways. First, with the exception of SaPIbov1 and SaPIbov2 [56], 
SaPIs are generally stably maintained into the bacterial genome [13] 
through the action of a SaPI-encoded master repressor [15], which is 
inactivated by helper-phage specific antirepressors [57,58]. Here, 
spontaneous excision of EfCIV583 in a monolysogen strain suggests that 
the activity of its predicted repressor (EF2954) is controlled by a helper 
phage-independent mechanism. Furthermore as EfCIV583 excision is 
increased by ciprofloxacin, this repressor is likely under the control of the 
SOS response. Similarly, SpyCIM1 of S. pyogenes responds to SOS 
system, however the implication of a helper phage for its induction 
remains to be investigated. Excision and reintegration of SpyCIM1 adjust 
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the adaptation capacity of the host strain by modulating expression of the 
gene mutL [11,59]. 
 
 
 
Figure 7. Model of P1 / EfCIV583 interplay. Infectious P1 and EfCIV583 particles are 
produced by strains WT and pp1+pp7+ whereas no particles are produced in the absence 
of pp1 (strains pp1¯ and pp7+), showing that pp1 is required to form EfCIV583 virions. This 
hijacking phenomenon impairs the production of P1 particles in favor to EfCIV583. As 
observed by SEM and TEM, strain pp1+pp7+ produces two different sizes of phage 
particles: the biggest package most probably P1 and the smallest EfCIV583. In the 
absence of EfCIV583 (strains pp7¯ and pp1+), P1 virions are produced at higher titer. 
 
 
Given that EfCIV583 integrates into the promoter region of a putative 
xanthine/uracil permease gene, it may dynamically modulate xanthine or 
uracil utilization. Secondly, while the best studied SaPIs, SaPI1 and 
SaPIbov, form mostly small capsids, their DNA can also be packaged as 
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multimers into large capsids [60,61]. In the case of EfCIV583, the 
packaging specificity seems to be tightly controlled since EfCIV583 DNA 
is packaged exclusively as the monomeric form. Lastly, different 
interference mechanisms used by the SaPIs to counteract capsid 
formation and DNA packaging of the helper phage have been recently 
deciphered [18,19]. They rely on capsid morphogenesis (cpm) and phage 
packaging interference (ppi) genes of which no close homolog can be 
identified in EfCIV583 (R. Guerois, Pers. Comm.), suggesting that 
EfCIV583 may use other mechanisms to interfere with P1. Thus, besides 
expanding and strengthening the concept of molecular piracy within 
bacteria, the enterococcal EfCIV583/P1 system exhibits specific molecular 
mechanisms that deserve to be further investigated. 
Remarkably, pp4 and pp6 are kept silent by other prophages. 
Prophage pp1 negatively interferes with pp4 excision at 37°C but not at 
42°C. As excision of pp1 is increased at 42°C, a simple explanation may 
be that the pp1 repressor is itself thermosensitive and controls pp4. We 
also found that pp6 excises only when pp3 and pp5 are deleted from the 
wild type strain. Since single deletion of pp3 or pp5 had no effect on pp6 
induction, it is conceivable that pp3 and pp5 exert redundant repression of 
pp6 induction. Noticeably, pp3 and pp5 share the highest homology 
compared to the other V583 prophages, suggesting a potential crosstalk. 
A recent study from Lemire et al., 2011 described a mechanism of 
antirepressor-mediated control of prophage induction involving recognition 
of both cognate and non-cognate repressors of Gifsy prophages in 
Salmonella [45]. Interestingly, their work suggests coordinate induction of 
lytic cycle of prophages in polylysogenic strains. Prophage interferences 
and low efficiency of lysis on V583 upon induction may contribute to 
maintain diversity within the bacterial population and ensure survival. 
Further genetic and molecular studies will be required to characterize the 
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crosstalk mechanisms between E. faecalis prophages, including 
prophage-related chromosomal islands.  
Gene dissemination is an important biological aspect through which 
temperate phages impact on bacterial species [17,62,63]. Prophage 
mediated gene transduction has been recently reported between E. 
faecalis strains and between enterococcal species [34,64]. We 
demonstrated that V583 pp1, pp3, pp5 and EfCIV583 form infectious 
particles suggesting that they are capable of mediating horizontal gene 
transfer. Their excision is enhanced by SOS-triggering agents, including 
mitomycin C, trimethoprim and the fluoroquinolone antibiotic ciprofloxacin. 
Fluoroquinolones inhibit DNA gyrase and topoisomerase IV and cause 
DNA double-strand breaks, as such, they are among the most efficient 
phage-inducing antibiotics [65,66]. Fluoroquinolones promote release of 
Shiga toxins encoded by prophages from Escherichia coli [67], potentiate 
the spread of virulence traits in Staphylococcus aureus [68] and eventually 
reduce strain competitiveness [69]. Though the impact of the E. faecalis 
prophages in promoting both strain fitness and horizontal gene spreading 
has yet to be studied, phage-inducing antibiotics may contribute to the 
emergence of E. faecalis polylysogenic strains, such as V583. Treatment 
with fluoroquinolones was identified as a risk factor for infection or 
colonization by vancomycin-resistant enterococci in the U.S, where the 
CC2 isolates have emerged [70].  
Given the complexity of the interplay between V583 prophages, we 
anticipate that mixed E. faecalis subpopulations may be formed upon 
prophage induction and could favor survival of one or several of them as 
described for different bacterial species especially in biofilms [20,71-73]. 
In all, temperate phages are likely to potentiate E. faecalis genetic and 
physiological flexibility for optimal adaptation during colonization or 
infection. 
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SUPPLEMENTARY INFORMATION 
 
Figure S1. Growth of ciprofloxacin-treated strains. The WT and isogenic strains pp¯, pp1+ 
and pp3+ pp5+ were grown at early exponential growth phase (OD600 ~ 0.2) before 
treatment with ciprofloxacin at 4 or 6 µg/ml. Relative optical density (OD600) was calculated 
for each strain as the ratio of OD600 of the ciprofloxacin-induced cultures (Cip 4 and Cip 6) 
with the non-induced culture (Cip 0) 6 h after addition of ciprofloxacin later. The mean and 
the standard error of the mean (SEM) obtained on two independent cultures for each strain 
is shown.  
 
 
 
Figure S2. pp1 interference with pp4 excision. PCR detection of pp4 circular forms in 
different isogenic strains (see Figure 2A): WT, pp3¯, pp3¯ pp5¯, pp1¯ pp3¯ pp5¯, pp4+ pp6+ 
and pp4+ (see Table S1). Circular forms of pp4 are detected only in the absence of pp1. 
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Table S1. Bacterial strains and plasmids used in this study. 
Strain or 
plasmid 
Short name Relevant characteristics Reference or 
source 
Strain   
E. coli    
TG1  supE hsdD5 thi (∆lac-proAB) F’ (traD36 proAB-
lacZ∆M15) 
[74] 
GM1674  dam-dcm- repA+ [75] 
E. faecalis   
VE14002 V583 V583 vancomycin resistant clinical isolate [30] 
VE14089  WT V583 vancomycin resistant clinical isolate cured of its 
plasmids 
[36]  
VE14492 V583pTEF1 V583 vancomycin resistant clinical isolate cured of its 
plasmids transconjugated with pTEF1 
This study 
VE14279  pp3¯ pp3 deletion in E. faecalis VE14089 This study 
VE18306 pp6¯ pp6 deletion in E. faecalis VE14089 This study 
VE18310 pp4¯ pp4 deletion in E. faecalis VE14089 This study 
VE18284  pp7¯ pp7 deletion in E. faecalis VE14089 This study 
VE14285  pp5¯ pp5 deletion in E. faecalis VE14089 This study 
VE18299  pp3¯ pp5¯ pp3 and 5 deletion in E. faecalis VE14089 This study 
VE18313  pp1¯ pp1 deletion in E. faecalis VE14089 This study 
VE18316  pp1+ pp7+ pp3, pp4, pp5 and pp6 deletion in E. faecalis VE14089 This study 
VE18566 pp1¯ pp7¯ pp1 and pp7 deletion in E. faecalis VE14089 This study 
VE18576 pp4+ pp6+ pp1, pp3, pp5 and pp7 deletion in E. faecalis VE14089 This study 
VE18589  pp7+ pp1, pp3, pp4, pp5 and pp6 deletion in E. faecalis 
VE14089 
This study 
VE18590 pp¯ pp1, pp3, pp4, pp5, pp6 and pp7 deletion in E. faecalis 
VE14089 
This study 
VE18559  pp1¯ pp3¯ pp5¯ pp1, pp3 and pp5 deletion in E. faecalis VE14089 This study 
VE18562 pp1+ pp3, pp4, pp5, pp6 and pp7 deletion in E. faecalis 
VE14089 
This study 
VE18581 pp6+ pp 1, pp3, pp4, pp5 and pp7 deletion in E. faecalis 
VE14089 
This study 
VE18582 pp4+ pp1, pp3, pp5, pp6 and pp7 deletion in E. faecalis 
VE14089 
This study 
VE18583 pp3+ pp5+ pp1, pp4, pp6 and pp7 deletion in E. faecalis VE14089 This study 
Plasmids    
pGEM-T  Ampr, linearized with 3’ T overhangs, ori ColE1 Promega 
pG+host9  Ermr, repATs [76] 
pVE14354  Ampr, pGEM-T with ef1417-ef1489 deletion This study 
pVE14357  Ampr, pGEM-T with ef2085-ef2145 deletion This study 
pVE14362  Eryr, pG+host with ef1417-ef1489 deletion This study 
pVE14364  Eryr, pG+host with ef2085-ef2145 deletion This study 
pVE14367  Ampr, pGEM-T with ef2798-ef2855 deletion This study 
pVE14368  Eryr, pG+host  with ef2798-ef2855  deletion This study 
pVE14369  Ampr, pGEM-T with ef1988-ef2043 deletion This study 
pVE14370  Eryr, pG+host with ef1988-ef2043 deletion This study 
pVE14371  Ampr, pGEM-T with ef0303-ef0355 deletion This study 
pVE14372  Eryr, pG+host with ef0303-ef0355 deletion This study 
pVE13473  Ampr, pGEM-T with ef2936-ef2955 deletion This study 
pVE13474  Eryr, pG+host with ef2936-ef2955 deletion This study 
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Table S2. Primers used in this study. 
Primer 
name 
Sequence (5’→3’)* Position of 
the primer 
5’ end† 
Reference 
or source 
ef0302f CGTGGATGGACGAATACAC 289 146 This study 
ef0303f GCAGTACAGATTATAAAA 289 672 This study 
ef0355f GATCGGCAACAAGTAATGTC 326 034 This study 
ef0357f AGAACATCAGTACATTTTACC 326 635 This study 
ef3155f ACAGCACCAGACCCGACAG 3 026 754 This study 
ef3155r ACGACGAGGTTCCATGTGATG 3 026 256 This study 
OEF470 AGACTAGAGTTACTACCCC 2 003 732 This study 
OEF471 AGCCACCTGCCGGGCTTG 2 004 735 This study 
OEF472 CAAGCCCGGCAGGTGGCTTTTTGGTAAAATCCCAACTC 2 048 272 This study 
OEF473 GCATCACCTGCGATATTTC 2 049 399 This study 
OEF474 TTGTGTTTAACACTCGGAGC 2 003 577 This study 
OEF475 AATTGGGTAGTTTCGACTTG 2 049 708 This study 
OEF476 GAAAGCGCCACAAATCTTC 1 396 960 This study 
OEF477 CTATAGGCGTGCATTTAAATC 1 397 966 This study 
OEF478 GATTTAAATGCACGCCTATAGTTTGTAAATAACAGAAGAAAA 1 446 359 This study 
OEF479 AATAGAGATACGCTCAGCC 1 447 403 This study 
OEF480 CTGGCTGGATTGATTTACC 1 396 770 This study 
OEF481 CAACAGCTTCTTCACTCTC 1 447 606 This study 
OEF483 CATATTTTCACCTCCTATCC 1 402 370 This study 
OEF485 TCTCTAGGATGTTGTTGAGG 1 401 513 This study 
OEF488 GCCGCACATATAGATGATG 2 045 368 This study 
OEF489 CTAATTTCTTTGGTTCTGCC 2 047 006 This study 
OEF490 CAGAGTTCCTAGGAGTAAC 2 045 792 This study 
OEF491 GTTGTTCTAAGGTTGGCTC 2 046 561 This study 
OEF531 GACGTAGCAATGGTACTGG 1 399 238 This study 
OEF532 GATCGTTCAGGTAACATTAG 1 445 898 This study 
OEF533 ATCCGAAGGAACATTGCTAG 2 005 292 This study 
OEF534 CAATGGATTAACTGGCTTGC 2 047 356 This study 
OEF546 CAGTTCGAGTCCTGTATGG 1 923 230 This study 
OEF547 AGAACGGCTTTTCAGAGAAG 1 962 161 This study 
OEF548 ACCTAGCATTCGTAGAACC 2 701 530 This study 
OEF549 TACTATGCCGACTTAGACTG 2 736 242 This study 
OEF551 AGGCTACATTACTAAAGAGC 1 962 985 This study 
OEF552 TCCGTATTGATAAGCAATGC 1 926 694 This study 
OEF553 GTTCAATCGACGGATGTAA 1 927 314 This study 
OEF554 TAGCCTGCATTTGCTGAAG 291 436 This study 
OEF555 CTTTTGCGGTACCATTAACG 291 919 This study 
OEF557 GCAACAGATGCTAATGGAG 2 737 353 This study 
OEF558 GCCAATCCATTTAACGAAGC 2 703 739 This study 
OEF559 GTATCCTATCGATGGTGTG 2 704 251 This study 
OEF560 TCGAAGGTTCCTGATGAAC 2 817 577 This study 
OEF561 ACTGCTCTCACCAAATGTAG 2829302 This study 
OEF564 AGCCAATTGGTAACGTCCAC 2 817 997 This study 
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Primer 
name 
Sequence (5’→3’)* Position of 
the primer 
5’ end† 
Reference 
or source 
OEF565 TTCAGCTCCTAATCTAGTAG 2 818 606 This study 
OEF573 ATGCAGACTACCAAGTCATG 323 573 This study 
OEF574 ATCATGTGCATAGCCAAAGC 325 002 This study 
OEF575 AGATTGTTGTGAAGCGAACG 1 443 399 This study 
OEF576 TGAGCAACTTAAAGGAGGTG 1 441 968 This study 
OEF577 TCAGCACGTTCATTTAATCC 1 958 890 This study 
OEF578 ATTCTTCGCAAATTTGACGG 1 960 329 This study 
OEF579 GATCAGAATGGGTAGCTAAG 2 732 677 This study 
OEF580 ATCGTCAGATGGTTTAGCAC 2 734 199 This study 
OEF581 ACATCCGTCATTGACTTACG 2 825 960 This study 
OEF582 CTATTAAGAGTGGAACGTGG 2 827 442 This study 
OEF585 GTACGGTTGGATTAACGAAC 2 816 552 This study 
OEF591 CGGAAGCAAGAGTTGAAAGC 1 255 569 This study 
OEF592 TTGCCAATCGGACCAAACG 1 259 906 This study 
OEF618 TAGCCATATGAGACGAAACG 2 699 418 This study 
OEF619 GTTAGATAGAGCCTAGAATC 2 700 416 This study 
OEF620 GATTCTAGGCTCTATCTAACTAAATTATTTAGTTTCACGGTG 2 736 907 This study 
OEF621 AACCATGCAATTAACTGCG 2 737 969 This study 
OEF622 AAACGATTGATAGTGAACCG 2 699 195 This study 
OEF623 TGGAGAAGTCACACCTAATC 2 738 142 This study 
OEF624 ACGATGTTACTCGCCTAAC 2 700 282 This study 
OEF626 AATAACGTACCCGTCTTTTC 288 080 This study 
OEF627 TGCCAAAACAGTTGGCGC 289 226 This study 
OEF628 GCGCCAACTGTTTTGGCACCTTGGGATCCAATGGGCGC 326 495 This study 
OEF629 TTGATTGATGCTGAAGGTAG 327 598 This study 
OEF630 CGTAAAATGAAAGGACGATG 287 920 This study 
OEF631 TGACAATCAACGTTACCAAC 327 779 This study 
OEF634 TATGTATAATCGAGGGTCAC 1 921 627 This study 
OEF635 CAAATATACGAAGAAAATTAAC 1 922 596 This study 
OEF636 GTTAATTTTCTTCGTATATTTGCCACTCCCCATCTGAAATTG 1 962 541 This study 
OEF637 ATTTGATGCGCCATACAACC 1 963 549 This study 
OEF638 TGGGAACAAATTAGCACCTC 1 921 400 This study 
OEF639 GTCCATACATTCTGGTTACC 1 963 762 This study 
OEF640 GAATATCCCTGCTATCACAC 1 922 523 This study 
OEF641 GGTTGTAATAGCTGTGATTCC 2 815 695 This study 
OEF642 CACGTTGTTTCATTAATAAAT 2 816 749 This study 
OEF643 ATTTATTAATGAAACAACGTGTTTAATCATATAATAAACCAA 2 829 750 This study 
OEF644 AGTGTCAATCATCCGGAACTG 2 830 756 This study 
OEF645 GAAATGCTGTATGTCAATGGC 2 815 501 This study 
OEF646 ATCTTCTTGCCACGATTATCC 2 830 927 This study 
OEF653 AAGTGCCAACAATGGATGC 1 397 790  This study 
OEF656 TCATCATTGTACTCCACTCC 2 048 416 This study 
OEF657 ATCAGTGAAATGGTTGTTCG 2 829 802 This study 
* Sequences added for fusion PCR are underlined. 
† Position of the primer 5’ end in the V583 genome. 
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Table S3 V583 phages infection and immunity. 
Indicator 
strain 
Lysate        
 WT37°C WT42°C pp3¯pp5¯ pp1
+ pp3+pp5+ pp4+ pp6+ pp7+ pp1+pp7+ 
pp¯ + + + + + - - - + 
pp1¯ - - - - - - - - - 
pp3¯ + + - - + - - - - 
pp4¯ - - - - - - - - - 
pp5¯ + + - - + - - - - 
pp6¯ - - - - - - - - - 
pp7¯ + + + - - - - - + 
pp1¯pp7¯ + + + + - - - - + 
pp3¯pp5¯ + + - - + - - - - 
pp1+ + + + - + - - - + 
pp3+pp5+ + + + + - - - - + 
pp4+ + + + + + - - - + 
pp6+ + + + + + - - - + 
pp7+ + + + - + - - - - 
+ Plaque formation detection 
- No plaque formation detection 
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SUMMARY 
 
Temperate bacteriophages impact on the fitness of their bacterial host 
in a number of different ways that depend either on cell lysis-mediated 
competitiveness, gene disruption or the acquisition of fitness factors that 
are able to convert their bacterial host, in a process known as lysogenic 
conversion, from a non-pathogenic strain into a strain with increased 
virulence. Enterococcus faecalis has a dual nature: commensal of the 
gastro-intestinal tract of humans and opportunistic pathogen in fragilized 
or immunocompromised patients. E. faecalis pathogenicity remains poorly 
understood, but it is multifactorial, involving both bacterial and host 
contributions. Studies on enterococcal temperate phages are scarce and 
their role on strain fitness and pathogenicity has yet to be addressed. 
Enrichment of prophage genes in E. faecalis isolates of the high-risk 
enterococcal clonal complex 2 (HiRECC-2), that gathers hospital-adapted 
strains, supports that E. faecalis prophages may be important for bacterial 
adaptation to hospital setting. In this work, we addressed the impact of 
enterococcal temperate bacteriophages in the lifestyle of V583, a 
polylysogenic CC2 isolate. For this purpose, we compared the behaviour 
of the WT strain and its phage-deleted derivatives on sensitivity to 
chemical compounds, intestinal colonization, adhesion to human platelets, 
mice infectivity and biofilm formation. While prophages seem to have no 
major impact on sensitivity to chemical compounds, intestinal colonization, 
mice infectivity and biofilm formation in the tested conditions, prophages 
encoding platelet-like binding proteins promote adhesion to human 
platelets. Adhesion to human platelets is a key step towards the 
development of infective endocarditis, thus involving prophages in E. 
faecalis V583 pathogenicity. 
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INTRODUCTION 
 
Bacteriophages are the most abundant entities on earth with an 
estimation of population size of more than 1030 viral particles [1]. They 
have a major impact on the ecological balance and dynamics of microbial 
life, and are also recognized as key players in the evolution of bacteria by 
shaping their genomes through horizontal gene transfer [2]. Lysogeny, 
which involves the integration of a temperate phage into the bacterial 
chromosome is more frequent than initially thought, and affects bacteria 
regardless of their lifestyles [3]. Thus, increasing evidence indicates that 
prophages can possibly confer advantages to their hosts whether they are 
pathogens, commensals or free-living organisms [4-6]. 
Temperate phages contribute to bacterial fitness or virulence in 
several ways: introduction of fitness factors, gene disruption, protection 
from lytic infection and lysis of competing strains [3]. Import of fitness 
factors is also referred to as lysogenic conversion, which confers new 
traits to the host bacterium by providing genes that are not essential for 
the phage life cycle. Over the last few years, a plethora of prophage-
associated genes that contribute to various aspects of bacterial 
pathogenesis has been identified [7,8]. They encode functions such as 
ADP-ribosyltransferase toxins in Pseudomonas aeruginosa and Vibrio 
cholerae [9,10], detoxifying enzymes, e.g. sodC in Escherichia coli O157 
[11], type III effector proteins such as sopE, sseI, sspH1 in Salmonella 
enterica [12-14], among many others (for review see [3]). Integration of a 
prophage may modify bacterial virulence or adaptability by disrupting 
bacterial genes or operons such as the Staphylococcus aureus β-toxin-
encoding gene inactivated upon integration of bacteriophage φ13 [15]. 
Prophage excision in a fraction of the bacterial population can also impact 
bacterial fitness. This excision, followed in most cases by induction of the 
phage lytic cycle can be beneficial for the surviving population. For 
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example, excision of a Listeria monocytogenes prophage is sufficient to 
restore a functional transcriptional regulator promoting escape from the 
phagosome and thus intracellular growth [16]. Likewise, excision of the 
prophage-like element SkinCd restores sigK gene in Clostridium difficile 
that is an essential step for proper activation of k, required for efficient 
sporulation [17]. In other cases, a complete lytic cycle is required for the 
expression and release of the Shiga toxins in E. coli [18] or for promoting 
adhesion to human platelets via PblA and PblB, two platelet-binding 
proteins that are integral part of the phage SM1 tail from Streptococcus 
mitis [19]. Indeed, PblA and PblB code the tail tape measure protein and 
the tail fiber protein, respectively [20]. These proteins are released in the 
medium upon phage-induced bacterial lysis. Then, they interact with 
choline residues on the surface of Streptococcus mitis intact cells, and 
promote their adhesion to α2-8-linked sialic residues on platelet 
membrane gangliosides [20,21]. Adhesion to platelets is considered as a 
key step towards the development of infective endocarditis generated by 
S. mitis [20]. Phage-mediated lysis is also important for biofilm formation 
and differentiation since it facilitates dispersion of the surviving cells in 
order to form a new biofilm, as seen for Pseudomonas aeruginosa [22] or 
due to the release of extracellular DNA (eDNA) which enhances biofilm 
development in Streptococcus pneumoniae [23]. 
Enterococci are commensal bacteria of the gastrointestinal tract (GIT) 
of humans and other animals as well as insects. They also colonize the 
genito-urinary tract and the oral cavity, and are detected in several 
environmental niches such as soil, sand, water, food products and plants, 
[24-27]. Given their intrinsic robustness, capacity to withstand 
environmental stresses, including high concentrations of antibiotics and 
biocides, and propensity to exchange genetic material, they have 
emerged as a major cause of nosocomial infections worldwide [28-31]. 
Enterococcus faecalis ability to cause infection and persistence in the 
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hospital settings has been associated with strain ability to form biofilms 
known to promote bacterial survival in harsh conditions such as 
desiccation and antibiotic-rich environments [32-36]. E. faecalis V583 
autolysis and subsequent release of eDNA is an important factor for 
biofilm development [37,38]. While autolysins have been implicated in E. 
faecalis V583 ability to form biofilms due to bacterial lysis the impact of 
phage-induced lysis has not yet been addressed.  
The E. faecalis V583 was isolated in the beginning of the 80s and 
belongs to the HiRECC-2, that gathers strains adapted to hospital setting 
harboring several antibiotic resistances and virulence factors [39]. The 
genome of this strain contains 6 prophage-like elements (V583-pp1 to 
V583-pp6, named hereafter pp1 to pp6) and a phage-related 
chromosomal island (EfCIV583) that we have characterized regarding 
induction and activity [40]. Interestingly, CC2-isolates are enriched in 
prophage-genes, supporting that these mobile genetic elements may have 
a role in increased survival of CC2 isolates in the host and hospital 
environment [41]. Even though several phage-encoded potential fitness 
factors have been predicted: platelet binding-like proteins (in pp1, pp4 and 
pp6), a ferrochelatase (in pp4) and more recently, a toxin ADP-
ribosyltransferase (in pp1) [39,42,43], their contribution to E. faecalis 
lifestyle remains to be explored.  
In this study we evaluated the importance of 6 non-ubiquitous 
prophages for E. faecalis lifestyle by mimicking conditions that may be 
faced by these bacteria: chemical stress, intestinal colonization in 
presence of a competitive microbiota, adhesion to human platelets, mice 
infectivity and biofilm formation. For this purpose, we used a polylysogenic 
WT and a set of isogenic phage-deleted strains. Capacity to withstand 
chemical stress, to colonize the intestine and infect the organs of mice, 
and to form biofilms was similar between the strains. However, several 
phage-deleted strains bound differentially to human platelets. Adhesion to 
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platelets correlates with prophages that encode platelet binding-like 
proteins and with their ability to perform lytic cycle. With this work we 
demonstrate the contribution of pp1, pp4 and pp6 to human platelet 
adhesion, suggesting a role of E. faecalis prophages in the development 
of nosocomial infective endocarditis.  
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MATERIALS AND METHODS 
 
Bacterial strains and growth conditions 
Strains used in this study are listed in Table 1. E. faecalis was grown 
in static conditions in appropriate media, either M17 supplemented with 
0.5% glucose (M17G), chemically defined medium (CDM) [44] or bile-
esculin agar (BEA) at 37ºC. Growth was monitored by measuring optical 
density at 600 nm (OD600). When needed, strains were transformed with 
plasmid pMV158-gfp [45], as described previously [46]. Tetracycline was 
used at 4 µg/ml for E. faecalis when required. 
 
Table 1. Bacterial strains and plasmids used in this study. 
Strains or 
plasmid 
Short 
name 
Relevant characteristics Reference  
Strains    
VE14002 V583 V583 vancomycin resistant clinical isolate [47] 
VE14089  WT V583 vancomycin resistant clinical isolate cured 
of its plasmids 
[46]  
VE18239 WT-GFP+ V583 vancomycin resistant clinical isolate cured 
of its plasmids transformed with pMV158-gfp 
This study 
VE18590 pp- VE14089 deleted for pp1, pp3, pp4, pp5, pp6 
and EfCIV583  
[40] 
VE18595 pp--GFP+ VE18590 transformed with pMV158-gfp This study 
VE18562 pp1+ VE14089 deleted for pp3, pp4, pp5, pp6 and 
EfCIV583  
[40] 
VE18583 pp3+ pp5+ VE14089 deleted for pp1, pp4, pp6 and 
EfCIV583  
[40] 
VE18582 pp4+ VE14089 deleted for pp1, pp3, pp5, pp6 and 
EfCIV583  
[40] 
VE18581 pp6+ VE14089 deleted for pp1, pp3, pp4, pp5 and 
EfCIV583  
[40] 
VE18589  pp7+ VE14089 deleted for pp1, pp3, pp4, pp5 and pp6 [40] 
Plasmids    
pMV158-gfp  TetR, GFP [45] 
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Genome re-sequencing and identification of polymorphisms 
VE14089 (WT) and VE18590 (pp-) (Table 1) genomes were 
sequenced on a Life Technologies 5500XL NGS system at the MetaQuant 
platform, INRA Jouy-en-Josas (www.mgps.eu). Mapping of the 
sequencing reads to the E. faecalis VE14089 reference sequence along 
with SNP analysis was performed using the Lifescope v2.0 software (Life 
Technologies). To identify any insertion, deletions, or duplication, mapping 
was compared to the reference V583 genome, by analysis of BAM 
alignment files in the Integrated Genomic Viewer (IGV, Broad Institute). 
Polymorphisms between V583 reference sequence, deposited in NCBI 
under the accession number NC_004668 [39], VE14089 and VE18590 
genomes were confirmed by PCR with primers listed on Table 2 followed 
by sequencing at GATC Biotech, France.  
 
Phenotype microarrays for microbial cells 
To access phenotypic differences between the polylysogenic strain 
(WT) and the phage deleted strain (pp-), pre-configured phenotypic 
sensitivity plates from BIOLOG were used: PM9, 10, 11C, 12B, 13B, 14A, 
15B, 16A, 17A, 18C, 19 and 20B. Detailed plaque configurations are 
available at the provider website: http://www.biolog.com. Briefly, PM9 
contains test for osmotic and ion effects, PM10 tests for pH effect and 
PM11C-20B contain chemicals that target stress pathways in the cell. 
Incubation and monitoring of optical density were performed using the 
OmniLog-PM system. Data were analyzed using the Omnilog-PM 
software. These experiments were performed at the Institute of 
Biochemistry and Biophysics (Warsaw, Poland), in a laboratory equipped 
with BIOLOG technology and according to the manufacturer’s instructions, 
which includes undisclosed growth media. To study differences of growth 
obtained with BIOLOG test, the growth of the two strains was tested in 
CDM in presence of copper chloride (9, 18, 36 μg/ml), carbenicillin (2, 4, 8 
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μg/ml), trimethoprim (0.05, 0.1 and 0.2 μg/ml) and potassium tellurite 
(0.07, 0.15, 0.3 μg/ml). Growth was followed by monitoring optical density 
at 600 nm at 30 minutes intervals for 15 hours in a TECAN microplate 
reader.	 
 
Table 2. Primers used in this study. 
Primer name Target ORF Sequence (5’→3’)  Reference 
or source 
OEF723 EF0151 AGGTACAGAATTGACGAAAG This study 
OEF724 EF0151 CCATTTTTACGATACCGACG This study 
OEF701 EF0172 AATGCAAAAGGAGACGTTGG This study 
OEF702 EF0172 AATCGTCCACTATCTCGTG This study 
OEF703 EF0295 ACAAAGAAATGGTAGAGGAG This study 
OEF704 EF0295 CAAATCAAAGCCAGCATTAC This study 
OEF707 EF0573 CCACAAATTACTAGTGCAG This study 
OEF708 EF0573 TCTCCTTTAGCATCTACTTG This study 
OEF709 EF1007 AGTCTGTGTATGAAGTACCC This study 
OEF710 EF1007 TAAAGCGCTAGGAGTTCTTC This study 
OEF711 EF1021 TTTTAATCAGGAACCCACGG This study 
OEF712 EF1021 TTCTGCTTTCCCTTCTGACG This study 
OEF727 EF1725 CTTCTGTTACGACATAATCC This study 
OEF728 EF1725 TCGATTAATCCAACACCAGC This study 
OEF721 EF1976 TAGAACTGTTTCGCCACCAC This study 
OEF722 EF1976 AGAGGTGAGAACATGAAGTG This study 
OEF713 EF2060 TCTGCATAATTTCGAGCACG This study 
OEF714 EF2060 TTGGCGAATGAGTACACTAC This study 
OEF729 EF2461 TCATAGGTTTCAGGAGTTGC This study 
OEF730 EF2461 CCGATGTGATTCGAATGAAC This study 
OEF717 EF2678 CCTGCCATTAATTGTGCTTG This study 
OEF718 EF2678 TTCGCGAAAAGGAGTGATGC This study 
OEF731 EF2688 CCTAATAATTGGCTGGTATG This study 
OEF732 EF2688 GTGAGTCGATGAAATGGAG This study 
OEF719 EF2914 GTCATAGATTGCGAAAGGAC This study 
OEF720 EF2914 GAACTACGTATCGTTAAGCG This study 
OEF733 EF2933 CCTGTCAATTCTAATACGTG This study 
OEF734 EF2933 AACGCATTAAATCACGAGAG This study 
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Mouse intestinal colonization model 
Six- to 8-weeks old male CF-1 mice (Harlan, USA) were used for 
intestinal colonization experiments as described previously [48]. Briefly, 
mice received a daily dose of 1.4 mg of subcutaneous clindamycin for 
three days. On the fourth day, mice were administered with 1010 CFU of E. 
faecalis strains prepared as dried frozen pellets, as described previously 
[46], by orogastric inoculation using a feeding tube (Ecimed) (Rigottier-
Gois et al., in preparation). Fecal samples were collected at baseline and 
at 1 and 4 days after orogastric inoculation of the strains. Endogenous 
enterococci were evaluated by plating serial dilutions of fecal samples 
from control mice on BEA. Inoculated E. faecalis strains were monitored 
by plating on BEA supplemented with vancomycin at 6 µg/. All animals 
were handled in strict accordance with good animal practice as defined by 
the local animal welfare bodies (Unit IERP, INRA Jouy-en-Josas, France) 
and all animal work was carried out under the authority of license issued 
by the Direction des Service Vétérinaires (accreditation number A78-187 
to LR-G).  
 
Platelet binding assay 
The ability of E. faecalis to bind to human platelets was assessed as 
previously described [49]. Briefly, platelet-enriched cells were obtained 
from human blood by adding Lymphoprep (Axis-shield, Norway) followed 
by centrifugation at 800 g for 25 minutes, at room temperature. After 
formation of the different phases, the second cloudy phase from the top, 
containing the platelets, was carefully removed, resuspended in PBS and 
centrifuged at 300 g for 10 minutes, at room-temperature. Supernatant 
rich in platelets was kept and washed five times in PBS at 500 g for 10 
minutes, at room temperature as described by [50]. After, platelets were 
fixed in paraformaldehyde 3.2% and immobilized on poly-L-lysine for 1h at 
37°C. Unbounded platelets were washed with PBS prior to saturation with 
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a 1% casein solution for 1h at 37°C. After removal of the saturating 
solution, platelets were incubated for 1h at 37°C with the indicated 
bacteria at a MOI of 1. After six washes, the bound bacteria were counted 
by plating serial dilutions on M17G. Binding was expressed as a 
percentage of the inoculum followed by normalization to wild-type strain 
adhesion. Platelet binding assays were performed three times in triplicate 
using platelets prepared from buffy coats of three, healthy and anonymous 
volunteers obtained through the Etablissement Français du Sang (EFS, Ile 
de France, Le Chesnay, France). As required for blood donation, written 
informed consents were obtained by EFS from all donors. 
 
Distribution analysis of pp1, pp4 and pp6 genes in E. faecalis draft 
genomes  
Nucleotide sequences of pp1, pp4 and pp6 annotated genes on E. 
faecalis V583 genome were aligned against the publicly available E. 
faecalis draft genomes (http://www.ncbi.nlm.nih.gov) using BLASTN, and 
their presence or absence was predicted as described by Solheim et al., 
2011 [41]. Briefly, predictions were made based on a score calculated as 
the number of identical nucleotides divided by the query gene length. 
Genes with a score higher than 0.75 were considered similar. Strains 
positive for pp1, pp4 or pp6 genes are listed in Table S2 along with their 
geographical origin, year of isolation, source, sequence type (ST) and 
presence of CRISPR1 and CRISPR3 cas genes. STs of strains TX4244, 
ATCC29212, TX1467 and ERV were deduced in silico accordingly with 
the MLST scheme developed by Ruiz-Garbajosa et al., 2006 [51]. 
Sequences for the seven housekeeping genes ghd (ef1004), gyd 
(ef1964), pstS (ef1705), gki (ef2788), aroE (ef1561), xpt (ef2365) and ygiL 
(ef1364) were recovered from NCBI web site and STs determined using 
the E. faecalis MLST database (http://efaecalis.mlst.net). Presence of cas 
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genes from CRISPR1 and CRISPR3 [52,53] was also predicted by BLAST 
search. 
 
Mouse infectivity models 
Groups of 10 six-week-old male C57BL6 mice were infected 
intraperitoneally with a sub-lethal dose of 1x108 CFU of E. faecalis strains 
prepared as dried frozen pellets [46]. Mice were sacrificed 12 hours post-
infection, and organs (hearts, kidneys, livers and spleens) were aseptically 
removed, weighed, homogenized, and serially diluted in saline solution for 
colony counts on BEA medium supplemented with vancomycin at 6 µg/ml. 
E. faecalis burden were expressed as CFU/g of organ. Statistical analyses 
were performed using GraphPad Prism version 4.03 (GraphPad Software, 
San Diego, CA). Bacterial counts were compared using the unpaired t 
test, and P values of < 0.05 were considered statistically significant. 
In the neutropenia model, six-week-old male C57BL6 mice were 
immunocompromised by intravenous administration of vinblastine 
(Velbe®) at 5 mg/kg. Seventy-two hours later, mice were injected 
intraperitoneally with a sub-lethal dose of 1x108 CFU of E. faecalis strains. 
Mice were sacrificed 24 hours post-infection, and organs were aseptically 
removed and treated as above. 
 
Biofilm formation assays 
Biofilm formation assays and data analysis were performed 
accordingly to Bridier et al. [54]. Briefly, 250 μl of green fluorescent protein 
(GFP) labeled strains cultured overnight in M17G in presence of 
tetracycline were diluted to approximately 107 CFU/ml, and seeded in 
wells of a polystyrene 96-well microtiter plate (Greiner Bio-one, France). 
After 1 h adhesion at 37°C, wells were rinsed with 150 mM NaCl in order 
to eliminate non-adherent bacteria. Wells were refilled with 250 μl M17G 
and microplate was incubated for 24 and 48 hours at 37°C. At each time 
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point, wells were rinsed with 150 mM NaCl and refilled with M17G. The 
microtiter plate was mounted on the motorized stage of a Leica SP2 
AOBS confocal laser-scanning microscope (LEICA Microsystems, France) 
at the MIMA2 microscopy platform (http://voxel.jouy.inra.fr/mima2). 
Emitted fluorescence was recorded within the range 500–600 nm in order 
to visualize GFP fluorescence. Three stacks of horizontal plane images 
(512Å~512 pixels corresponding to 119 Å~119 μm) with a z-step of 1 μm 
were acquired for each biofilm at different areas in the well. Two 
independent experiments were performed in triplicate for each strain. 
Three-dimensional projection of biofilm structure was reconstructed using 
the Easy 3D function of the IMARIS 7.0 software (Bitplane, Switzerland). 
Quantitative structural parameters of the biofilms were calculated using 
PHLIP [55]. 
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RESULTS 
 
pp- genome sequence analysis 
The E. faecalis strain VE14089, referred as WT in this study, is a 
plasmid-cured derivative of V583 (VE14002) obtained after chemical 
treatments (Figure 1A) [46]. To study, the potential role of the six non-
ubiquitous prophages or phage-related elements pp1, pp3, pp4, pp5, pp6 
and EfCIV583 in E. faecalis lifestyle, we used a set of isogenic strains 
deleted for individual or combinations of phage-elements in strain 
VE14089 [40]. Strain VE18590 (pp-) is deleted for the six non-ubiquitous 
prophages of V583, representing a 215 kb loss (~ 6.6 % in chromosome 
size) compared with VE14089. It was obtained by sequential deletion of 
pp3, pp5, pp4, pp6, EfCIV583 and pp1 (Figure 1B). In preliminary 
experiments, we compared the growth of strain pp- with the wild-type 
parental strain in M17G and CDM, at 37°C (Figure 1C). No major change 
in the growth on rich and minimal media was observed, supporting the 
accessory nature of these elements and suggesting that no major 
underlying sequence changes resulted from the serial genetic 
recombination events. Previously, we excluded major chromosomal 
rearrangements in pp- strain, due to the sequential deletion events, by 
pulse-field gel electrophoresis [40]. As a prerequisite to study prophage 
impact on bacterial phenotypes, we sequenced and compared the whole 
genome of both pp- and WT strains, which were also compared with the 
V583 reference genome sequence [39].  
Along with the expected prophage deletions, comparison of the whole 
genome sequence of WT and VE18590 (pp-) uncovered only 6 single 
nucleotide polymorphisms (SNPs), which we confirmed after amplification 
and re-sequencing using WT and pp- as templates. The SNPs are located 
within six open reading frames (ORFs) not localized in the close vicinity of 
the deletion region (Table 3). 
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Figure 1. V583 derivatives used in the genome sequencing project. (A) VE14089 was 
obtained from VE14002 (V583) by plasmid curing (pTEF1, pTEF2 and pTEF3) through 
chemical treatments [46]. VE18590 was obtained from the plasmid-cured V583 by 
sequential deletion of pp3, pp5, pp4, pp6, EfCIV583 and pp1 through double crossing-
over. (B) Prophage sequential deletions. (C) WT and pp- growth curves at 37°C in M17G 
and CDM. 
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One gene has a silent mutation, and the others have missense mutations 
resulting in an amino acid substitution in the encoded protein, however 
prediction of the functional consequences of SNPs remains challenging 
[56]. Of the predicted functions, EF1725 a formate-tetrahydrofolate ligase 
and EF2461 an inositol monophosphatase exert two important metabolic 
activities, suggesting that the substitution has no major impact on strain 
growth. EF2933 is annotated as oxidative stress response regulator of the 
Rex family, however recent experimental evidences indicate that 
contribution of EF2933 to redox homeostasis is minor [57].  
Strain WT is a derivative of V583. In addition to the 20.5 kb insertion 
from efa0063 to efa0006 of pTEF1 plasmid between genes ef3209 and 
ef3210 [46], a total of 43 differences, including deletions, insertions and 
SNPs, were detected between WT and V583 genome sequences [39]. 
From these, 34 differences have been recently reported by Palmer et al., 
[58], leading us to consider them as real differences, which may be due to 
sequencing errors and/or reflect the evolution of independent isolates of 
strain V583 (Table S1). The other 9 differences were confirmed after PCR 
amplification and sequencing of the corresponding regions using WT and 
VE14002, our V583 isolate as templates (Table 4). They are all located 
within ORFs. One deletion and 2 missense SNPs are in both VE14002 
and WT strains, being specific of our laboratory strains (Table 4). 
Remarkably, the deletion in ef1007 generates a predicted protein of 243 
residues annotated as regulator of sugar fermentation. Noticeably, this 
protein is predicted in all available E. faecalis genomes, but V583, strongly 
indicating an assembly error in the reference genome. The remaining six 
SNPs were specific to VE14089 and are probably due to the chemical 
agents used for plasmid curing (Table 4). The nonsense SNP generates a 
premature stop codon in ef0295 predicted to encode subunit J of a V-type 
ATP synthase acting as a primary ion pump transporting Na+ or K+ ions.  
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Such mutation is likely to impair ion transport and affect osmotic 
adjustment impacting the overall fitness of VE14089 compared with 
VE14002 [46]. Moreover, the three other substitutions predicted as non-
neutral are in annotated transcription factors. The substitution in the DNA-
binding domain of the predicted sugar-binding transcriptional regulator 
EF0172 may affect regulatory efficiency of its unknown targets. The E. 
faecalis SpxA regulator EF2678 is a global transcriptional regulator, which 
modulates RNA polymerase specificity in response to oxidative stress in 
aerobic condition. It promotes colonization of the peritoneum and 
dissemination in the blood in mice [59]. The transcription elongation factor 
GreA acts on the fidelity and processivity of RNA polymerase [60]. 
However, the substitution effect on these two regulators is difficult to 
predict.  
Overall, the plasmid-cured VE14089 strain harbors 1 truncated gene 
(ef0295) and 5 missense mutated ORFs relative to our V583 strain. Six 
additional mutations (5 missense and 1 silent) were accumulated in 
VE14089-derivative strain pp- during sequential prophage deletions. 
 
WT and pp- growth in presence of chemical compounds  
We previously showed that VE14089 prophages are induced by 
antibiotics and SOS-inducing agents. To examine the impact of deleting 
the six excisable prophage elements on E. faecalis physiology, we 
compared the growth of WT and pp- strains in the presence of 288 
different compounds, at 4 different concentrations each, using BIOLOG 
phenotypic array plates PM9-20. We found 16 compounds in the presence 
of which pp- reached higher OD than WT, and 5 for which WT growth was 
favored. Each compound effect was observed at a specific concentration 
(Table 5).  
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Table 5. BIOLOG results. 
Molecule Target / mode of action  Functional 
family 
Concentration 
(µg/mL) 
Compounds for which WT was fittest 
Lincomycin Protein synthesis  Antibiotic 60 
Erythromycin Protein synthesis 50S 
ribosomal subunit  
Antibiotic 6.6 
Copper chloride Transport, toxic cation Biocide 18 
Phenylarsine oxide Tyrosine phosphatase Biocide 3.7 
Antimony (III) chloride Toxic cation Biocide 50 
Compounds for which pp- was fittest 
Democlocycline Protein synthesis 30S 
ribosomal subunit  
Antibiotic 0.3 
Rolitetracyclin Protein synthesis  Antibiotic 1.6 
Carbenicillin Cell wall Antibiotic 4 
Trimethoprim Folate antagonist Antibiotic 0.1 
Blasticidin Protein synthesis Antibiotic 50 
5-fluorouracil Thymidylate synthetase Antimetabolite  0.8 
Amitriptyline Membrane, transport Antimicrobial 
effect 
210 
Protamine sulfate Membrane, transport Antimicrobial 
peptide 
52 
Acriflavin DNA intercalator Biocide 24 
Sodium dichromate Toxic anion, SO4 analog Biocide 6.5 
1,10-Phenanthroline Chelator, Fe++, Zn++, divalent 
metal ions 
Biocide 34 
Chlorohexidine Membrane, biguanide, 
electron transport 
Biocide 0.5 
8-hydroxyquinoline Chelator, lipophilic Biocide 315 
Menadione Respiration, uncoupler Oxidation 300 
1-chloro-2,4-
dinitrobenzene 
Glutathione oxidation  Oxidation 1077 
Potassium tellurite Transport, toxic anion Oxidation 0.15 
 
The implicated compounds belong to three main functional classes: 
biocides, antibiotics and oxidative stress inducing agents. Out of the 21 
compounds, we selected copper chloride, potassium tellurite, carbenicillin 
and trimethoprim as representative chemical agents to challenge WT and 
pp- strain. The biocides copper chloride and potassium tellurite cause 
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damage to the bacterial cell through the formation of reactive oxygen 
species [61,62]. Carbenicillin and trimethoprim are two antibiotics used in 
hospitals to treat bacterial infections. BIOLOG protocol uses a chemical 
defined medium of undisclosed composition to grow E. faecalis. Thus, we 
attempted to approach BIOLOG growth conditions, using a chemically 
defined medium [44] to grow bacteria in the presence of the selected 
compounds, tested at three different concentrations (see Materials and 
Methods). None of the differences observed with the PM plates were 
confirmed: WT and pp- growth was similar in the presence of trimetoprim 
and carbenecillin, and was the opposite of the BIOLOG results for copper 
chloride and potassium tellurite (Figure 2). Absence of reproducibility 
between the experimental settings may be related to the difference of 
growth medium composition and monitoring conditions. 
 
Figure 2. WT and pp- growth curves in presence of selected compounds. Copper 
chloride, potassium tellurite, trimethoprim and carbenicillin were used at 18 μg/mL, 0.15 
μg/mL, 0.1 μg/mL and 4 μg/mL, respectively. Early stationary phase cultures were diluted 
1/500 in 200 μL of CDM and incubated at 37°C for 15h in a TECAN microplate reader. 
Data presented are representative of two independent experiments. 
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Prophages do not modify intestinal colonization potential in 
conventional mice 
To evaluate prophages impact on bacterial ability to colonize the 
gastro-intestinal tract (GIT), we used a model based on the orogastric 
inoculation of E. faecalis in mice harboring their complex microbiota 
imbalanced by a treatment with clindamycin [63]. Clindamycin is a 
lincosamide with broad spectrum against firmicutes and obligate 
anaerobic bacteria, which favors the emergence of enterococci by causing 
microbiota dysbiosis, and facilitates GIT colonization by inoculated E. 
faecalis strains [63,64]. To analyze the effect of different prophages and 
limit the number of animals used, we tested colonization ability of strains 
WT, pp1- and pp7+, that differ in prophage content and phage production 
in vitro [40]. Strain WT harbors all prophages and produces P1, P3, P5 
and EfCIV583 particles; strain pp1- carries all but pp1 prophage and 
produces only P3 and P5 while strain pp7+ harbors only EfCIV583 and 
does not produce phage particles. GIT colonization by these strains was 
monitored for 96h (Figure 3A and B). WT strain transiently colonized the 
mouse gut at ~109 CFU/g one day after inoculation, decreasing to 
between 105 and 104 CFU/g four days after arrest of antibiotic treatment. 
No significant difference in the efficiency of the GIT colonization was 
observed between the WT and the pp1- strains, indicating that the 
presence of pp1 or the production of P1 and EfCIV583 virions is 
dispensable for GIT colonization by E. faecalis V583 in a complex 
ecosystem of intestinal microbiota. Similarly, no significant difference of 
GIT colonization was observed between WT and pp7+ or between pp1- 
and pp7+. Altogether, these results indicate that prophages and virions do 
not confer a detectable advantage to WT in the gut microbiota of mice. 
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Figure 3. Mice gastro-intestinal 
tract colonization by E. faecalis 
strains WT, pp1- and pp7+. After 
three days of subcutaneous 
administration of clindamycin, 
1x1010 CFUs of each strain were 
force-fed independently into five 
mice. E. faecalis burden in stools 
was monitored 24h and 96h after 
oral gavage. (A) WT vs pp1-. (B) 
pp7+ vs pp1-. (C) Endogenous 
enterococci levels before and after 
clindamycin treatment. No 
significant differences in the 
efficiency of colonization between 
strains were observed. Data 
presented are representative of two 
independent experiments. 
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In addition to the strains under study, we also monitored the endogenous 
enterococci of the mice gut microbiota and we observed a transient 
colonization that reached the highest level after the 3 days of clindamycin 
treatment (Figure 3C). A decrease of endogenous enterococci 4 days 
after arrest of clindamycin treatment was observed as for the inoculated 
strain. Flourishing endogenous enterococci were identified at the species 
level, using partial sequencing of the 16S rRNA genes (Rigottier-Gois et 
al., in preparation). Interestingly, E. faecalis was identified as a member of 
the clindamycin-treated gut microbiota, forcing inoculated E. faecalis to 
compete with endogenous isolates for the same niche.  
 
Prophages promote bacterial binding to human platelets 
PblA and PblB of S. mitis phage SM1 are multifunctional proteins that 
are both important for platelet adhesion and for normal phage 
morphogenesis: PblA is the phage tape measure protein and PblB is the 
tail fiber [20]. Prediction of pp1-, pp4- and pp6-encoded platelet-binding 
factors prompted us to investigate E. faecalis V583 prophages impact on 
binding to human platelets [39] (Figure 4).  
 
 
Figure 4. E. faecalis platelet-like binding proteins identified in V583 prophages. pp1, 
pp4 and pp6 carry homologous genes to pblA and pblB, both code for platelet-binding 
proteins identified in phage SM1 from Streptococcus mitis.  
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Since neither pp3 nor pp5 encode predicted Pbl, strain pp3+ pp5+ that 
harbors pp3 and pp5 only, was constructed as a negative control and 
verified for the production of P3 and P5 particles (Table 1). We tested the 
ability of strains WT, pp¯, pp1+, pp4+, pp6+, pp7+ and pp3+ pp5+ to bind 
human platelets (Figure 5).  
 
Figure 5. Impact of prophages on E. faecalis adhesion to human platelets. The values 
shown are normalized to the percentage of adhesion to platelets of the WT strain. Data are 
expressed as mean ± SD. Platelet binding assays were performed in platelets from three 
different donors. P value is indicated. 
 
Removal of six V583 prophages (pp¯) reduced by ~8-fold the adhesion 
ability of E. faecalis, revealing that prophages contribute to the interaction 
with human platelets. Similarly to pp¯ strain, strains that have pp3 and pp5 
or EfCIV583 bound poorly to platelets, indicating that pp3, pp5 and 
EfCIV583 are not involved in platelet adhesion. In contrast, strains 
carrying prophage-encoding platelet-binding factors, i.e. pp1+, pp4+ and 
pp6+, bound significantly more than pp¯ strain, with a significant higher 
platelet adhesion for strains pp1+ and pp4+. These results show that E. 
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faecalis platelet-binding ability correlates with prophage-encoding platelet-
binding factors. Given the importance of bacterial-platelet binding in the 
development of infective endocarditis it is tempting to speculate that these 
phages might contribute to enrich the repertoire of virulence traits of the 
species. 
In addition to V583 genome, prophage-encoded platelet-binding 
proteins have also been identified in other E. faecalis isolates and all of 
them harbor tail proteins with sequence identity to either PblA or PblB 
[42]. BLAST search homology for the 160 genes of pp1, pp4 and pp6 
were performed against the ~80 E. faecalis draft genomes publically 
available. While, prophage gene orthologs were detected in 63 genomes 
(Table S2) full-length genomes of pp1, pp4 and pp6 were detected in only 
few E. faecalis strains (Figure 6-8). Interestingly, pp1 orthologs are less 
disseminated than pp4 and pp6 ones. Moreover, despite the low 
representation of each CC, pp1, pp4 and pp6 orthologs seem to be 
enriched in CC2 and CC9 strains. While, pblA-like ef0348 is mostly 
associated with pp1-orthologs, pbl-like orthologs of pp4 and pp6 (ef2001, 
ef2003, ef2811 and ef2813) are not systematically detected with pp4- and 
pp6-orthologs.	 Among E. faecalis genomes, three CRISPR loci were 
identified: CRISPR1, CRISPR2 and CRISPR3. CRISPR1 and 3 are linked 
with cas genes and exhibit the typical organization of Nmeni CRISPR/Cas 
subtype [65], whereas CRISPR2 is an orphan locus and is not associated 
with cas genes [52,53]. CRISPR-Cas has been correlated with the 
absence of genetic mobile elements, such as prophages [52], and 
antibiotic resistance [53]. Interestingly, presence of CRISPR1 and 
CRISPR3 do not inversely correlate with pp1, pp4 and pp6 genes (Table 
S2).  
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Figure 6. Distribution of pp1 gene orthologs in E. faecalis sequenced genomes. pbl 
genes are highlighted in bold. 
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Figure 7. Distribution of pp4 gene orthologs in E. faecalis sequenced genomes. pbl 
genes are highlighted in bold. 
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Figure 8. Distribution of pp6 gene orthologs in E. faecalis sequenced genomes. pbl 
genes are highlighted in bold. 
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Prophages do not significantly impact bacterial infectivity in mice 
To evaluate the impact of prophages carrying pbl-like genes in vivo, 
we compared the ability of the most adherent strain (pp1+) with strain pp- 
to infect healthy mice. Both strains were injected intraperitoneally at 1x108 
CFU. Mice were sacrificed 12 hours post-infection and bacterial burdens 
on heart, kidneys, liver and spleen were evaluated. In average, pp1+ and 
pp- presented similar counts on heart (~1.4x104 CFU/g), kidneys (~7x104 
CFU/g), liver (~4x105 CFU/g) and spleen (~9x105 CFU/g) (Figure 9), 
indicating that pp1+ has no detectable effect on bacterial infectivity in mice.  
 
Figure 9. Mice infectivity by pp1+ and pp- strains. Mice were injected intraperitoneally 
with 1x108 CFUs of each strain. E. faecalis bacterial counts in the heart, kidneys, liver and 
spleen were monitored 12 hours after injection. No significant differences in the efficiency 
of organ colonization between strains were observed. 
 
To evaluate the impact of all prophages on bacterial infectivity in 
conditions that mimic immunocompromised hosts, we tested WT and pp- 
strains in a neutropenic mice model adapted from Balloy et al., [66]. 
Overall, our data show that mice response upon bacterial infection is 
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highly variable which is illustrated by the variation on bacterial counts 
reached in each organ, 24 hours after injection (Figure 10). Despite the 
high variability, bacterial burdens detected on heart, kidneys, liver and 
spleen are globally similar between WT and pp- strains (Figure 10). In 
average, bacteria were detected in the heart at ~5x104 CFU/g, in the 
kidneys at ~8.2x104 CFU/g, in liver at ~9x105 CFU/g and in the spleen at 
~1.2x106 CFU/g. Analysis of blood samples recovered from mice after 
induction of neutropenia revealed a high variability in leukocytes, 
neutrophils, lymphocytes and monocytes counts, reflecting heterogeneous 
restoration of cellular immunity. In regards of such variability, bacterial 
infectivity of strains WT and pp7+ deserves to be assessed either in 
healthy mice, for a shorter period of time, or in a refined neutropenic 
model. 
 
 
Figure 10. Mice infectivity by WT and pp-. Immunocompromised mice were injected 
intraperitoneally with 1x108 CFUs of each strain. E. faecalis bacterial counts in the heart, 
kidney, liver and spleen were monitored 24 hours after injection. No significant differences 
in the efficiency of organ colonization between strains were observed. 
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Prophages have no significant impact on biofilm formation 
Given that biofilm-forming ability enhances E. faecalis persistence in 
the hospital setting, we compared biofilm-forming ability of strains WT and 
pp- in static conditions at 24h and 48h. Three quantitative structural 
parameters of the biofilms were calculated: i) biovolume, which represents 
the overall volume of cells (μm3), ii) roughness, which provides a measure 
of variations in biofilm thickness, and is an indicator of the superficial 
biofilm interface heterogeneity, and iii) maximum thickness (μm) of biofilm 
(Figure 11). Overall, the two strains formed biofilms with identical values 
for each measured parameter, indicating that prophages do not impact on 
biofilm formation in the tested conditions. A recent study by Bridier et al., 
evaluated the ability of several E. faecalis isolates to form biofilm in TSB 
using the same approach [54]. The E. faecalis strains tested, including 
V583 strain (ATCC 700802), form biofilms that have 10 times more 
biovolume and are two times thicker than the biofilms formed by WT and 
pp- strains [54]. We cannot exclude that WT strain forms less biofilm than 
V583 as a result of plasmid curing. Hence, differential biofilm formation 
between WT and pp- strains might be difficult to detect.  
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Figure 11. Biofilm quantitative structural parameters. (A) Biovolume. (B) Roughness. 
(C) Maximum thickness. Data are expressed as mean ± SD and are the result of two 
independent experiments performed in triplicates. (D) Three-dimensional projections of 
biofilms structure reconstructed with the Easy 3D function of the IMARIS 7.0 software for 
WT and pp- strain at 24 and 48h. These images represent an aerial view of biofilm 
structures with the shadow projection on the right.  
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DISCUSSION 
 
Upon DNA injection and establishment of the prophage state, 
temperate bacteriophages can impact bacterial fitness in several ways. 
Either they carry useful genes for the bacteria, and are maintained in the 
prophage state or they help to eliminate niche competitors through 
induction of the lytic cycle and release of phage progeny. In the present 
study, we provide for the first time direct evidence that prophages carrying 
pbl-like genes are important for E. faecalis adhesion to human platelets. 
pp1, pp4 and pp6 encode predicted phage tail proteins homologous to 
platelet binding proteins, PblA and/or PblB, of S. mitis φSM1 [39,42]. Thus 
is likely that these proteins (EF0348, EF2003, EF2001, EF2811, EF2813) 
mediate E. faecalis binding to platelets. Platelet binding activity of S. mitis 
is linked to lysis induced by φSM1, implying that lytic activity of this 
prophage is required [19,20]. Upon prophage induction, platelet-binding 
proteins PblA and PblB, coded in φSM1, exert a dual function. They are 
part of φSM1 capsids as a tape measure and side tail fiber respectively, 
and they bind as free proteins to the cell wall of non-induced bacteria, 
promoting bacterial adhesion to platelets [20]. Interestingly, E. faecalis 
platelet-binding capacity varies from strong for the pp1+ strain, to 
intermediate for the pp4+ strain and to low for the pp6+ strain. It is possible 
that the various platelet-binding efficiencies are the consequence of Pbls 
distinct binding capacity. However, such variation correlates with the 
efficiency of pp1, pp4 and pp6 to perform their lytic cycle [40]. Indeed, 
adhesion is minimal for the strain that harbors pp6, which only excises, 
maximal for strain that forms pp1 progeny, and intermediate with pp4 that 
excises and replicates. Even if pp4 and pp6 do not form infectious virions, 
they excise from the chromosome suggesting that their genes are 
expressed. We propose that this correlation may reflect different levels of 
expression and/or accessibility resulting from prophage activity. E. faecalis 
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adhesion to platelets has been reported before with strain OG1RF and 
clinical E. faecalis strains isolated from infective endocarditis [67,68]. 
Inactivation of the pathogenicity island-encoded transcriptional regulator 
PerA in E. faecalis E99 represses orthologs of the putative pp4-pblA, pp4-
pblB and pp4-lysin genes, and increases the ability of E99 to bind to 
human platelets [49]. This apparent contradiction may result from the 
concomitant induction of the enterococcal biofilm-associated pilus epb 
locus that also promotes adhesion to human platelets [68]. PerA is 
present in several E. faecalis strains but its expression is probably 
dependent on the orientation of an IS element inserted upstream [69]. 
V583 has a perA gene and the IS orientated in the same direction, 
suggesting that perA is transcribed. It is possible that V583 PerA 
contributes to the platelet-adhesion phenotype mediated by pp4. Infectivity 
of pp1+ strain, the most adherent to human platelets, did not differ from pp- 
strain in healthy and immunocompromised mice models. This result 
indicates that either pp1 does not promote infectivity or that mice are not 
suitable for analyzing E. faecalis interaction with platelets. Given that pp1 
mediates adhesion to human platelets in vitro, it is possible that the 
bacterium interacts with human-specific receptors. Since adhesion to 
platelets can lead to platelet activation, which promotes infective 
endocarditis, the role of prophage-encoded Pbl-like proteins in E. faecalis 
pathogenesis deserves further investigation.  
GIT colonization and persistence are key steps for E. faecalis 
pathogenesis. Infectious virions produced by lysogenic strains are likely to 
form progeny on phage sensitive strains and thus be an asset for the 
bacteria in competitive environments like the complex microbial 
ecosystem of the GIT [70-72]. We investigated V583 prophages impact on 
intestinal colonization using strains that harbors different combinations of 
phage genomes. Our results show that P1, P3, P5 and EfCIV583 
genomes and/or particles do not represent an advantage to their host in a 
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complex ecosystem where other enterococci, including E. faecalis, are 
overrepresented. Endogenous E. faecalis present in the mice microbiota 
may not be sensitive to V583 phage infection, thus competitive advantage 
of the prophage-producing strains WT and pp1-, if any, would not be 
detected. Duerkop and collaborators recently reported that pp1 and 
EfCIV583 confer a subtle competitive fitness against phage sensitive 
strains in the intestine of gnotobiotic mice devoid of endogenous 
microbiota [73]. However, their experiments are difficult to interpret as the 
CH188 competitor strain was lysogen for P1 [40]. Competition between 
isogenic lysogenic and susceptible strains in a complex GIT ecosystem 
deserves to be further investigated.  
E. faecalis ability to thrive in a broad range of ecological niches 
derives from its capacity to cope with a broad range of chemical 
compounds, including antibiotics and biocides. Comparison of WT and pp- 
growth using phenotypic microarray plates revealed growth differences in 
the presence of 21 compounds, mainly antibiotics, biocides and ROS 
inducing compounds. For the majority of compounds WT growth reached 
lower cell density when compared with pp- strain possibly due to phage 
induction followed by WT cell lysis. Consistently, we have previously 
demonstrated that trimethoprim induces E. faecalis V583 prophages [40]. 
Conversely, pp- growth reached lower cell density with a few number of 
compounds. In this case, prophages may carry additional genes that 
confer advantages for the bacteria as reported for the prophage pool of E. 
coli K12 [74]. Unfortunately, the effects of the identified compounds could 
not be reproduced in a medium different from the one used for microarray 
phenotyping. However, this technical problem needs to be further worked 
out to verify whether prophage impact on strain fitness towards the 
identified chemical compounds, particularly with potassium tellurite and 
copper chloride, which cause slight growth difference in both tested 
conditions.  
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Biofilm growth confers higher resistance to hostile environments 
encountered in the hospital setting and during pathogenesis [35,75]. 
Recent studies reported the importance of phages and phage remnants in 
E. coli and P. aeruginosa for biofilm formation, especially for the dispersal 
phase [76,77]. To withstand harsh conditions and shield against biocides, 
antimicrobials and predators, E. faecalis can grow in biofilm [24-26,78]. 
V583 prophages do not influence biofilm formation by its host, at least 
during the first 48h, since both strains produce biofilms with similar 
quantitative structural parameters (biovolume, roughness and maximum 
thickness). Nevertheless, we cannot exclude that over time, phage 
production, in WT strain, could enhance cell lysis and release of eDNA 
and thus promote the formation of a more robust biofilm. Although biofilms 
formed by WT and pp- present the same characteristics, it would be 
interesting to determine their resistance to antibiotics and biocides.  
Overall, the six consecutive deletion events performed to generate pp- 
produced only 6 SNPs compared with WT. Given a genome of ∼3.23 Mbp 
and ~1200 cell generations separating the two sequenced strains, the 
spontaneous mutation rate is estimated at ∼1.5×10−9 SNPs per base pair 
per generation. This rate is 10-fold higher than the rate estimated for E. 
coli [79]. Such a difference may result from the use of antibiotics during 
pp- construction, since their usage is known to accelerate mutation rate 
[80]. Nevertheless, even if these mutations may not be silent in a future 
study, the absence of striking phenotypic differences between WT and pp- 
indicates that the mutations were not detrimental to pp-.  
In this work, we studied V583 prophages contribution to resistance to 
chemical compounds, intestinal colonization, adhesion to platelets, 
infectivity and biofilm formation. Under the tested conditions, prophage 
presence did not significantly impact on biofilm formation, intestinal 
colonization and infectivity of the host strain. Their role to sustain growth 
in the presence of chemical compounds needs to be further investigated. 
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pp1, pp4 and pp6 promote E. faecalis adhesion to human-platelets, 
probably through the release of PblA/B-like proteins upon prophage 
induction. Establishing a direct link between Pbls and endocarditis is 
required to open new perspectives towards diagnosis and eventually 
prevention of enterococcal endocarditis. 
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SUPPLEMENTARY INFORMATION 
 
Table S1. Differences detected in VE14089 common with Palmer et al., [58]. 
Reference 
positiona 
Variation 
type 
Variation Annotation Predicted function 
132143 Insertion -  G IR ef0126-0127 - 
179987 Deletion  A  - EF0183 Hypothetical protein 
191992 SNP T  A EF0199 Ribosomal protein S7 
229297 Deletion  C  - IR ef0252-0253 - 
611688 SNP G  T EF0660 MATE efflux family protein 
872056 SNP C  A EF0906 Hypothetical protein 
921232 SNP A  G EF0958 PTS system, IIABC components 
931162 SNP G  T IR ef0967-0968 - 
998111 SNP C  T IR ef1036-1037 - 
1170952 Insertion -  T EF1205 Transcriptional regulator 
1303060 Deletion  A  - IR ef1331-1332 - 
1474120 SNP C  A EF1519 Cation-transporting ATPase, E1-E2 
family 
1534568 Deletion A  - EF1581 Transketolase 
1571355 SNP C  T EF1614 DNA topoisomerase IV, A subunit 
1651141 SNP T  C EF1704 Sensory box histidine kinase 
1651146 SNP T  C EF1704 Sensory box histidine kinase 
1917084 SNP T  A EF1979 ATPase, AAA family 
2059477 Insertion --  AA EF2155 Phosphoglucomutase family protein 
2117617 Insertion -  C EF2204 Aminopeptidase 
2232992 Deletion T  - EF2308 Hypothetical protein 
2234179 Insertion -  G IR ef2311-2312 - 
2234474 SNP C  G EF2312 DNA topoisomerase III 
2309182 SNP C  A IR ef2380-2381 - 
2323031 Deletion  C  - EF2399 Acetyltransferase 
2325873 Insertion -  G EF2405 Hypothetical protein 
2452948 Insertion -  C IR ef2528-2529 - 
2452957 Insertion -  C IR ef2528-2529 - 
2570780 SNP T  C IR ef2658-2659 - 
2578163 SNP C  G IR ef2665-2667 - 
2677895 Deletion  A  - EF2772 Drug resistance transporter 
3000492 Deletion  -  C EF3124 Polypeptide deformylase 
3015992 SNP T  A IR ef3142-3244 - 
3100859 Deletion  G  - EF3231 Ribosomal protein L13 
3125849 Insertion -  C EF3251 Hypothetical protein 
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Table S2. Strains used to study prophage genes distribution and cas genes presence. 
Strain Geographical 
origin  
Year of 
isolation 
Source CC ST C11 
599 - - - 16 16 + 
TX4244 Netherlands  1998 Fecal  27 27 + 
ATCC29200 Canada  <1974 Urogenital  21 21 + 
AR01/DG New Zealand  2001 Dog  108 108 - 
TX0031 USA <1993 Endocarditis 21 21 + 
ATCC29212 USA - Urine 30 30 - 
TX4248 Netherlands  2002 Seal  40 40 + 
E1Sol 
Salomon 
Islands 
1960s Fecal  93 93 + 
T8 Japan  <1992 Urine  8 8 - 
62 Norway 2002 Feces 66 66 - 
TX1467 - - Feces  40 40 + 
TuSoD USA <2009 Root canal 364 364 - 
TX1322 USA 1994 Feces 8 64 - 
TX4000 - <1974 - 8 8 - 
ATCC4200 - 1926 Blood  105 105 + 
TX0312 USA <1998 Urine  21 21 - 
HH22 USA 1981 Urine 2 6 - 
TX1341 USA 1994 Fecal  287 287 - 
HIP11704 USA 2002 Clinical  4 4 - 
TX0411 USA <1954 Clinical  8 90 - 
TX0855 Thailand  1980 Urine  4 4 - 
TX0635 USA 1986 Urine  9 9 - 
TX1342* USA 1994  Feces 134 134 - 
TX0470 USA 1963 Clinical  110 110 + 
TX0860 Thailand  1980 IV catheter  28 11 - 
D6 Denmark  - Pig  16 16 + 
TX2137 Spain  2001 Fecal  16 16 + 
TX0102 USA <2001 Endocarditis  21 21 + 
X98 - 1934 Fecal  19 19 + 
TX0017 USA 1992 Endocarditis  144 144 - 
T1 Japan  <1950 - 21 21 - 
TX0043 USA 1983 Endocarditis  19 19 + 
TX2141 Spain  2001 Blood 25 25 - 
JH1 UK <1974 Clinical  40 40 - 
Merz96 USA 2002 Blood  103 103 - 
TX0104 USA <2002 Endocarditis 2 2 - 
TX0309A USA <1996 Clinical 2 6 - 
TX0309B USA <1996 Clinical 2 6 - 
DS5 USA <1974 - 55 55 + 
TX0027 USA 1975 Endocarditis 55 55 + 
PC1.1 Australia  - Feces 40 40 - 
TX1346 - - - 192 192 - 
CH188 USA 1980s Liver 9 9 - 
TX0630 Argentina  1989 Blood 9 9 - 
TX0645 Lebanon  1989 Blood 23 10 - 
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Strain Geographical 
origin  
Year of 
isolation 
Source CC ST C11 
D32 Denmark  2001 Pig 40 40 + 
V583 USA 1987 Blood  2 6 - 
TX2134 Netherlands  1998 Fecal  30 30 - 
ERV103 - - - 238 238 - 
ERV116 - - - 238 238 - 
ERV129 - - - 238 238 - 
ERV25 - - - 238 238 - 
ERV31 - - - 238 238 - 
ERV37 - - - 238 238 - 
ERV41 - - - 238 238 - 
ERV81 - - - 238 238 - 
ERV85 - - - 238 238 - 
ERV62 - - - 238 238 - 
ERV63 - - - 238 238 - 
ERV68 - - - 238 238 - 
ERV72 - - - 238 238 - 
ERV73 - - - 238 238 - 
ERV93 - - - 238 238 - 
ERV65 - - - 238 238 - 
1CRISPR1.+ Present; - Absent. *TX1342 harbors a CRISPR3 locus. 
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Figure 1. E. faecalis V583 prophages. I (grey circle). Prophage induction and particle 
production. pp1, pp3, pp4, pp5, pp6 and EfCIV583 induction occurs spontaneously and 
can be enhanced by environmental cues such as antibiotics. pp1, pp3, pp5 and EfCIV583 
active particles are produced at different titers. II (blue circle). V583 prophage-prophage 
interactions: a) pp1 and EfCIV583 are involved in a phenomenon of molecular piracy in 
which EfCIV583 hijacks P1 structural proteins (Chapter 2); b) pp1 blocks pp4 excision at 
37°C; c) pp3 and pp5 block pp6 excision. III (red circle). Prophage contribution to bacterial 
biological traits. pp1, pp4 and pp6 contribute for V583 adhesion to human platelets, 
probably through the action of pbl genes, in a process that correlates with prophage’s 
ability to accomplish a full lytic cycle (Chapter 3).  
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Polylysogeny and prophage interaction networks  
 
The advent of whole genome sequencing revealed the extensive 
dynamic of bacterial genomes that can suffer accretion or reductive 
evolution depending on bacterial lifestyles. Accretions in genome size rely 
on the duplication or acquisition of exogenous genetic material, whereas 
reductive evolution relies on drift and deletions that remove nonfunctional 
DNA [1]. The larger genome size of free-living bacteria reflects frequent 
acquisition of new genes and greater need for metabolic versatility. On the 
contrary, the transition to intracellular lifestyle probably reduces the 
opportunity for gene uptake and imposes the need to retain the most 
essential functions [1]. Most of the bacterial species harbor prophage 
elements, and polylysogeny is frequently encountered among bacteria. 
The most extreme cases of polylysogeny are illustrated by Escherichia 
coli O157:H7 strains Sakai and K12 in which prophage genome elements 
represent 16% and 18% of the genome content, respectively [2,3]. 
Furthermore, the acquisition of multiple prophages plays a fundamental 
role in the emergence of pathogenic strains, as observed in Streptococcus 
pyogenes, for which the content of prophages accounts for up to 12% of 
the bacterial genome and correlates with the severity of the virulence [4].  
Enterococcus faecalis prophages are probably important for the 
evolution of the species as they account for an important part of the 
intraspecies variability [5,6]. In the V583 strain, seven prophage-related 
elements (pp1-pp7) are present, representing ~6.4 % of its total genome. 
pp2 is ubiquitous among E. faecalis strains; pp1, pp3, pp4, pp5 and pp6 
are excisable and participate in unanticipated prophage-prophage 
interactions; and pp7 was re-classified, based on our experimental 
evidences, as phage-related chromosomal island (PRCI) and renamed 
EfCIV583 [7]. Four phage particles are released and belong to P1, P3, P5 
and EfCIV583 (Figure 1.I). EfCIV583 is not only the first PRCI to be 
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identified in Enterococcus genus but it is also the first for which 
experimental evidences of molecular piracy have been provided in 
species other than Staphylococcus aureus. EfCIV583 hijacks P1 structural 
proteins in order to get its own genome packaged and probably 
disseminated (Figure 1.II). Although the resemblance with the molecular 
piracy system of S. aureus SaPIs and their helper phages are numerous 
[8,9], EfCIV583/P1 system is different in two main aspects: i) EfCIV583 
excises spontaneously through a helper phage-independent mechanism, 
whereas SaPIs are generally stably maintained into the bacterial genome 
through the action of a SaPI-encoded master repressor, which is 
inactivated by helper-phage specific antirepressors [10,11]; ii) EfCIV583 
DNA is packaged exclusively in the monomeric form while some SaPIs 
can have their DNA packaged in the monomeric form, into small capsids, 
or as multimers, into large capsids [12,13]. As SaPIs, EfCIV583 controls 
helper phage structural proteins and interferes with its helper phage titer. 
P1 titer is thus 10-fold lower than EfCIV583. Interestingly, although the 
proportion is maintained, in the context of the WT polylysogenic strain P1 
and EfCIV583 particles are released at lower amounts than by the 
dilysogen strain pp1+pp7+. This difference could be due to prophage 
within-host competition in the WT, which was showed to impair phage 
productivity in a polylysogenic strain of E. coli [14]. Interestingly pp4 and 
pp6 are kept silent through unknown mechanisms by pp1 and pp3/pp5, 
respectively (Figure 1.II). Prophages in a polylysogenic strain develop 
mechanisms to interact with each other in order to guarantee their vertical 
propagation. The fastest prophage to accomplish the lytic cycle dictates 
the time of lysis for all other prophages [15]. As none of the single 
deletions (pp3 or pp5) had effect on pp6 excision and pp3 and pp5 share 
the highest homology among V583 prophages, their ability to repress pp6 
excision might be redundant. Recently, a study described a mechanism of 
antirepressor-mediated control of prophage induction based on the 
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recognition of cognate and non-cognate repressors of Gifsy prophages in 
Salmonella [16]. This interaction could lead to the coordination of lytic 
cycles in a polylysogenic strain in order to give time to ‘slower’ phages to 
finish their cycles [16]. Prophage interference can influence strain’s 
behavior and impact on its fitness. Various types of prophage-prophage 
interactions occur within the prophage pool of E. coli O157:H7 strain 
Sakai, and these interactions promote the activity of strain defective 
prophages [2]. Furthermore, prophages can interact with other mobile 
genetic elements such as plasmid pCM194, which increases phage 
production of a SPO2 lysogen Bacillus subtilis strain [17]. It is the case of 
strain V583, which exhibits a lower efficiency of phage production 
compared to its plasmid-cured derivative. Moreover, prophages regulate 
host gene expression and improve the fitness of the lysogen under certain 
conditions, such as acid stress [18]. Actually, a prophage-encoded AraC-
like regulator, PatE, activates transcription of several acid resistance 
pathways in the enterohemorrhagic E. coli strain EDL933 [18]. Although 
this aspect of prophages interaction with their host was not addressed in 
this thesis, it might be relevant to determined V583 transcriptomes in the 
presence and absence of prophages.  
Within the polylysogenic strain V583, prophages interact with each 
other in order to get excised and produce phage active particles. Those 
interactions deserve further investigation that will allow determining the 
molecular mechanism underlying them. The identification of the 
enterococcal phage-related chromosomal island, EfCIV583, constitutes for 
us a major point of interest. Given PRCIs prevalence and impact on S. 
aureus virulence, it would be interesting to study PRCI distribution in 
enterococci and determine their impact for bacterial fitness. Regarding the 
molecular piracy phenomenon, several questions remain to be 
investigated namely the molecular partners, in both pp1 and EfCIV583, 
Chapter 4 
184 
coordinating the interference mechanism and the re-direction of the capsid 
size.  
 
Environmental cues involved in prophage induction  
 
Once the prophage state is established, prophages are stably 
maintained in the host cell by the expression of a repressor that blocks 
phage lytic cycle and provides immunity to the lysogenic strain against 
phage superinfection. pp1, pp3, pp5 and EfCIV583 of E. faecalis V583 
provide homo-immunity to their lysogenic host, which can constitute an 
advantage for the host in complex ecosystems. Prophages can switch 
irreversibly into the lytic development and release phage progeny under 
certain conditions, which generally trigger the SOS response [19]. This 
process allows prophages to sense host physiological state and escape 
bacterial cell death. Although the classical induction pathway involves 
RecA and the SOS response, in other cases it can occur independently 
[20]. Triggering signals for the SOS response are diverse and include 
exposure to DNA-damaging agents such as UV light, mitomycin C and 
certain antibiotics, reactive oxygen species, pressure and chelating agents 
[21-25]. Lambda and other lambdoid phages can be induced 
independently of RecA through the action of RcsABC system, which is 
involved in capsular polysaccharide synthesis [26]. RcsB and RcsC are 
members of a two-component system whereas RcsA is an additional 
transcriptional activator in. RcsA pathway is activated under high cell 
density mediated by a quorum-sensing effector (acyl-homoserine lactone) 
that upon binding to its receptor induces the switch into the lytic growth for 
E. coli λ prophage [27]. RcsA role in prophage induction may involve the 
regulation of an alternative RecA co-protease [20].  
Opportunistic bacteria are likely to face different stressful conditions 
imposed by their lifestyles: commensal and pathogen. In addition to the 
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stresses encountered in the human host, E. faecalis copes with several 
other environmental conditions that may induce its prophages. E. faecalis 
V583 prophages are induced spontaneously and their excision is globally 
enhanced by sub-inhibitory concentrations of ciprofloxacin, mitomycin C 
and trimethoprim, while temperature has different effects depending on 
the prophage. Fluoroquinolones and β-lactams are the most efficient 
phage-inducing antibiotics [28]. Ciprofloxacin is a fluoroquinolone 
antibacterial agent that traps DNA gyrase on DNA and blocks the 
replication fork movement, inducing the SOS-response [22]. Actually, 
increase of recA transcription was concomitant with phage induction in E. 
faecalis in presence of ciprofloxacin (data not shown), suggesting that this 
antibiotic induces V583 prophages through activation of the SOS-system. 
On the contrary, ampicillin had no inducing effect on V583 prophages or 
on recA transcription. Antibiotic-mediated induction of the SOS-response 
promotes the spread of virulence traits by generalized or specialized 
transduction in S. aureus [22] and E. coli [29]. Therefore, the use of SOS-
inducing antibiotics in hospital setting and for animal growth promotion 
has consequences both at the resistance level and for the dissemination 
of virulence traits [30,31]. Despite not being recognized as typical SOS-
system inducing condition, temperature can impact phage induction and 
activity. High temperature has the strongest negative effect on phage DNA 
packaging as illustrated for Escherichia coli (STEC) prophages [32]. 
Indeed, high temperature decreases excision efficiency of pp5 and 
EfCIV583 but provokes the release of pp4 from pp1 inhibitory effect, 
possibly due to thermosensitivity of pp1 repressor. 
Although poorly studied, spontaneous excision of prophages 
maintains a small but constant background of prophage particles and 
induces lysis on a fraction of the population. It also provides a competitive 
advantage for the lysogens by killing phage-sensitive strains [33,34]. 
Induction of prophages not only releases phage particles but can also 
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increase toxin production, which worsens the disease symptoms like 
Shiga toxin-encoding prophages [35,36]. V583 harbors three prophages, 
pp1, pp4 and pp6, carrying platelet-binding proteins (Pbl) involved in the 
adhesion to human platelets (Figure 1.III) and an ADP ribosyl-transferase 
(EFV toxin on pp1) [7,37]. EFV toxin expression in yeast induces cell 
death through its ADP ribosyl-transferase activity [37]. This family of 
toxins, which includes cholera and diphtheria toxins, damage host cells by 
mono-ADP-ribosylation of intercellular targets that are usually key 
regulatory proteins in the target cell [38]. Both pbls and efv genes are 
annotated as phage structural proteins and therefore they seem to have a 
dual role. As for Pbls, EFV toxin is non-classically secreted (without signal 
peptide) and it is likely released upon phage-induced cell lysis. 
Spontaneous induction of V583 prophages can release these genes into 
the different environments where the strain thrives and promote horizontal 
gene transfer. The work of this thesis reports a direct correlation between 
prophages harboring platelet-binding proteins and bacterial adhesion to 
human platelets. To improve our understanding of this phenomenon, it 
should be established whether PblA and PblB are involved in the 
phenotype and how pp4 and pp6, that are unable to complete a full lytic 
cycle, release their Pbls and thus contribute to platelet adhesion. Given 
the contribution of other virulence factors for E. faecalis adhesion to 
platelets, such as Ebp [39], the relative contribution of Pbls and those 
other factors should be determined. As adhesion to platelets is considered 
the first step towards development of infective endocarditis, 
monolysogenic strains for pp1, pp4 and pp6 should be tested in an 
infective endocarditis model [40]. However, the outcome of such test may 
depend on the specificity of the platelet receptors. 
In addition to the spreading of virulence factors, prophage excision 
can restore gene function or modify their expression [41-43]. In the case 
of E. faecalis V583 prophages, excision of pp4 restores an open reading 
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frame of an operon that encodes orthologs of a DNA uptake machinery 
[44]. Interestingly, Rabinovitch and colleagues recently reported that 
excision of the L. monocytogenes prophage φ10403S induces the 
expression of a DNA uptake machinery needed for intracellular growth 
[41]. Although, probably not functional in strain V583, due to a premature 
stop codon in another gene of the same operon [44], such a complex is 
likely to be expressed in strains devoid of mutation. Resemblance of the 
DNA uptake machinery with type IV secretion systems suggests that its 
expression may confer new biological traits. 
 
Bacteriophages in human associated microbial communities 
 
Understand lysogeny is extremely important due to prophages impact 
on host physiology, community composition in complex ecosystems and 
gene transfer. Recent metagenomic studies of different environmental 
niches as diverse as soil, ocean and human oral and intestinal microbiota 
have highlighted the importance of bacterial virome impact on microbial 
communities [45-48]. Interestingly, the microbial metabolic activities 
encoded by the viromes were broad and enriched in nucleic acid 
metabolism and virulence genes [45]. 
E. faecalis is a member of several human and animal associated 
microbial communities such the oral cavity and the gastrointestinal tract 
(GIT) [49,50], and E. faecalis phages have been found in root canals [51], 
saliva [52] and intestine [53]. Lysogeny state is favored under poor 
growing conditions due to nutrient limitations, and also lack of suitable 
hosts such as in human related microbial ecosystems [54]. As a member 
of the oral cavity microbiota and as a major cause of post-treatment 
endodontic infections, E. faecalis, similarly to S. mitis, has the potential to 
gain access to the bloodstream through the root canals [55,56]. 
Metagenome analysis of the oral cavity microbiota demonstrated that pblA 
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and pblB sequences are enriched in the oropharyngeal and saliva 
samples [48]. Prophages can also be induced with some ingested 
substances and represent a risk factor in the development of endocarditis 
[48]. Accordingly with these data, it is reasonable to think that the 
presence in the oral cavity of E. faecalis strains that harbor prophages 
carrying pbl genes could also represent a risk of infection. 
Prophages of commensal bacteria have the potential to shape the gut 
microbial communities and the resulting metabolic activities, as well as 
promote horizontal gene transfer. V583 prophages present a basal level of 
spontaneous excision, which is increased by environmental stress 
including antibiotics. It was reported recently that P1 and EfCIV583 may 
represent a competitive advantage to their hosts in the gut [57], however 
the phage-susceptible competitors they have used did not seem 
appropriate. Antibiotic pressure is an important driving force in bacterial 
evolution, and the extensive use of antibiotics that induce prophages can 
stimulate their dissemination and favor host fitness [30]. While we have 
shown that antibiotics and temperature influence prophage induction, 
other stress found in the GIT (e. g. physiochemical defenses of the host, 
including low pH of the stomach and elevated osmolarity) may also induce 
enterococcal prophages. Prophage induction can be thus a factor 
contributing to dysbiosis in the GIT due to their potential impact on the 
ratio between symbionts and pathobionts.  
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